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The discovery of regulatory elements that can direct tissue specific
expression to adipocytes has made possible experiments to study the function of
endogenous genes in fat metabolism and to assess the effect of these genes in other
metabolic pathways. It has also opened up the possibility of regulating the fatness of
laboratory and domestic animals by directing targeted expression of cytotoxic genes
to this tissue.
The present dissertation describes the use of a novel system to achieve
specific cell ablation in fat tissue. The method is based on the use of E.coli
nitroreductase (NTR) enzyme that activates certain nitro compounds into cytotoxic
DNA interstrand cross-linking agents. This system was assessed first in vitro, in a
preadipocyte cell line (3T3L1). Clones of cells that expressed NTR were
successfully killed after treatment with CB1954. It was confirmed that the
mechanism of cell killing involved is apoptosis and the presence of a cell-permeable
metabolite that is released to the medium triggering a bystander effect was observed.
This prodrug system was also assessed in vivo, for which transgenic mice
were generated expressing NTR specifically in adipose tissue under the control of
the aP2 promoter. Upon CB1954 treatment, transgenic mice showed extensive cell
depletion in different fat deposits, which was directly correlated to both the dose of
prodrug and the levels of NTR expressed. The present model provides a new
inducible approach to manipulate the number of adipocytes at different stages of the
mouse development and provides a new system for the study of fat metabolism
especially in abnormal conditions such as obesity and its modulation through the
manipulation of the target cell population.
Also reported are preliminary experiments to assess a novel system of
ablation mediated by the murine adapter molecule RAIDD. Stable cell lines were
generated to overexpress RAIDD after differentiation. A range of phenotypes was
observed with these clones from a complete blockage of the differentiation to the
killing of cells that escape the blockage. The present results suggest a new
developmental role for this gene and strongly encourage further experimentation to
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CHAPTER 1
1 INTRODUCTION.
1.1 THE BIOLOGY OF WHITE AND BROWN ADIPOSE TISSUE.
Obesity refers to a complex and heterogeneous group of disorders in which
there is an increase of the adipose tissue. This increase leads to a perturbation in the
general metabolic state and as a result, obesity is a major risk factor for a number of
clinical diseases, such as non-insulin-dependent diabetes mellitus (NIDDM),
cardiovascular diseases, hyperlipidemia and hypertension. Because of these
associated disorders, the life expectancy of obese people is greatly decreased. This
has motivated new directions of research aimed at understanding the mechanism
involved in the deposition and mobilisation of fat reserves. Many of these directions
are underpinned by genetic and molecular biological techniques. The recent
elucidation of the leptin pathway is a testament to the power of these new
technologies.
Adipocytes represent between one third and two thirds of the total number of
cells in adipose tissue. The remaining cells are various blood cells, endothelial cells,
adipose precursor cells of varying degree of differentiation and most likely
fibroblasts (Geloen et al. 1989). These cells serve an important function in the
energy economy of vertebrate organisms by providing a massive energy reserve that
can be mobilised upon demand. Thus when caloric intake exceeds expenditure,
metabolic flux is directed into pathways leading to triacylglycerol synthesis for
storage in the adipocyte. Conversely when caloric expenditure exceeds intake, this
energy reserve is mobilised to meet the deficiency and to provide needed
physiological fuel (i.e. free fatty acids) for other cell types. Each of these specific
lipogenic and lipolytic functions are realised by two types of adipose tissue known
as white adipose tissue (WAT) and brown adipose tissue (BAT). In contrast to the
development of BAT, which takes place mainly before birth, the development of
WAT represents a continuous process throughout life and the acquisition of fat cells
appears as an irreversible phenomenon. The capacity for white adipose tissue to
store fat is a function of the repertoire of fat-specific genes which provides those
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enzymes and proteins required for the transport and conversion of energy substrates
into fat and others which enable it to be mobilised for the energy needs of the body
(Kopecky et al. 1995). This function to store energy in its most concentrated form
makes the white adipocyte one of the most energetically efficient cells in the body.
Another adipocyte, the brown adipocyte, expresses a similar set of fat-specific genes
plus a few others that enable it to produce heat as its major function.
The brown adipose tissue (BAT) has been proposed to play an important role
in the regulation of energy balance (Himms-Hagen 1990). Unlike other tissues in
which fuel oxidation is linked to the energy needs of the cell, BAT is distinguished
by the unique presence of an uncoupling protein (UCP), a mitochondrial protein
transporter that uncouples oxidative metabolism from ATP synthesis. This capacity
permits BAT to expend calories unrelated to the performance of work, the net result
being the generation of heat. Thermogenesis in BAT is under the control of the
sympathetic nervous system via noradrenergic innervation of BAT cells (Himms-
Hagen 1990). The neural signals emanate from the hypothalamus and are
transmitted by the autonomic nervous system to regulate this highly innervated
tissue, which employs the uncoupling protein (UCP), a 32 kDa protein from the
inner mitochondrial membrane to uncouple mitochondrial respiration (Jezek et al.
1994). BAT activity is stimulated during cold exposure (non-shivering
thermogenesis) and during the ingestion of excess calories (diet-induced
thermogenesis). The role ofBAT in mediating diet-induced thermogenesis led to the
suggestion that BAT activity might provide protection from obesity. This was
recently demonstrated, using genetic ablation techniques to generate mice with
isolated brown fat deficiency (Lowell et al. 1993). Regulatory elements from UCP
gene were used to direct the expression of the A subunit of diphtheria toxin to the
brown fat. At the age of 16 days transgenic mice had markedly decreased functional
brown fat mass, which was accompanied by moderate obesity, with a 31% increase
in total body lipid. But as the transgenic mice aged, they showed excessive weight
gain compared with control littermates and developed obesity in the absence of
hyperphagia demonstrating the decreased energy expenditure of these mice.
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1.2 ADIPOCYTE DEVELOPMENT AND TRANSCRIPTIONAL CONTROL
IN VITRO.
The availability of immortalised cell lines (such as 10T1/2 stem cell line and
the 3T3 and OB 1771 preadipocyte lines), which represent different stages of
adipocyte development, has greatly facilitated the characterisation of the
differentiation program and the identification of many cis-regulatory elements and
trans-acting factors involved in the coordinate expression of adipocyte genes during
differentiation. Adipogenesis in vitro follows a highly ordered and characterised
temporal sequence. Initially, there is growth arrest of proliferating preadipocytes,
usually achieved in culture cell lines after contact inhibition. In culture cells models,
initial growth arrest is induced by the addition of a prodifferentiative hormonal
regimen, which includes insulin, glucocorticoids and an agent that increases the
intracellular level of cAMP. Upon induction (day 0 in Figure 1.1), the cells undergo
one or two additional rounds of cell division known as clonal expansion then
become quiescent as the coordinate transcriptional activation of adipocyte genes is
initiated and acquire early markers but do not yet accumulate triacylglycerol.
C/EBPp and C/EBP8 are expressed immediately following hormonal induction of
differentiation. These two synergistically stimulate the expression of C/EBPa and
peroxisome-proliferator-activated receptor y (PPARy) both of which contain C/EBP
binding sites in their promoters. While C/EBPa can also induce expression of
PPARy, C/EBPP is probably the initial inducer since it is expressed before C/EBPa
in the differentiation program (see Figure 1.1). The induction of these two proteins
is characterised by a second, permanent period of growth arrest followed by
expression of fully differentiated phenotype. The exact mechanism by which PPARy
and C/EBPa bring about this change is unclear, but several important clues have
appeared recently. In 3T3L1 cells, the shift from dividing preadipocytes to growth-
arrested cells to fully differentiated fat cells was associated with changes in the
expression of several cyclin-dependent kinase inhibitors, pi8, p21 and p27
(Morrison and Farmer, 1999). The expression of PPARy in NIH-3T3 fibroblast
specifically induced pi8 and p21. C/EPBa has also been shown to have antimitotic
properties (Umek et al. 1991).
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The process of terminal differentiation occurs over several days in cultured
cell lines. This is followed by the appearance of PPARy and C/EBPa, which activate
de novo or enhance the expression of most or all of the genes that characterise the
adipocyte phenotype. C/EBPa activates the expression of several adipocytes specific
genes, a number of which have been found to have C/EBP binding sites in their
promoter (Herrera et al. 1989). Some of these genes include glycerophosphate
dehydrogenase, fatty acid synthase, acetyl CoA carboxylase, Glut 4, insulin receptor
and aP2 (the adipocyte-selective fatty acid binding protein) (Spiegelman et al. 1993).
PPARy also transactivate the expression of some of these genes whose promoters
contain regulatory elements for PPARy. This process of terminal differentiation
leads to the formation of triacylglycerol-filled, mature adipose cells that are
accompanied by the emergence of a2-adrenergic-mediated antilipolytic response
(Ailhaud et al. 1992). Throughout this process, lipid-laden droplets begin to appear
in the cytoplasm, and over time they increase in size and often coalesce into one or











Figure 1.1 Expression of C/EBP and PPAR family members during
differentiation of 3T3L1 preadipocytes. Magnitude of expression is indicated by
the intensity of the horizontal band. (Modified from Mandrup and Lane, 1997).
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1.3 HORMONAL REGULATION OF THE DIFFERENTIATION PROCESS.
After cell attachment in the presence of serum and the formation of an
extracellular matrix, growth of adipoblasts and commitment to preadipose cells
takes place in the presence of a few growth factors; insulin at high concentrations or
IGF-I at low concentrations and basic fibroblast growth factor (bFGF) (Gaillard et
al. 1984). Adipogenic hormones are only required subsequently for the terminal
differentiation of preadipose to adipose cells, which corresponds to the formation of
new fat cells. Among the circulating hormones, GH, acting as a protein kinase C
(PKC) activator by means of diacylglicerol production from phosphatidylcholine,
with activation of PKC pathway, is required for the terminal differentiation of 3T3-
F442A and Ob 17 cells, whereas in the presence of IGF-I, the adipogenic activity of
GH can be mimicked by other PKC activators. Triiodothyronine (T3) also appears to
be implicated in the terminal differentiation of Ob 17 and 3T3L1 cells.
Glucocorticoids, including the synthetic glucocorticoid dexamethasone, stimulate
terminal differentiation of 3T3L1 and Ob 17 preadipocytes as well as that of
preadipocytes from rabbit and human (Hauner et al. 1989). Insulin modulates
positively the differentiation program by affecting the expression of various proteins
involved in triacylglycerol accumulation, such as GLUT4, fatty acid-synthesising
and esterifying enzymes. Although a few differences can be observed between
different species, the most common requirements for terminal differentiation appear
to be IGF-I, insulin and glucocorticoids.
1.4 ADIPOSE TISSUE DEVELOPMENT IN VIVO.
During development the adipocyte acquires the full complement of enzymes
and accessory proteins with which to carry out and regulate these lipogenic and
lipolytic functions (Cornelius et al. 1994). The regulatory proteins include the
receptors and second messenger system necessary to confer responsiveness to the
hormones that regulate these processes e.g. insulin, which promotes lipogenesis, and
counter-regulatory hormones such as glucagon, ACTH, epinephrine and
glucocorticoids, which promote lipolysis. Although adipose tissue appears late in the
embryonic development, the major expansion of the adipocyte population occurs
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only after birth. This expansion coincides with the need for an energy reserve
enabling the newborn to survive in a new environment in which the intervals
between nutrient intake may be lengthy. The adipose lineage arises relatively late in
the developmental pathway from a multipotent stem cell of mesodermal origin that
also gives rise to the muscle and cartilage lineages. Previous studies on the
development of white adipose tissue (WAT) and to a lesser extent of brown adipose
tissue (BAT) have led to much controversy regarding the existence of distinct
precursor cells and the interchangeability between both tissues. Most recent
evidence supports the view that BAT and WAT are distinct organs containing
distinct adipose precursor cells. At the cell level, the existence of distinct BAT
precursor cells is demonstrated by their unique ability to express the uncoupling
protein (UCP) gene (Kopecky et al. 1990). The anatomical location in various
species indicates that BAT occurs at specific sites, for instance in interscapular and
axillary regions, whereas WAT occurs also at specific but distinct sites e.g.
subcutaneous, omental, perirenal and inguinal depots. The development of BAT and
WAT in uterus and postnatally differs according to animal species. After birth, the
growth of the various WAT depots has been shown in different animal species to
respond differentially to age, diet and cold exposure. White adipose tissue cannot be
detected macroscopically during embryonic life and at birth in rodents (rat, mouse),
whereas it is present at birth in the pig, rabbit, guinea pig and humans. The
development of white adipose tissue has been studied in pig fetuses (Hausman G.J.
1987). Approximately at the beginning of the last third of the gestation period, large
and small arterioles can be detected in the vicinity of small developing fat cell
clusters that are surrounded by extensive stroma. Cell cluster size increases steadily
with fetal age, but the number of clusters does not change significantly before birth.
The embryonic development of human adipose tissue takes place earlier than
that of the pig, i.e. at the beginning of the second third of the gestation period in
various sites (buccal, neck, shoulder, gluteal, perirenal) (Burdi et al. 1985). Adipose
tissue appears and develops in those areas where it remains after birth. Postnatal
development of adipose tissue shows sex and site-related differences in body fat
distribution in human and various animal species. The ability of adult rodents and
human to increase the number of adipocytes depending on the localisation of the fat
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depot, the nature of the diet, and the environmental conditions to which the animals
were exposed, has been long known (Miller et al. 1983). Some controversy exists,
however, as to whether the formation of new fat cells takes place during refeeding
after a prolonged period of food deprivation. The hyperplastic development of
adipose tissue in aging animals fed a high-carbohydrates or high-fat diet has
thoroughly been studied. Miller et al. (1983) demonstrated the ability of rats to
increase the fat cell number in most of their adipose depots (retroperitoneal,
perirenal) in response to high-carbohydrates or high-fat diet. The life-long potential
to make new fat cells has been clearly illustrated in rodents. For instance, the
perirenal fat depots of very old mice from both sexes contain large amounts of early
markers of differentiation, i.e. A2COL6/pOb24 mRNAs, LPL mRNAs and IGF-I
mRNAs, indicating that preadipocytes at stages 2 and 3 are indeed present in these
depots (Ailhaud et al. 1990). A similar conclusion has been found in humans, where
a significant proportion of stromal-vascular cells from subcutaneous fat tissue of
elderly men and women was found to differentiate in vitro into adipose tissue cells
(Hauner et al. 1989). This finding indicates that adipose precursor cells, which are
not likely to give rise to new fat cells, are indeed present in those individuals. This
observation can also explain the acquisition of new fat cells, which is known to take
place at the adult stage in normal subjects and obese patients.
2. GENERAL ASPECTS OF CELL ABLATION.
2.1 INTRODUCTION.
The mechanisms governing organogenesis and other morphogenetic
processes in higher organisms involve complex interactions among different cell
types. Both intrinsic and extrinsic factors may act to determine cell fate, rendering it
difficult to discern the role that individual processes play in effecting cell
commitment. The ability to ablate specific cell types during development provides
an experimental approach for investigating these processes and assessing the
specific contributions that cellular interactions play in determining cell fate.
Although developmentally related, tissues may remain near one another in the adult
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animal, it is also common for cells to relocate far from their initial origins. Thus, it is
not possible to determine lineage relationships by examining adult tissues. A useful
method for investigating the role of a specific cell type is to remove them and
determine what effect this has on the normal organogenesis. This can be achieved by
genetic ablation approaches, which uses transgenic technology to direct expression
of intracellular toxins to certain cells during development (Breitman et al. 1987).
This approach allows then to determine how the loss of these cells affects the
development of the animal (Evans G. 1989, Palmiter et al. 1987, Camper et al.
1995).
The programmed ablation of specific cell types by genetic approaches
provides a novel means of generating mutant animals that lack a specific cell type or
an entire cell lineage. These animals thus provide a novel approach for asking
questions about the role of specific cell types in physiological processes and cell fate
during embryogenesis. As well, animals that lack specific cell types can be used to
create models of certain human diseases.
The ablation of specific cell types in a transgenic animal relies on the fact
that virtually all differentiated cell types in the body can be characterised by the
expression of highly specialised proteins whose synthesis is restricted to that cell
type. Through the use of gene transfer into various cell types in culture and more
importantly into the mouse germ line, it has become clear that there exist cis-acting
sequences located around the coding regions of genes that are responsible for
ensuring that developmentally regulated genes are expressed in the appropriate cell
types at the appropriate times during both embryological development and during
cellular differentiation in the adult. The cis-acting sequences responsible for
programming gene expression can be identified and dissected away from the
structural regions of a gene and used to direct the expression of heterologous
sequences, regardless of chromosomal location, in transgenic mice. Thus, cis-acting
regulatory elements can be used to target expression of genes that encode toxic
proteins to specific cell types in transgenic animals. Cancer chemotherapy provides
a promising area where genetic ablation can be used. In this case, retroviral-
mediated gene transfer could be used for the transduction of functional foreign
genes into human cancer cells. If the inserted gene codes for drug sensitivity,
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administration of an appropriate drug will selectively kill those cells expressing the
gene.
2.2 STRATEGIES FOR GENETIC ABLATION.
Two main approaches have been generally used to achieve selective cell
ablation. Physical methods, which involve physical destruction of target cells, as for
example the UV-laser ablation (Lohs-Schardin et al. 1979), dye photo ablation
(Miller and Selverson, 1979), current intracellular injection (Kuwada and Goodman,
1985), surgery (Smith TJ, 1989) and genetic ablation methods, which involve
targeting expression of a potentially lethal toxin to a specific cell type in transgenic
mice using appropriate gene promoter/enhancer.
With this last method, two main strategies have been devised to generate
selective ablation of different cell types in transgenic mice. One involves the
expression of toxin genes, such as the A subunit of diphtheria toxin or the A subunit
of ricin. Expression of the transgene provides high levels of the toxin and results in
cell death in all toxin-expressing cells. The second strategy involves the use of an
enzyme-prodrug combination, which involves expressing a gene encoding an
enzyme that converts an inactive prodrug to a cytotoxin. The most widely used gene
in this approach is the thymidine kinase (tk) gene (Borreli et al. 1989) from herpes
simplex virus, whose expression in animal cells and animals is only toxic in the
presence of certain nucleoside analogous that can be metabolised only by the herpes
enzyme.
More recently, a new system for achieving the inducible ablation of specific
cell types in transgenic mice has been developed (Clark et al. 1997). The system is
based on the E.coli nitroreductase enzyme (NTR), which activates certain nitro
compounds such as the antitumor drug CB1954 to potent cytotoxic agents. The
compounds generated are secondarily activated in cells by thioesters to very reactive
species that cross-link DNA (Knox et al. 1993). DNA cross-linking results in cell
death that is independent of cell division.
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2.2.1 TOXINS.
a) The A subunit of diphtheria toxin:
Diphtheria toxin (DT) is synthesised by Corynebacterium diphtheriae (the
causative agent in human diphtheria) as a precursor polypeptide that is secreted and
enzymatically cleaved into two fragments, of 193 and 342 aminoacids (designed A
and B chains), joined by a disulphide bridge (reviewed by Pappenheimer, 1977).
The B subunit binds to the surface ofmost eukaryotic cells, where it is internalised
by endocytosis and delivers the A chain (DT-A) into the cytoplasm. DT-A then
catalyses the transfer of ADP-ribose from NAD to a modified histidine residue on
elongation factor 2, thereby inhibiting protein synthesis and resulting in the cell
death (Collier, 1975; Mohering et al. 1984; Kohno et al. 1986). Thus, the expression
of the A subunit in eukaryotic cells, in the absence of the B subunit, results in cell
death without killing neighbouring cells due to the release of the A subunit from
dying cells. Once inside, the DT-A is extremely toxic: a single molecule has been
shown to be enough to kill a cell (Yamaizumi et al. 1978).
The extreme toxicity of DT-A provides a powerful way of killing cells that
express this protein. However, the exquisite sensitivity of eukaryotic cells to DT-A
poses a potential problem, since its use for genetic ablation requires absolute lineage
or cell type specificity of the promoter/enhancer used to drive expression in
transgenic mice. Because of the extreme lethality, it is important to have very
restricted expression of the targeted toxin. Low levels of expression in tissues
required for fetal survival can lead to the death of the entire transgenic animal
instead of producing selective ablation of the targeted cell type. Additionally, many
genes are normally expressed at low level in a diverse set of tissues. Thus, death of
the animal could result from an appropriate low level of transgenic expression. One
way to avoid this has been to use an attenuated form of the diphtheria toxin, tox 176
(see below).
b) Attenuated diphtheria toxin (tox 176):
Tox 176 has a single aminoacid substitution (G/D) which makes it -30 fold less
active (Breitman et al. 1990). This attenuated toxin has been successfully used in
transgenic toxin studies (Lowel et al. 1990; Breitman et al. 1990 and Ross et al.
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1993), but limited comparative information has been available, with the only
exception perhaps being the work of Burrows et al. (1996). They prepared
constructs using 4.6 kb of the a-GSU promoter to direct expression of both forms of
the diphtheria toxin to pituitary gonadotrope and lactotrope cells and compared
viability and ablation efficacy between the two sets of transgenic mice. These
authors found that the attenuated version of the diphtheria toxin gene is a better
choice for transgenic toxin studies because of its decreased lethality and equivalent
ablation. In contrast, Lowell et al. (1993) observed regression of the phenotype in
mice after ablation of the brown fat tissue with this attenuated toxin, an effect that
was not observed with the diphtheria toxin A subunit. Thus, what has been proved
successful in some cases may not necessary work in others.
c) Ricin:
Ricin is produced by the castor bean Ricinus communis as a nontoxic precursor
preproricin that is processed and activated by protease activity (Sandvig and Olsnes,
1982). Mature ricin consists of a 262 aminoacid B polypeptide, containing
galactose-specific cell-surface binding and membrane translocation activity,
disulphide cross-linked to a 267-aminoacid toxic A subunit, which is a N-
glycosidase specific for A4324 of ribosomal 28S RNA (Endo et al. 1987).
Internalisation of the A subunit, mediated by cell-surface binding of the B subunit,
catalytically destroys ribosome function and blocks protein synthesis. In the absence
of the binding and internalisation functions inherent in the B subunit, the ricin A
subunit remains in the extracellular space where its toxicity is extremely low (Pastan
et al. 1986). This property is important for the precision of genetic ablation in
transgenic mice, because the release of endogenously synthesised A chain during
genetically programmed cell death will not kill surrounding cells.
2.2.2 ENZYME PRODRUGS COMBINATIONS,
a) Thymidine kinase (fk)-Gancyclovir system:
In this strategy it is possible to control the timing of ablation by administering
the prodrug at appropriate times. Expression of HSV-tk is not by itself, harmful to
cells, but it is capable of selectively catalysing the incorporation of certain
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nucleoside analogues, such as l-(2-deoxy-2fluro-P-D-arabinofuranosil)-5-
iodouracil, gancyclovir and acyclovir, into host cell DNA resulting in cell death.
Limitations of this approach are ectopic expression in the testis, which results in
difficulties in the establishment of breeding lines (Al-Shawi et al. 1991) although a
new truncated version of the herpes simplex thymidine kinase gene has recently
demonstrated to allow the generation of fertile homozygous mice (Cohen et al.
1998). Another drawback is the belief that HSV-rfr kills only proliferating cells but
not differentiated cells. However, this view has also been challenged by a number of
workers who have described effective inducible ablation in tissues with low mitotic
indices (Wallace et al. 1991; Allen et al. 1995). In these cases the mode of action of
the activated prodrug is not clear, although in non-proliferating thyrocytes it
apparently occurs by p53-independent apoptosis (Wallace et al. 1996).
b) Nitroreductase (NTR)-CB1954 system:
One of the main drawbacks of the inducible system described earlier is the large
dose of active drug that needs to be present for long periods in order to produce
cytotoxicity. In addition to this, non-cycling cells are resistant to these agents.
Alkylating agents, on the other hand, do not suffer from these intrinsic drawbacks. A
suitable prodrug-enzyme combination using one of these alkylating agents (NTR-
CB1954 system) has demonstrated that can generate highly cytotoxic species, which
are not cell cycle specific. Furthermore these species may have a bystander effect so
that they migrate and kill surrounding cells, non-infected tumour cells, in the case of
gene therapy or non-expressing cells when used to ablate specific normal cells, for
example in a transgenic animal model (Knox et al. 1988; Clark et al. 1997; Drabek
etal. 1997).
Whilst chemically only a monofunctional alkylating agent (by virtue of its single
aziridine function), CB1954 exhibited a dramatic and highly selective activity
against the rat Walker 256 tumour (a rat mammary gland tumour cell line) and could
actually cure this tumour. The hope that a human tumour could be found that shared
the Walker tumour's sensitivity has made the mechanism of action of CB1954 the
focus of continual research for over 30 years (for a review see Knox et al. 1993a).
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Although CB1954 showed high sensitivity to Walker tumour cells both in vitro
and in vivo, it was soon established that CB1954 was ineffective in a range of
animals and human tumours (Workman et al. 1986). Roberts et al. (1986) shown
that the basis of this sensitivity is that CB1954 can form DNA interstrand cross¬
links in Walker cells but not in insensitive cells. All steps in the bioactivation of
CB1954 have been elucidated and the intermediates synthesised and studied for
biological activity. The initial step is the reduction of CB1954 (Figure 1.2) by the rat
form of the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC
1.6.99.2 to form 5-aziridin-l-yl-4-hydroxylamino-2-nitrobenzamide (Knox et al.
1988). This is the active derivative of CB1954, which can then react with thioesters
in the cytosol of the cells to produce DNA reactive species, that form DNA
interstrand cross-links (Knox et al. 1991). The major product of this reaction is
however 4-amino-5-(aziridin-l-yl)-2-nitrobenzamide that does not react readily with
DNA and therefore is in competition with the production of DNA binding products










THIOESTER e.g. Acetyl CoA
O-C- CH,
NH,
Figure 1.2. Bioactivation ofCB1954 by the DT-diaphorase.
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These DNA interstrand cross-links are formed with very high frequency and
can contribute up to 70% of the total lesions (Friedlos et al. 1992). These interstrand
cross-links formations are generally accepted as the most toxic lesion, being poorly
excised by the cell and therefore inhibiting DNA function resulting in cell death.
The marked increased cytotoxicity ofCB1954 has been suggested to be due to some
unusual properties of these interstrand cross-links. In fact, molecular modelling
studies carried out by Friedlos et al. (1992) showed that the 4-hydroxylamine, (after
activation as detailed above) reacts predominantly with the C8 position of
deoxyguanosine, thus leaving the aziridine function in the DNA available to react
preferentially with the 06 position of a deoxyguanosine on the opposite strand of
DNA.
A number of human cell lines were shown to contain DT diaphorase levels
comparable to those found in Walker and some other rat cell lines (Boland et al.
1991). The rat cell lines were all sensitive to CB1954 and the resulting cell killing
approached that obtained in Walker cells. Human cell lines however, were much
less sensitive to CB1954 with 500 to 5000 higher dose of the agent being required to
produce a comparable cytotoxic response. In contrast, both the rat and human cell
lines were similarly affected by the 4-hydoxylamino derivative of CB1954 (Boland
et al. 1991). This fact showed that the resistance to CB1954 was not due to any
failure to activate further the hydroxylamine or to an intrinsic resistance to the DNA
adducts formed. It was therefore suggested that CB1954 was reduced differentially
by the human form of DT diaphorase as compared to the rat form (Boland et al.
1991). The human form of DT diaphorase was purified to homogeneity from Hep
G2 cells and significant differences could be observed in its ability to reduce
CB1954 to the active 5-(aziridin-l-yl)-4-hydroxylamino-2-nitrobenzamide
derivative as compared to the rat form. Although, both forms of the enzyme
produced the 4-hydroxylamino derivative as the single product, the human Hep G2
form of the enzyme was intrinsically less able to carry out this reduction and the Kcat
value was over six-fold higher for the Walker cell form of the enzyme (4.1 min"1)
than for the human DT diaphorase (0.64 min"1) (Boland et al. 1991). The intrinsic
inability of human DT diaphorase to produce the required cytotoxic species from
CB1954 accounts for the lack of sensitivity of human cells towards this agent. To
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overcome this intrinsic resistance of human cells to the prodrug CB1954, it has been
proposed that the activating enzyme could be targeted towards a human tumour by
conjugating it to a localising antibody, such a strategy is known as antibody directed
enzyme prodrug therapy or ADEPT therapy (Knox et al. 1993). For this approach a
nitroreductase enzyme has been purified and cloned from E.coli (Anlezark et al.
1992).
NTR like DT diaphorase is also capable of reducing CB1954 in air to 5-
(aziridin-l-yl)-4-hydroxylamino-2-nitrobenzamide (Knox et al. 1992). In contrast to
DT diaphorase, which can only reduce the 4-nitro group of CB1954, NTR can
reduce either (but not both) nitro groups of CB1954 to the corresponding
hydroxylamino species, these are formed in equal proportions and at the same rate.
However, no products are formed in which both nitro groups have been reduced.
Thus, once one nitro group has been reduced, NTR can not then reduce the other
nitro group (Knox et al. 1992). 5-(Aziridin-l-yl)-4-hydroxylamino-2-
nitrobenzamide is a potent cytotoxic drug capable of producing DNA-DNA
interstrand cross-links in cells (Knox et al. 1988). In contrast the 2-hydroxylamino
species is less cytotoxic and can not produce interstrand cross-links. It is however,
much more cytotoxic than CB1954 itself (Knox et al. 1988). CB1954 is reduced
about 90-fold more rapidly by NTR than by DT diaphorase (Figure 1.3).
NHOH NOj
Figure 1.3 Bioactivation ofCB1954 by the E.coli nitroreductase.
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As well as being able to reduce CB1954, NTR shares some other
biochemical properties with DT diaphorase. It can reduce menadione and utilises
either NADH or NADPH as a cofactor. However, it is a much smaller protein
(24kD) than DT diaphorase (33.5kD) and there is no obvious sequence homology
between the two enzymes (Anlezark et al. 1992).
Recently, new possibilities for the use of CB1954 have arisen with the
advent of antibody-directed enzyme prodrug therapy or ADEPT (Knox et al. 1993)
and gene-directed enzyme prodrug therapy or GDEPT (Connors TA 1995). In these
approaches either E.coli nitroreductase or the gene encoding this enzyme are
delivered to the tumour site where they locally activates a prodrug. Bridgewater et
al. (1995) have used a recombinant retrovirus encoding the E.coli NTR gene to
infect mammalian cells. Murine (NIH3T3) cells expressing NTR were killed by the
prodrug CB1954, demonstrating that the system is effective in non-cycling cells. In
the same report NTR expression in human melanoma, ovarian carcinoma or
mesothelomia cells also rendered them sensitive to CB1954 killing. A number of
studies attempting gene delivery to tumours in vivo have shown that a proportion of
cells remain unmodified (Ram et al. 1993). Gene delivery is probably limited both
by the efficiency of various current gene delivery technologies and by restricted
access to some tumour regions. Thus, a desirable feature of enzyme/prodrug
combinations for use in GDEPT is that the killing of modified cells result in the
killing adjacent unmodified cells. This "bystander" effect described with TK/GCV
system (Freeman et al. 1993) was also observed by Bridgewater et al. (1995).
Improved cytotoxicity and bystander killing was achieved by simultaneous
use of both NTR/CB1954 and TK/GCV systems. Two other articles showed the
potential of the NTR/CB1954 system not just in cells in culture but also in vivo
(Clark et al. 1997; Drabek et al. 1997). Both groups directed expression of the
bacterial enzyme to specific cellular targets by placing the gene under the
transcriptional control of tissue-specific elements. In the work of Clark et al. (1997)
the ovine P-lactoglobulin promoter directed expression of the luminal cells of the
mammary gland whereas in Drabek et al. (1997)'s studies control elements of the
human CD2 locus restricted nitroreductase expression to T cells. This targeted
destruction of particular cell types allowing the ablation of selected tissues offers a
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powerful tool for many types of studies. Though, as both groups point out, it is the
possibility of using the nitroreductase (NTR) gene in anticancer therapy, which
appears to offer greatest promise.
The cytotoxic effects of the prodrug in a mouse model in vivo were observed
relatively shortly after prodrug administration, i.e. by 48 hr (Clark et al. 1997).
Following drug administration in vitro Drabek et al. (1997) observed morphological
changes in murine L cells, that included the generation of enlarged mulinucleate
cells. The authors proposed that the changes could be due to a block in DNA
synthesis with continued RNA and protein synthesis. DNA strand breaks and
interstrand cross-links were observed in CB1954-treated cells (Clark et al. 1997)
suggesting that these may be involved in the mechanism of cytotoxicity. As a
consequence of these lesions in the genome of the cells a possible mechanism of
apoptosis has been suggested to be involved. Thus, Drabeck et al. (1997) who
targeted NTR expression to T cells using the CD locus control region (LCR),
reported an increased proportion of apoptotic thymocytes in CB1954 treated mice
relative to controls. The same group suggested that the killing of non-expressing B
cells was a consequence of an in vivo bystander response while in Clark's studies
mammary luminal cells were ablated leaving closely associated myoepithelial cells
unaffected. Clearly the underlying fact is what may be a desirable attribute under
one set of circumstances need not be so desirable under other circumstances. Thus in
cell-lineage studies the aim would be to minimise the bystander effect whereas in
tumour destruction the aim would be to maximise the response. These two studies
clearly demonstrated the feasibility to of the NTR/CB1954 system to kill specific
cells in an animal model.
3 IN VIVO ABLATION.
3.1 INTRODUCTION.
A number of systems have been described where complete cell lineages have
been ablated in transgenic mice, that carry constructs in which a cellular toxin is
linked to a tissue-specific promoter (as it as been described above). Such
experiments with the diphtheria toxin A and elastase I promoter have succeeded in
ablating the exocrine pancreas (Palmiter et al. 1987), and with the toxin and the
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promoter for crystalline to have resulted in destruction of lens tissue (Breitman et al.
1987). The reader is referred to Berstein and Breitman, (1989) for a comprehensive
review, as this chapter will only describe the ablation of the pituitary gland as an
example where by using some of the systems described above it has been possible to
develop models for analysis of very specific interactions between cells of the
pituitary gland. More detail will be given on the description of the studies of
ablation and manipulation of the adipose tissue stores, as it is the most relevant
example to this project.
3.2 PITUITARY ABLATION.
The anterior pituitary gland (or adenohypohysis) develops from an
ectodermal bend that protrudes from the roof of the oral cavity and becomes
juxtaposed to a neuroectodermal extension from the base of the brain. The posterior
pituitary synthesises and secretes polypeptide hormones such as growth hormone
(GH), prolactin (PRL), gonadotropins (FSH and LH), corticotropin (ACTH) and
thyrotropin (TSH) (Simmons et al. 1990). The hormones of the mature pituitary are
expressed in a specific temporal pattern during the organogenesis, with the entire
complement present at birth. The ordered appearance of these cell types has made
the anterior pituitary an interesting model for studying cell lineage relationships.
One approach to examining the origins of various cell types in the pituitary has been
the generation of transgenic mice in which the expression of Diphtheria toxin A
chain (DT-A) gene has been targeted by the growth hormone (GH)
promoter/enhancer sequences, (Behringer et al. 1988). In this study a line of
transgenic mice was established which lacked detectable levels of circulating GH.
This deficiency resulted in dwarfism, and a very marked reduction in the number of
GH-positive somatotrope cells in the pituitary. There was also a large decrease in
the number of lactotropes in these mice, suggesting that both somatotropes and
lactotropes derive from a common precursor cell. Later, Borrelli et al. (1989)
generated transgenic mice carrying the herpes tk gene under the control of either the
rat growth hormone (GH-/£) or the rat prolactin (PL-tk) promoter. Treatment of the
GW-tk mice FIAU resulted in dwarfism and ablation of both somatotropes and
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lactotropes. In contrast, transgenic mice expressing HSVl-t/c in the lactotropes
treated with FIAU had anatomically and histologically normal pituitaries. On the
basis of these observations, the author concluded that somatotropes and lactotropes
derived from a common cycling stem cell pool that is already committed to GH, but
not prolactin expression. This was thought to be due to the fact that prolactin
expression is activated postmitotically in the lactotropes so making them refractory
to cell killing.
3.3 ADIPOCYTE ABLATION AND TRANSGENIC AND KNOCKOUT
RODENT MODELS OF ALTERED BODY FAT DISTRIBUTION.
3.3.1 INTRODUCTION.
The ability to genetically alter the expression of adipocyte genes and control
the fatness of feed animals remains as an important goal of agricultural research.
Adipocytes play a central role in maintaining the energy balance of vertebrate
animals. These cells store energy in the form of triglycerides during periods of
nutritional abundance and release it in a biochemical useful form at times of
nutritional deprivation. Overall excess of body fat as well as regional adiposity are
recognised risk factors for type 2 diabetes, dyslipidemia, hypertension, and coronary
heart disease. Other disorders with extreme abnormalities in body fat distribution,
such as familial and acquired lipodystrophies, are also frequently associated with
marked insulin resistance, early-onset diabetes mellitus, hypertriglyceridemia, and
low serum concentration of high density lipoprotein (HDL) cholesterol (Foster, D.
1998).
Earlier attempts to reduce adiposity have included the use of hormones such
as growth hormone and (3-adrenergic agonists due to their lipolytic and thermogenic
properties. Both schemes have been shown to improve carcass composition (Futter
and Flint 1987), however they are not free of unwanted side effects (Warriss et al.
1990) and increased consumer resistance has ended with these approaches being
banned, for agricultural purposes, in Europe and other countries. This situation
directed the attention of some researches to develop new technologies to overcome
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some of the problems associated with the use of hormones. One of such approaches
includes the use of antibodies to target adipocytes for destruction with the immune
system (Flint et al. 1986). These early studies were conducted in rats using
antibodies to adipocytes plasma membranes raised in sheep. Injection of antibodies
produced a significant decrease in adiposity mass for up to 8 weeks (Futter and
Flint, 1987). Furthermore, beneficial effects, in agricultural context, could also be
observed in terms of increased appetite, protein deposition and feed conversion
(Panton et al. 1990), which has extended the focus of attention of this technology to
other species including sheep, pigs, chickens, and rabbits (for review see Flint DJ,
1996).
Recently, great progress has been made in identifying several genes and
understanding the molecular mechanisms underlying spontaneous syndromes of
obesity and abnormal body fat distribution in animal models and humans. Progress
has also been made in establishing transgenic animal models with altered body
adiposity and peculiar body fat distribution similar to that seen in familial forms of
human lipodystrophy. Table 1.1 displays several mouse models with either
transgenic or knockout of specific genes that alter the amount or the distribution of
body fat. These animal models not only reveal that certain genes may affect body
adiposity by influencing energy balance, but also indicate the critical role of genes
in adipocyte proliferation and differentiation.
Table 1.1 Transgenic and knockout models of obesity and altered body fat
distribution.
Models with Increased Body Fat or Obesity.
Overexpression ofglut-4 gene in adipose tissue.
Overexpression ofAGRP gene.
Ablation of brown fat.
Inactivation ofGH transgene.
Knockout of neuropeptide Y-Yl receptor gene.
Knockout of (33-adrenergic receptor gene.
Knockout ofMc4-r gene.
Knockout of ICAM-1 gene or integrin a-Mp2 gene.
Knockout of bombesin receptor subtype-3 gene.
Knockout ofPPARa gene.
Knockout of 5-HT2 serotonin receptor gene.
(Shepherd et al. 1993)
(Graham et al. 1997)
(Lowell et al. 1993)
(Pomp et al. 1996)
(Kushi et al. 1998)
(Susulic et al. 1995)
(Huszar et al. 1997)
(Dong et al. 1997)
(Hamazaki et al. 1997)
(Costet et al. 1998)
(Tecott et al. 1998)
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Models with Decreased Body Fat or Lipodystrophy.
Antibodies to adipocytes membranes.
Overexpression of LPL gene in muscle and cardiac
tissues.
Overexpression of (31- adrenergic receptor gene.
Overexpression of uncoupling protein gene.
Overexpression ofA-Zip/F gene.
Overexpression ofnSREBP-lc gene.
(Flint et al. 1986)
(Levak-Frank et al.
1995)
(Soloveva et al. 1997)
(Kopecky et al. 1995)
(Moitra et al. 1998)
(Shimomura et al.
1998)
(Katz et al. 1995)
(Wang et al. 1995 and
Tanaka et al. 1997)
(Bunger et al. 1998)
(Cummings et al. 1996)
(Dinulescu et al. 1998)
Knockout of the glut-4 gene.
Knockout ofC/EBPa, (3, 6 genes.
Ablation of thyroid hormone production.
Knockout ofRII (3 subunit of protein kinase A gene.
Knockout ofmg gene.
(Adapted from Chen and Garg 1999)
Studies of the differentiation of adipocytes in vitro have shown that this
process is accompanied by the transcriptional activation of many genes, some of
which have been cloned at cDNA level (Spiegelman et al. 1983; Chapman et al.
1984). As expected, many of these encode gene products that are involved in lipid
metabolism. One of these gene products is adipocyte P2 (aP2), a very abundant
adipocyte-specific member of the large family of intracellular lipid carrier proteins
that includes the liver, heart and intestinal fatty acid binding proteins (Cook et al.
1988). The gene for adipocyte P2 (aP2) has been used as a model for understanding
gene regulation in this cell type. Ross et al. (1990) found the first cis-acting
regulatory sequences that can specifically direct gene expression to adipocytes in
vivo. In that report, they found that the specific expression of the gene for aP2 in
adipocytes derives from an enhancer element at kilobase (kb) -5.4 that directs linked
chloramphenicol acetyltransferase (CAT) marker gene expression very strongly and
specifically to fat tissue. Further analysis of this fragment defined a smallest
fragment (-4.9 to -5.4) to the distal end of the 5.4 kb fragment as the primary
determinant of the tissue-specific expression of this gene. This 500 bp enhancer
directed expression of the CAT gene in a differentiation-dependent fashion when
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linked to its own minimal promoter and stimulated very strong and highly specific
expression from CAT gene in the adipose tissue of transgenic mice. Since its
identification, this enhancer has been used in transgenic animals to direct adipose-
specific expression of a number of genes that alter the biological function of this
tissue including, SV40 large T antigen (Ross et al. 1992), diphtheria toxin A chain
(Ross et al. 1993), and the insulin sensitive glucose transporter GLUT4 (Shepherd et
al. 1993).
Multiple cis-acting elements within the 518 bp enhancer have been shown to
be important for its differentiation-dependent activity in cultured 3T3-F442A
preadipocytes and adipocytes. Initial studies identified a binding site (ARE1) for a
member of the NF-1 transcription factor family. This NF-1 site appears to contribute
to the overall activity of the enhancer, but is not functional as an isolated element,
and the enhancer retains differentiation-dependent activity in the absence of this site
(Graves et al. 1991). Further analysis established the presence of 4 additional cis-
acting elements, each of which is also required for full enhancer activity in transient
transfection assay (Graves et al. 1992). One pair of elements, ARE2 and ARE4,
binds a ubiquitous positive-acting factor termed ARF2. A second pair of elements,
ARE6 and ARE7, binds a separate nuclear factor termed ARF6 that is detected in
nuclear extracts derived from adipocytes. Cloning of this factor identified it as a
heterodimer consisting of PPARy (Peroxisome proliferator-activated receptor) and
its obligate partner, RXR (retinoid X receptor) (Tontonoz et al. 1994). These
findings constituted the demonstration of the first adipocyte specific transcription
factor. Thus, the demonstration that this DNA element directs strong and specific
expression to adipose cells in vivo has opened up the possibility of experiments to
genetically manipulate the adipose tissue in vivo. Some of these experiments include
the delivery of toxic genes to the adipose tissue (Ross et al. 1993, Burant et al.
1997), expression of transgenes that can alter the amount or distribution of body fat
by influencing energy balance, or disrupting adipocyte differentiation or
proliferation (Soloveva et al. 1997, Moitra et al. 1998, Shimomura et al. 1998) and
finally the delivery of transgenes that are non-toxic themselves but that can be
activated by the downstream administration of a substance (prodrug) that make them
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capable of selective cell killing once they are activated as it is the NTR-CB1954
system (Clark et al. 1997) that was used in this research project.
3.3.2 MICE MODELS WITH REDUCED ADIPOSE TISSUE STORES.
Ross et al, (1993) developed a mouse model with reduced adiposity to
investigate the interrelationships between excessive adipose tissue mass and the
disorders associated (diabetes, hypertension and hyperlipidemia). Reduction of the
adipose tissue was achieved by the targeted expression of an attenuated diphtheria
toxin A chain (described above) to adipose tissue, using the 5' regulatory region of
the adipocyte P2 (aP2) gene. Transgenic mice with high levels of toxin expression
developed chylous ascites and died shortly after birth. Transgenic mice expressing
lower levels of the transgene had normal adiposity and survived to adulthood,
however, these mice showed a loss of adipose tissue while they aged, which was
accompanied by a progressive increase in serum glucose and insulin levels that
culminated in the development of frank diabetes at approximately 8 months of age.
Other characteristics of these mice were a complete resistance to chemically induced
obesity. Nevertheless, these animals developed hyperlipidemia equal or greater than
their non-transgenic obese littermates. Despite these diabetic symptoms, the authors
could not pin down the link between the lack of fat and diabetes because these mice
did not lose fat cells until they reached middle age.
Two recent experiments do a better job in reducing fat from animals. Both
Shimomura et al. (1998) and Moitra et al. (1998) genetically blocked the growth of
fat cells by altering transcriptions factors, proteins that turn genes on or off and are
crucial to cell growth and differentiation. Moitra et al. inactivated the genes of two
families of transcription factors that normally help fat cells grow and develop. They
used tissue-specific expression of a dominant-negative protein transgene termed A-
ZIP/F, that inhibits the DNA binding and function of B-ZIP protein in both the
C/EBP and AP-1 families of transcription factors. Shimomura et al. on the other
hand, altered the gene for another transcription factor so that the cells would
overexpress it. Both mutations were designed to affect only fat cells, as the
regulatory elements of the aP2 gene were again used in these studies to get the
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specific expression in the fat cells. The changes produced by these two teams have
similar effects: The mice were born with little or no white adipose tissue. The
transgenic mice also failed to develop mature brown fat, which normally serves as a
warming function in hibernating animals. Many of the animals died before they
reached adulthood, but those that survived developed diabetes. Their cells no longer
responded properly to insulin, as a result insulin levels in the bloodstream were
increased up to 442 times normal levels for some mice and glucose levels at least
tripled. Like human diabetics, the animals also had high levels of triglycerides and
other fat building blocks in their circulation, and their organs became enlarged with
the liver showing the presence of triglycerides.
3.3.3 MICE MONOGENIC MODELS OF OBESITY.
Body weight and body composition have been extensively studied in mice as
model mammalian quantitative traits (Falconer, 1992). However, the number,
location, and effects of individual genes contributing to variation in those traits are
mostly unknown. A number of well described spontaneous monogenic rodent
models of obesity syndromes have been known for decades, but only in the last 7
years have the molecular basis and the underlying pathophysiological mechanisms
of obesity in these animals been elucidated.
a) The agouti gene mutation.
Agouti was the first of the obesity genes to be cloned (Bultman et al. 1992)
and encodes a novel 131 residue secreted protein a, agouti signalling protein (ASP).
The mRNA has been detected in many tissues although it is only known to function
in the skin of wild-type mice in the neonatal period (Yen et al. 1994). It induces
pheomelanin production in melanocytes to form the characteristic banded pattern of
coat hair (yellow subapical band in black and brown hair). Dominant mutations,
such as Ay and Avy, in the promoter region of the agouti gene result in its ectopic
overexpression in all tissues (Bultman et al. 1992). Mice with this mutation exhibit
24
yellow coat colour, hyperphagia, obesity, increased lean body mass,
hyperinsulinemia and infertility (Yen et al. 1994).
b) The tubby gene mutation (tub).
This phenotype is due to a point mutation that results in an error in the
transcript splicing and the loss of the carboxyl terminus of the protein product
(Kleyn et al. 1996). The mice homozygous for tub mutation develop late-onset
obesity without diabetes (Coleman and Eicher, 1990). Affected mice also develop
slow-onset deafness and retinal degeneration. This is in contrast to obese and
diabetes mice that begin rapid weight gain soon after birth. Although tubby obese
phenolype is inherited in a recessive manner, some significant differences have been
observed in plasma triglycerides and susceptibility to arteriosclerosis in
heterozygous mice.
c) The carboxypeptidase E (Cpe) gene mutation (fat).
The mutation underlying the fat phenotype has been shown to be within the
gene encoding carboxypeptidase E (CPE), a prehormone-processing enzyme. The
T729C nucleotide point mutation in Cpe gene causes a Ser202Pro substitution in
CPE and renders this protein enzymatically inactive. CPE is present in many tissues,
including the brain, pituitary, pancreas, and adrenals and is involved in the post-
translational processing of many pro-hormones and neuropeptides, including
proinsulin and POMC (Cool et al. 1997, Cool et al. 1998). Mice with homozygous
fat mutation develop late-onset obesity, infertility, and hyperproinsulinemia
(Coleman and Eicher, 1990).
d) The leptin (Lep) gene mutation (ob).
Recessive mutations in the mouse obese gene results in early-onset obesity in
a syndrome resembling morbid human obesity (Coleman and Burkart, 1977). In
addition, affected mice exhibit hyperphagia, hypothermia, hypercorticosteronemia,
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decreased linear growth, and infertility (Coleman and Burkart, 1978). Cross-
circulation experiments (parabiosis), over 20 years ago, suggested that the obese
gene was likely to encode a circulating factor acting on a receptor (encoded by the
diabetes gene) to regulate food intake (Pelleymounter M, 1995). The obese gene
was eventually cloned in 1994 and the protein product named leptin (Zhang et al.
1994).
The Lep gene encodes a 167 amino acids (16 kD) protein, member of a class
I of cytokine superfamily. The ob mutation is a single base substitution (C428T) that
results in premature termination of the protein synthesis at codon 105 (Zhang et al.
1994). Although ob trait is autosomal recessive, mice heterozygous for lep mutation
(06/+) are more obese and hypoleptinemic than the wild-type (+/+) littermates
(Chung et al. 1998).
Leptin is secreted by both white and brown adipose tissue cells in proportion to
fat mass (Flier J.S, 1997). Leptin administration normalises all aspects of obesity
and diabetes syndrome and restore reproductive function in ob/ob mice by acting
through leptin receptors in the central nervous system (Campfield et al. 1995,
Pelleymounter et al. 1995).
c) The leptin receptor (Lepr) gene mutation (db).
Mice carrying mutations at the diabetes locus exhibit a very similar phenotype to
obese mice but they are resistant to leptin (Coleman, 1978; Pelleymounter et al.
1995, Halaas et al. 1995). The mutation resides in leptin receptor, a member of
class-1 cytokine receptor family. Leptin receptor exists in several isoforms due to
alternative splicing of the transcript. Ob-Rb, the long form expressed most highly in
the hypothalamus, is the main isoform mediating leptin signalling. It consists of a
large extracellular domain, a single transmembrane domain, and an intracellular
domain that contains a motif important for interaction with Janus kinase (JAK) and a
motif of signal transducer and activator of transcription (STAT). The mouse and the
human leptin receptor (OB-R) molecules share 71% identity in intracellular domain.
The db mutation is a single base substitution (G-T) in the intracellular domain of ob-
Ra, which creates a splice site homologous to that in the intracellular domain of ob-
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Rb. This results in the insertion of the C-terminus of ob-Ra into the cytoplasmic tail
of ob-Rb transcript and subsequent premature termination of the ob-Rb synthesis
(Lee et al. 1996).
4 AIMS AND APPROACHES OF THE PROJECT.
The general aim of this project was to assess the efficacy of CB1954
mediated ablation in adipocytes by directing the expression of the E.coli ntr gene to
the adipose tissue using an adipocyte specific promoter. It was envisaged that an
inducible model for the adipocyte ablation would provide a novel system for the
study of fat metabolism and it would allow to investigate the interrelationship
between excessive adipose tissue mass and the disorders associated (diabetes,
hypertension, hyperlipidemia) through manipulation of the target cell population.
It was anticipated that such system would overcome some of the problems
normally encountered with other suicide systems and provide a more flexible model
where to study the physiology of adipose tissue at different stages of the mouse
development including in utero, juvenile and adult. The system to be described is
cell-type specific, it is effective in non-dividing cells and cell killing is inducible
therefore this system affords the practical advantage of allowing stable pedigrees to
be established before the initiation of the ablation studies. It also provides the means
to control the timing and duration of toxic insult and to assess the potential for
recovery of an ablated cell population after a prodrug free period in the transgenic
animal.
This thesis also describes the preliminary experiments carried out in 3T3L1
cells to assess a novel approach of cell-mediated ablation, which was envisaged it




2. MATERIALS AND METHODS
2.1 DNA MANIPULATION.
2.1.1 RESTRICTION DIGESTION OF PLASMID DNA.
Digestions of DNA with restriction endonucleases were carried out
according to the conditions recommended by the manufacturers. Restriction
enzymes were supplied by Boehringer Mannheim, NEB and Gibco BRL. Normally,
1 pg of DNA was digested in 10-20 pi volumes, using 1-2 units of enzyme for 90
minutes. When two different enzymes were used, both of which required the same
buffer, the digests were carried out simultaneously. Otherwise, the lower salt
concentration digest was carried out first and then the salt concentration increased
for the second digest. When necessary, the reactions were terminated by heating to
68°C or 80°C for 15 minutes, according to the heat sensitivity of the enzyme.
Restriction digests, which were to be run on gels, were terminated by addition of 0.1
volume of "stop mixture" (100 mM EDTA, pH 8.0, 20 % Ficoll and 0.1 % orange
G).
2.1.2 ISOLATION OF DNA FRAGMENTS FROM AGAROSE GELS.
DNA fragments were purified using the QIAquick gel extraction kit
(QIAGEN) according to the instruction of the manufacturer. Briefly, after running
the DNA sample, the gels were viewed on a middle range UV transiluminator and
the required fragments excised in the smallest possible amount of agarose, using a
sterile scalpel blade. The exposure to UV light was kept at a minimum in order to
prevent excessive nicking of the DNA. The excised agarose containing the DNA
fragment was weighed and 3 volumes of Buffer QG was added to 1 volume of gel
(100 mg~100 pi) then incubated at 50°C to dissolve the gel. After dissolving the gel
completely 1 volume of isopropanol was added, mixed and then the sample bound to
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the QIAquick column by centrifuging at 12,000 rpm for 1 minute. The flow-through
from the column was discarded and the column washed with 750 pi of buffer PE, by
centrifugation at 13,000 rpm for 1 minute. The flow through was again discarded
and the column spun for a further 1 minute at 13,000 rpm to ensure that buffer PE is
washed from the column so the salts of this buffer will not interfere with later steps.
The column was then placed into a clean 1.5ml microcentrifuge tube, to collect the
purified DNA. To eluate the purified DNA from the column, 30-50 pi of dH20 was
added and left for 1 minute before centrifuging at 13,000 rpm for 1 minute. The
purified DNA eluated from the column was then stored at -20°C.
2.1.3 BLUNT ENDING OF DNA.
Klenow enzyme was used to fill in recessed 3' terminal created by digestion
ofDNA with restriction enzyme. 0.5 pg of DNA was blunt ended with 2.5 units of
Klenow enzyme (Boehringer Mannheim), 5x buffer L, (10 mM Tris-HCl, 10 mM
MgCb, 1 mM Dithiothreitol, pH 7.5), along with 2 mM of each dNTP. The reaction
was incubated for 30 minutes at R.T. and then stopped by adding 1 pi of 0.5 M
EDTA.
2.1.4 REMOVAL OF 5' PHOSPHATE GROUPS FROM DNA.
The dephosphorylation of DNA for the purposes of minimising
recircularisation of vector DNA was accomplished by treating the restricted DNA
with calf intestinal phosphate (CIP) (Boehringer Mannheim). 10-20 pg of plasmid
DNA was digested with a two-threefold excess of restriction enzyme until digestion
was complete. The sample was then extracted with an equal volume of
phenol ".chloroform and the remainder of the DNA was then precipitated by addition
of 2.5 volumes of ethanol. After 20 minutes on ice the DNA was recovered by
centrifugation for 30 minutes at 12,000 rpm. The DNA was then resuspended in
90pl of T.E. buffer (pH 8.0). 10 pi of lOx CIP dephosphorylation buffer (10 mM
ZnCb, 10 mM MgCh, 100 mM Tris-HCl pH 8.3) was added to the sample along
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with 2 units of CIP enzyme. This was incubated at 37°C for 60 minutes. After
incubation EDTA (pH 8.0) was added to a final concentration of 5mM and the
reaction heated to 85°C for 15 minutes to inactivate CIP. The solution was then
extracted with phenol and phenohchloroform. DNA was then precipitated by
addition of 0.1 volumes of 3 M sodium acetate (pH 7.0) and 2.5 volumes of ethanol.
The DNA was recovered by centrifugation at 12,000 rpm. The pellet was washed in
70 % ethanol, air dried and the DNA resuspended in T.E. buffer (pH 8.0).
2.1.5 LIGATION OF COHESIVE AND BLUND TERMINI.
Rapid DNA Ligation kit was used as follows: Insert DNA and vector DNA
were mixed on ice normally in a ratio 1:3 vector to insert. 100 to 150 ng of DNA
mix was used, and made up to 10 pi with lx DNA dilution buffer (Boehringer
Mannheim). After mix thoroughly 10 pi of T4 DNA ligation buffer and 1 pi of T4
DNA Ligase were added to this reaction. The ligation reaction was mixed
thoroughly again and incubated at R.T. for 5 minutes and then 5 pi used to transform
E.coli DH5 a competent cells (see section 2.1.6). In blunt-end ligations -200 ng of
DNA was used and incubation time extended to 30 minutes.
2.1.6 TRANSFORMATION OF COMPETENT CELLS WITH PLASMID
DNA.
An aliquot of competent cells (E.coli DH 5 a purchased from Life
Technologies, Inc.) was thawed on ice, and then the transforming DNA (usually 5 pi
of the ligation reaction) was added, mixed with 50 pi of the cells and left on ice for
30 minutes. This was then incubated at 42°C for 45 seconds before being placed
back on ice for a further 2 minutes. The cells were swiftly mixed with 1 ml of L-
broth, transferred to a microfuge tube and left at 37°C for 60 minutes. After the
incubation step, the cells are centrifuged for 1 minute at R.T. followed by
resuspension of the pellet in approximately 200 pi of medium. This is then pippetted
onto the surface of the L-agar, and is spread by a sterile bent glass rod until the
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liquid has thoroughly soaked into the agar. The plates are then inverted and
incubated for 12-16 hours at 37°C.
2.1.7 PREPARATION OF AGAR PLATES.
LB bottom (1 % w/v Tryptone, 0.5 % w/v yeast extract, 1.5 % w/v agar, 0.2
% w/v MgCb x 6H2O, 0.1 M NaCl) was melted and cooled to 37°C before adding
(50 pg/ml) ampicillin. Agar plates were poured using aseptic technique and allowed
to set. Unused plates could be stored for approximately 2 weeks at 4°C.
2.1.8 SMALL SCALE PREPARATION OF PLASMID DNA.
The desired colony on an agar plate was used to inoculate 5ml of LB-media
plus antibiotic and was grown at 37°C overnight with continuous shaking at 250
rpm. 1.5ml of each culture were decanted into eppendorf tubes and centrifuged at
13,000 rpm for 10 seconds to pellet the cells. After removal of the supernatant the
pellet was then resuspended in 200 pi of solution I (50 mM Glucose, 25 mM Tris-
HC1 pH 8.0, 10 mM EDTA, and 2 mg/ml fresh made lysozyme) by vortexing. Next,
200 pi of freshly prepared solution II (1 % SDS, 0.2 M NaOH) was added, mixed
gently by inverting. This step is required for bacterial cell wall lysis and for DNA
denaturation. To neutralise, 200 pi of 3 M KAc (pH 4.8) was then added mixed
thoroughly as before and left on ice for 10 minutes. The tube was then centrifuged
for 5 minutes at R.T. at 13,000 rpm. The supernatant was retained and the cellular
debris discarded. The DNA was then precipitated, by adding 600 pi of 100 %
isopropanol and storing on ice for 10 minutes. The precipitate was spun for 8
minutes at 13,000 rpm at 4°C, and the supernatant discarded. The pellet was then
washed briefly in 500 pi of 70 % ethanol, re-spun at 13,000 rpm for 5 minutes at
4°C and dried to be then resuspended in appropriate volume of buffer T.E.
supplemented with DNase-free pancreatic RNase (20 pg/ml).
31
2.1.9 LARGE SCALE PREPARATION OF DNA.
Plasmid DNA was purified in large scale using the Qiagen Plasmid Kit
(MAXI 25). The Qiagen plasmid purification protocol is based on a modified
alkaline lysis procedure followed by binding of plasmid DNA to Qiagen anion-
exchange resin under appropriate low salt and pH conditions. RNA, proteins and
low molecular weight impurities are removed by a medium salt wash. Plasmid DNA
is eluted in high salt buffer then concentrated and desalted by isopropanol
precipitation.
The selected bacterial colony was grown overnight at 37°C in 200 ml
standard LB medium plus the appropriate antibiotic in a shaking incubator (220
rpm). The culture was then centrifiiged at 6000 rpm for 15 minutes at 4°C. The
supernatant was drained by inverting the open centrifuge tube. The bacterial pellet
was then completely resuspended in 10 ml of Buffer PI (50 mM Tris-HCl, pH 8.0,
10 mM EDTA, 100 pg/ml RNase A). This was followed by addition of 10 ml of
Buffer P2 (200 mM NaOH, 1.0 % SDS). After gentle mixing the bacteria were left
to lyse the cells at R.T. for 5 minutes. Subsequently, 10 ml of chilled Buffer P3 (3.0
M potassium acetate, pH 5.5) were added, the solution mixed by inversion for 5-6
times and then incubated on ice for 20 minutes. The lysate was centrifuged in a non
glass tube at over 15,000 rpm for 30 minutes at 4°C. The clear supernatant was
removed promptly and filtered over a prewetted folded filter.
Qiagen-tip columns (one per each culture) were equilibrated by applying 10
ml of Buffer QBT (750 mM NaCl, 50 mM MOPS, pH 7.0, 15 % ethanol, 0.15 %
Triton X-100), which was allowed to drain by gravity. The filtered supernatant was
then loaded onto the column and allowed to enter the resin by gravity flow. The
Qiagen-tip column was washed twice with 30 ml ofBuffer QC (1.0 M NaCl, 50 mM
MOPS, pH 7.0, 15 % ethanol). Finally the plasmid DNA was eluted by gravity from
the column with 15 ml of Buffer QF (1.25 M NaCl, 50 mM Tris-HCl, pH 8.5, 15 %
ethanol). The DNA was then precipitated with 10.5 ml (0.7 volumes) of isopropanol
at R.T. The precipitate was centrifuged immediately at 11,000 rpm for 30 minutes at
4°C. Supernatant was carefully removed and DNA was washed with 5 ml of 70 %
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ethanol, allowed to air dry for 5 minutes and resuspended in a suitable volume of
H20.
2.1.10 PURIFICATION OF DNA.
a) Phenol/chloroform extraction.
To remove proteins from DNA samples, the DNA was extracted twice with a
mixture containing a phenol/chloroform (1:1). Normally, 0.1 volume of the organic
mixture was added to the tube, followed by a brief vortexing and then centrifugation
at 11,000 rpm for 2 minutes. The upper aqueous layer was then carefully removed,
avoiding the protein precipitate at the interface between the 2 layers. The DNA was
then recovered by ethanol precipitation as detailed below.
b) Ethanol precipitation.
To concentrate DNA and remove salts 0.1 volume of 5 M sodium acetate
(pH 5.5) and 2 volumes of 100 % ethanol were added to the DNA solution in a
microfuge tube. The contents of the microfuge tube were mixed and chilled at -70°C
for 1 hour. The tube was then centrifuged at 11,000 rpm for 15 minutes at 4°C.
Supernatant was poured off and the pellet washed in 70 % ethanol, re-spun and
finally resuspended in the desired volume of dH20 or buffer T.E.
2.1.11 CONCENTRATION OF DNA.
The DNA concentration and purity was estimated by measuring absorbance
ratio at 260/280nm. In general highly pure DNA has a 260/280nm ratio >1.8, while
protein contamination lowers this ratio. The quality of DNA was checked by
running a mini-ethidium bromide agarose gel. Typically a 5 pi aliquot of the
plasmid and 5 pi loading dye (40 mM EDTA, 0.1 %SDS, 30 % w/v Ficoll and 1.2
mg/ml bromophenol blue) was loaded and run on the gel.
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2.1.12 PURIFICATION OF TRANSGENE FRAGMENT FOR
MICROINJECTION.
The 6.95 kb aP2-NTR fragment was isolated from the plasmid by double
digestion Sal I/Not I and purified using a QiaQuick spin gel extraction kit as
described in section 2.1.2. Approximately 5 pg of DNA was used in the digestion.
The transgene was resuspended in low salt buffer (0.2 M NaCl, 20 mM Tris-HCl pH
7.4, 1 mM EDTA) and purified by phenol/chloroform extraction (see above 2.1.10).
The concentration (60 ng/pl) was estimated by comparison with a standard of
known concentration on a 1% agarose gel.
2.2 NUCLEIC ACID ANALYSIS.
2.2.1 ISOLATION OF MOUSE-TAIL GENOMIC DNA.
Five weeks old mice were anaesthetised and l-2cm tail biopsies taken for
preparation of genomic DNA according to the method described by Laird et al.
(1991). The biopsies were incubated in 0.5 ml digestion buffer (100 mM Tris-HCl
pH 8.5, 5 mM EDTA pH 8.0, 200 mM NaCl, 0.2 % SDS and fresh 100 pg
Proteinase K/ml) overnight in a shaking incubator at 55°C. Tail residues were
centrifuged for 5 minutes at 13,000 rpm in a microfuge at 4°C and the supernatant
decanted into 0.5 ml of isopropanol, inverted several times until threads of DNA
were visible. The DNA is recovered by lifting the aggregated precipitate from the
solution using a disposable yellow tip. Excess of liquid is dabbed off and the DNA
is dispersed in a prelabelled tube containing an appropriate volume of T.E.
Complete dissolution of the DNA required incubation for a few hours at 55°C. The
DNA was then stored at -20°C and used for PCR and/or Southern blotting.
2.2.2 ISOLATION OF GENOMIC DNA FROM LIVER.
Liver samples that were kept in liquid nitrogen were thawed into a Dounce
homogeniser with 3ml of ice cold RSBE (10 mM Tris, 10 mM NaCl, 2 mM EDTA
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pH 7.4) plus 0.5 % NP40 and homogenised with as few strokes as possible.
Homogenates were transferred to a 13 ml plastic Sorval tube, spun down at 4,500
rpm 5 minutes at 4°C. Supernatant was then poured off and the pellet resuspended in
3 ml of RSBE plus NP40 as above. The samples were re-spun and the pellet washed
3 times with the same solution as above. Then, the pellet was resuspended in 3 ml of
RSBE, resuspended completely before 3 ml of SNET (1 % SDS, 0.6 M NaCl, 10
mM EDTA, 20 mM Tris) were added. 40 pi of Proteinase K (10 mg/ml) were added,
mixed by inversion and incubated at 37°C overnight or at 55°C for 2 hours.
Proteinased samples were extracted with an equal volume of phenol:chloroform
(1:1), and the final extract precipitated with an equal volume of isopropanol. The
visible clump of white strands of DNA was pulled out of the solution using a heat
sealed pasteur pipette. DNA was dipped/washed into 75 % ethanol and allowed to
air dry before being resuspended in approximately 1 ml ofT.E. buffer.
2.2.3 ISOLATION OF GENOMIC DNA FOR DNA FRAGMENTATION
ASSAYS.
Cells were harvested by centrifugation at 200 x G for 10 minutes. The pellet
was lysed with 0.4 ml hypotonic lysing buffer (10 mM Tris, 1 mM EDTA, pH 7.5)
containing 0.2 % Triton-X 100, and the lysates were centrifuged at 13,000 x G for
10 minutes to separate intact from fragmented chromatin. The supernatant,
containing fragmented DNA, was placed in a separate microfuge tube. The pellet
was digested as described in section 2.2.1 (above) and the supernatant was
precipitated overnight at -20°C in 50 % isopropanol and 0.5 M NaCl. The
precipitate was pelleted by centrifugation at 13,000 x G for 10 minutes, air-dried,
and resuspended in appropriate volume of T.E.
2.2.4 ISOLATION OF TOTAL RNA FROM CULTURED CELLS.
The extraction of total RNA from cultured cells was performed using
RNazolB (Biogenesis, Poole, UK), which promotes the formation of complexes of
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RNA with guanidinium and water molecules and abolishes hydrophilic interactions
of DNA and proteins. During the extraction step the RNA remains in the aqueous
phase, separated from DNA and proteins. Cultured cells (confluent flasks with
n
approximately lx 10 cells) were washed once in PBS and harvested by
trypsinisation. The cells were pelleted by centrifugation at 1,000 rpm for 5 minutes
and the supernatant removed. The cells were then lysed by resuspending in 1ml of
RNAzol B. The RNAzol B solution containing the resuspended cultured cells was
transferred to a screw-cap micro fuge containing lOOpl of chloroform. The tube was
inverted repeatedly for 15 seconds and placed on ice for 15 minutes, then
centrifuged at 13,000 rpm for 15 minutes at 4°C. The aqueous phase was transferred
to a fresh tube where it was washed twice in 70 % ethanol and then vacuum-dried.
The pellet was then left to dissolve overnight in 50-100 pi ofDEPC treated dH20 at
4°C.
The concentration of RNA was measured by reading the absorbance of 1 pi
in 200 pi dilution in DEPC treated dH20 at 260 nm wavelengths. The concentration
was then calculated in mg/ml by multiplying the A26o nm of the diluted sample by
10. The ratio A260:A280, indicating a measure of the quality of RNA, was
considered optimal within a range of 1.6 to 2.0.
2.2.5 ISOLATION OF TOTAL RNA FROM TISSUES.
Epididymal fat pads as well as other tissues were removed and snap frozen in
liquid nitrogen. Total RNA was isolated using the RNAzol B method (Biogenesis,
Poole, UK) as described above for cells.
2.3 ELECTROPHORETIC TECHNIQUES.
2.3.1 AGAROSE GEL ELECTROPHORESIS OF GENOMIC DNA.
DNA molecules were separated according to their size on horizontal agarose
gels. The percentage of agarose used to make the gel was dictated by the size of the
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range of the DNA molecules to be resolved. Digested genomic DNA or plasmid
DNA were commonly run on 1 % agarose gels, whereas smaller fragments were run
on 1.5-4 % agarose gels. All agarose gels were made and run in lx TAE (40 mM
Tris-acetate, 2.5 mM EDTA pH 7.7). To stain the DNA, ethidium bromide was
added to a final concentration of 1 pg/ml. The gel was poured and allowed to set
before submerging in lx TAE running buffer. Blue/Orange loading dye was added
to the DNA at 1 pi per 10 pi sample volume prior to loading the sample onto the gel.
Either minigels (30 ml agarose solution) or midi gels (120 ml agarose solution) were
run at 40-100V depending on resolution and run-time required. DNA fragments
were visualised on a mid-range UV transiluminator and photographed using video
copy processor (Mitsubishi).
2.3.2 FORMALDEHYDE GEL ELECTROPHORESIS OF TOTAL RNA.
RNA molecules were separated by electrophoresis on 1.5 % denaturating
MOPS-formaldehyde agarose gels (0.02 M 3-N-[morpholinol] propanesulfonic acid,
5 mM sodium acetate containing 6.8 % (v/v) formaldehyde essentially as described
by Sambrook et al. (1989). Agarose was dissolved in dH20, left to cool to 50°C,
then the formaldehyde solution and lx MOPS were added. The gels were left to set
and then loaded in a fume hood. The RNA sample to be loaded onto the gel (5-20
pg) was made up to the required volume containing 50 % formamide, lx MOPS and
8 % formaldehyde. Prior to loading the samples lx loading buffer was added. Gels
were run at 40 V over night. The gel was then stained with ethidium bromide and
photographed as for DNA.
2.3.3 DENATURING (SDS/PAGE) POLYACRYLAMIDE GEL
ELECTROPHORESIS.
One dimensional SDS-PAGE gel electrophoresis was performed as described
by Laemmli, (1970). Using a premixed polyacrylamide solution (30 %) supplied by
Scotlabs, a 12 % running gel with 4 % stacking gel was cast. Protein samples in
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electrophoresis sample buffer (62.5 mM Tris-HCl, pH 6.8, 10 % Glycerol, 2 % SDS,
5 % P-Mercaptoethanol) were boiled for 5 minutes to ensure complete denaturation
of the proteins before loading on the gel. Gels were electrophoresed at a constant
current of 32 mA for about 1 hour (stacking gel) and 48 mM for 5 hours (separating
gel) in running buffer (25 mM Tris, 192 mM glycine, 0,1 % SDS, pH 8.3).
2.4 NUCLEIC ACID TRANSFERS.
2.4.1 TRANSFER OF DNA FROM AGAROSE GELS TO NYLON
MEMBRANE.
DNA fragments were separated by agarose gel electrophoresis and
transferred to nitrocellulose membranes (Zeta-Probe, BioRad) using the blotting
method essentially described by Southern, (1975). The DNA (fragments >8 kb) was
firstly depurinated by gently shaking in two changes of 0.2 N HC1 for 15 minutes.
Then, the gel was soaked in 1.5 M NaCl, 0.5 M NaOH for 2x 20 minutes, and then
in 1 M NH4OAC, 0.02 M NaOH for 2x 30 minutes. The gel was placed on a wick
consisting of two sheets ofWhatman 3 MM paper on a glass plate and soaked in lOx
SSC (3 M NaCl, 0.3 M sodium citrate). A piece of membrane cut to the size of the
gel was prewetted in 2x SSC before being placed onto the gel. This was followed by
two pieces of Whatman 3MM paper cut to the same size and prewetted in 2x SSC.
Air bubbles were removed using a sterile plastic pipette. Paper towels were placed
on top of the 3 MM paper followed by a glass plate and finally a weight
(approximately 0.5 kg) and the DNA allowed to transfer to the membrane by
capillary action as the transfer buffer (MUOAc/NaOH) is drawn through the paper
towels. After 3 hours the wet paper towels nearest to the gel were replaced by dry
towels and the transfer allowed proceeding for approximately 20 hours in total. The
membrane was removed, rinsed in 2x SSC, air-dried and the DNA cross-linked onto
the membrane using an automatic UV-linker (Stratagene).
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2.4.2 TRANSFER OF RNA FROM FORMALDEHYDE GELS TO NYLON
MEMBRANES.
A similar procedure as above was used to transfer RNA but depurination,
denaturation and neutralisation steps were omitted. The transfer of the RNA was
done with lOx SSC, Boehringer membrane and Whatman paper were prewetted with
sterile DEPC-treated water.
2.5 RADIOLABELLING OF DNA.
2.5.1 RANDOM PRIMING OF DNA PROBES.
This method is adapted from Feiberg and Vogelstein (1984). DNA labelling
with [a-32P]-dCTP involves random priming from hexanucleotides and then
polymerisation along the DNA strand by Klenow fragment of E.coli polymerase I.
The DNA (1-25 ng) was initially denatured by heating to 100°C for 5 minutes. DNA
was then kept on ice to prevent re-annealing of the denatured DNA strands. The
labelling reaction was carried out using a Hi-Prime kit (Boehringer Mannheim): 11
pi of DNA plus water was mixed with 5 pi of 10 pCi/pl [a-32P]-dCTP (3000
Ci/mmol;Amersham), and 4 pi Hi-Prime (containing the enzyme, nucleotides and
buffer). The reaction was then incubated at 37°C for 30 minutes, and purified
through a Nick column (Pharmacia Biotech) prior to be added to the hybridisation
solution.
2.6 HYBRIDISATION OF DNA AND RNA PROBES TO NYLON
MEMBRANES.
The hybridisation conditions described by Church and Gilbert (1984) were
used with some minor modifications. Membranes were prehybridised for 30 minutes
with 10 mis of hybridisation solution (0.5 M phosphate buffer pH 7.2, 7 % SDS, 1
mM EDTA) in a roller oven (Techne) at 65°C. The excess probe was removed by
washing with 2x SSC/0.1 % SDS for 10 minutes followed by a wash with 0.2x
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SSC/0.1% SDS for 15 minutes. Membranes were wrapped in saran Wrap and either
exposed to phosphorimager screen or to X-ray film (AGFA: CURIX RP1) at -70°C
with intensifying screens.
2.7 TRANSGENE MICROINJECTION.
Approximately 10 pg of the aP2-NTR was double digested with Sal l/Not I
and the transgene purified free of any plasmid sequences, which are thought to
interfere with the stable integration of the transgene. The concentration of the
transgene DNA was determined by agarose gel analysis comparing with a standard
of known concentration and aliquots of 60 ng/pl stock prepared in T.E. buffer. The
DNA was microinjected at a concentration of 1.5 ng/ml into pronuclear stages eggs
from superovulated (C57B1/6J x CBA Fl) females by Roberta Wallace.
2.8 AMPLIFICATION OF DNA AND RNA BY THE POLYMERASE CHAIN
REACTION (PCR).
2.8.1 GENOTYPING OF TRANSGENIC MICE BY TAIL DNA PCR.
Tail DNA samples were subjected to a PCR reaction to analyse for the
presence of the transgene (E.coli NTR gene). The reaction tube in a total volume of
25 pi contained 2 pi of commercial lOx buffer supplied by Promega (500 mM KC1,
100 mM Tris-HCl pH 9.0, 15 mM MgCh, 0.1 % gelatin, 1 % Triton X-100), 1 pi of
each primer (see below for the sequence) at 30 pmol/pl, 2.5 pi of dNTPmix (2,5 mM
stock mix) and 0.3 pi of thermostable DNA polymerase (Thermus aquaticus) also
supplied by Promega. 1 pi of crude tail DNA was added to each tube and a known
positive and negative tail sample set up alongside to act as controls for the reaction.
Thermal cycling was controlled by a programmable heating block (Perkin Elmer
9700) and the following program executed:




94°C/4' followed of 30 cycles of 94°C/1', 62°C/1', 72°C/1' and a final extension of
72°C/7\
b) Genotyping for Lep"h/Lepob:
5' TGACCTGGAGAATCTCT 3' (forward mutant)
5' GACCTGGGAGAATCTCC 3' (forward wild type)
5' GCACATGGCTCTCTTCT 3' (reverse common for both)
94°C/4' followed of 30 cycles of 94°C/1', 58°C/1', 72°C/1' and a final extension of
72°C/7'. Annealing temperature was modified from 52°C (originally described by
Anand and Chada (2000) to 58°C.
Normally, 10 pi of the amplified DNA samples was electrophoresed in a 1 %
agarose gel.
2.8.2 AMPLIFICATION FROM RNA (RT-PCR).
Amplification ofRNA was carried out using the SupersScript™ II RNase H"
Reverse Transcriptase and the conditions given by the provider (Gibco BRL). 1-5
pg of RNA (DNase-treated), 1 pi of Oligo (dT)i2-i8 and 12 pi of DEPC-dH20 were
mixed in a nuclease-free microcentrifuge tube. The mixture was then heated at 70°C
for 10 minutes and quick chilled on ice. 4 pi of 5x first strand buffer (250 mM Tris-
HC1 pH 8.3, 375 mM KC1, 15 mM MgCl2), 2 pi of 0.1 M DTT, and 1 pi of 10 mM
dNTP mix (10 mM each dATP, dGTP, dCTP and dTTP) were added to the tube and
incubated at 42°C for 2 minutes. 1 pi of Superscript II (200 units) were mixed by
pipetting gently up and down and the mixture incubated 50 minutes at 42°C. The
reaction was then inactivated by heating the tube at 70°C for 15 minutes. Normally
10 % of this final reaction was used in a standard PCR reaction. PCR primers were
chosen from published sequence data using the software Primer design. PCR
conditions for each set of primers were assessed considering the temperature melting
for each of the primers.
Primer sequences and parameter of the PCR reactions:
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a) Prefl:
5' GATTCTGCGAGGCTGACAAT 3' (forward)
5' ATCGTTCTCGCATGGGTTAG 3' (reverse)
94°C/4' followed of 30 cycles of 94°C/r, 60°C/1', 72°C/r and a final extension of
72°C/7\
d) Adipsin:
5' ATGACGACTCTGTGCAGGTG 3' (forward)
5' GTATAGACGCCCGGCTTTTT 3' (reverse)
94°C/4' followed of 30 cycles of 94°C/1', 61 °C/172°C/1' and a final extension of
72°C/7\
e) RAIDD Endogenous/exogenous:
5' AAACGGTACGTGGTCGCAGA 3' (forward)
5' GCGAATGCACGTTGTGGGGA 3' (reverse)
94°C/4' followed of 30 cycles of 94°C/r, 63°C/1', 72°C/1' and a final extension of
72°C/7\
f) RAIDD Exogenous:
5' AGCACCCTCCTGTGCAG 3' (forward)
5' GCGAATGCACGTTGTGGGGA 3' (reverse)
94°C/4' followed of 30 cycles of 94°C/1\ 68.5°C/1\ 72°C/1' and a final extension
of 72°C/7\
2.9 CULTURING OF 3T3L1 PREADIPOCYTE CELL LINE.
2.9.1 CULTURE MEDIUM.
Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing:
-10 %FCS
-L-glutamine (final conc. 50 pg/ml)
-Penicillin/Streptomycin (final conc. 10,000 U/ml of each)
42
-Non-essential aminoacids (5.6 ml of 100 X stock)
Medium was changed every 3 days when cells were subconfluent and every 2 days
when cells were confluent.
2.9.2 FREEZING AND RESUSCITATION OF 3T3L1 CELLS.
Cells were harvested from either a T-25cm2 or T-80 cm2 flasks as described
above and resuspended in 0.5 ml of complete medium and placed on ice. An equal
volume of ice-cold freezing mix was added drop-wise with continual mixing of the
contents of the tube.
Freezing mix:
60 % (v/v) Complete medium
20 % (v/v) FCS
20 % (v/v) dimethyl sulfoxide (Sigma)
The mixture was dispensed into 1 ml aliquots into pre-chilled screw cap
tubes, placed in a polystyrene box and incubated at -20°C overnight before
transferring to liquid nitrogen for long term storage.
To resuscitate the cells, the vial was transferred from the liquid nitrogen to a
beaker of water preheated to 37°C and agitated until the mixture thawed. The
contents of the tube were added to 10 ml of complete medium and the tube rinsed
with 1 ml of medium. The cells were pelleted by centrifugation at 1000 rpm for 5
minutes, and then the supernatant removed. The pellet was resuspended in 5 ml of
complete medium, with a glass pipette to help formation of single cell suspensions.
The resuspended cells were transferred to a T-25cm2 flask and placed in a CO2
incubator at 37°C.
2.9.3 INDUCTION OF DIFFERENTIATION OF 3T3L1 CELLS.
The protocol used to differentiate these cells was basically as described by
Student et al. (1980). Two days post-confluent cells were induced to differentiate in
medium containing the following cocktail of hormones:
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-Insulin (final conc. 1.7 pM).
-Dexamethasone (final conc. 1 pM).
-IbuMeXan (final conc. 0.5 mM).
Cells were incubated in this medium for two days after which time medium was
replaced with DMEM supplemented only with insulin and 10 % FCS.
2.9.4 TRANSFECTION OF 3T3L1 CELLS.
Cells were transfected using the Calcium phosphate protocol as described in
Sambrook et al. (1989). The day before of the transfection 5 xlO5 3T3L1 cells were
seeded in a T-80 flask (80 cm2) with DMEM complete medium and incubated at
37°C, 5 % CO2. On the day of the transfection the medium was changed to 15 ml of
fresh medium and the cells incubated for 3 hours at 37°C, 5 % CO2. Whilst the cells
were incubating, CaCL, 2x HBS and the DNA solutions were left to defrost at room
temperature. One hour before the transfection 0.5 ml aliquots of 2x HBS were
prepared in bijoux's. In a separate tube the plasmid DNA's were mixed to CaCL and
made up to 0.5 ml with dH20, to give a final concentration of 20 pg of DNA and
250 mM CaCL- The DNA-calcium chloride solution was then added drop-wise to
the 2x HBS and left at R.T. for 20 minutes. After the three hours incubation period,
1 ml of the DNA-calcium chloride/HBS solution was added in a drop-wise fashion
to the cells, and gently shaken to mix. The precipitated DNA was left on the cells for
four hours in the incubator at 37°C, 5 % CO2. After 48 hours the medium was
changed to selection medium containing G-418 (400 pg/ml). G-418 selection
medium was applied for a further 12 days, with media being changed every second
day and the cells incubated at 37°C, 5 % CO2. After 14 days of selection, individual
colonies were picked up and transferred to small 6 well dishes. Transformed cells
were cultured in complete medium without the drug and each of the clones
expanded and kept in liquid nitrogen for future analysis.
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2.10 PROTEIN EXTRACTION AND ANALYSIS.
2.10.1 PROTEIN EXTRACTION FROM CELLS AND TISSUES.
Medium was removed from the cells and the flasks or dishes were incubated
on ice for 5 minutes. Cells were washed twice with ice cold PBS and 1 ml of lysis
buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 % Nonidet-P40, 1 mM EDTA, 2
mM EGTA, 1 mM DTT, 0.057 mM PMSF (phenylmethylsulfonyl fluoride) was
added to the cells in a 75 cm flask. The flask was incubated on ice for 30 minutes
and the cells were scrapped and transferred into a 1.5 ml eppendorf tube. After
centrifugation of the cells for 5 minutes at 4°C, the supernatant was transferred in
aliquots of 100 pi to ice cold eppendorf tubes, and these were kept for long storage
at -70°C till analysis. The procedure for tissues was basically the same with the
difference that tissues had to be homogenised in the lysis buffer before proceeding
as described above for cells.
2.10.2 ESTIMATION OF PROTEIN CONCENTRATION.
Protein concentration was measured using the PIERCE detection system and
the standard protocol. Protein standards were prepared in the range 200 pg/ml-1200
pg/ml by diluting the bovine serum albumin stock (2 mg/ml) provided by the
manufacturers and a blank prepared with no protein. 10 p.1 of the nuclear extracts
were diluted 10 fold with ddEhO to make a total volume of 100 pi. Then, 0.1 ml of
each of the standards and the samples were pippetted into a fresh tube and 2.0 ml of
Working Reagent added to each tube, mixed and incubated at 37°C for 30 minutes.
During the incubation time there is a colour change from pale green to purple due to
the reaction of protein with Cu2+ in an alkaline medium to yield Cu1+ which when
complexed with bicinchoninic acid (BCA) gives a purple reaction product which
exhibits strong absorbance at wavelength 562 nm.
The absorbances at wavelength 562 nm of the standard (blank corrected)




One-dimensional SDS-PAGE was performed to detect the NTR protein.
Proteins were transferred to nitrocellulose at 0.8 mA/cm2 for 1 hour using a semi-
dry Electro blotter (Khyse-Anderson, 1984). To block non-specific protein, the
membrane was incubated in a solution of TBS-T (Tris buffer saline/Tween)
containing 3 % BSA for 1 hour at R.T. Then, nitrocellulose membrane was exposed
to a polyclonal anti-NTR antibody diluted in 1:1500 in blocking solution containing
1 % BSA for 1.5 hours at R.T. The membrane was then washed 5x with TBS/Tween
at 5 minutes intervals (R.T.). The primary antibody was visualised using peroxidase-
conjugated HRP-anti-rabbit IgG secondary antibody (1:5000 dilution in TBS-T/1%
BSA) for 1 hour at R.T. and ECL detection reagents (Amersham).
2.11 HISTOLOGY AND IMMUNOCYTOCHEMISTRY.
2.11.1 PREPARATION OF PARAFFIN TISSUE SECTIONS FOR STAINING.
Typically the left epididymal fat pads (male) and the left parametrial fat pads
(female) alongside with skin and liver samples, were removed for analysis from
normal and transgenic C57BL6xCBA mice. The tissues were fixed in NBF (neutral
buffered formalin) for at least 24 hours before embedding in paraffin using standard
procedures. 5-8 pm sections were cut from blocks using a Microm (HM 325)
Microtome. The sections were floated in a 40°C water bath and collected on glass
slides.
The sections were dewaxed and rehydrated in Coplin jars using standard
procedures. Briefly, sections were dewaxed in two changes of xylene and rehydrated
through graded alcohol 100 %, 90 %, 80 %, 70 % ethanol/ddEBO (v/v). Finally the
sections were washed in running tap water before staining procedures were carried
out.
2.11.2 HISTOLOGICAL STAINING.
Mayer's haematoxylin-eosin staining were routinely performed to examine
the morphology of the tissues. The sections were placed in Mayer's haematoxylin
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solution (BDH) for 5 minutes and washed in running water for 3 minutes. The
sections were then counterstained for 2 minutes with eosin (BDH), rinsed in running
tap water for 30 seconds and dehydrated through graded alcohols, cleared in Kem
sol and mounted in DPX mounting medium.
2.11.3 APOPTOSIS STAINING.
In situ apoptosis was detected using the apoTag kit. The test works by
linking digoxigenin-nucleotides to DNA 3'OH ends, which are generated during
apoptosis, using terminal deoxynucleotidyl transferase (TdT). Either dewaxed
sections or fixed cells were pretreated with proteinase K (20 pg/ml) for 15 minutes
at R.T. in a coplin jar or directly on the slide. Endogenous peroxidase was blocked
with 3 % (v/v) hydrogen peroxide for 5 minutes at R.T. After treatment of the
sections with the equilibration buffer the samples were incubated with TdT enzyme
in a humidified chamber at 37°C for 1 hour. Anti-digoxigenin peroxidase conjugate
was applied directly to the slides and incubated in a humidified chamber for 30
minutes at R.T. The colour was developed by incubation with a DAB/H2O2 solution
for 10 minutes. Sections were counterstained with methyl green, washed in 3
changes of water, then washed in 3 changes of n-butanol, dehydrated in Kem sol,
mounted in DPX and visualised by light microscopy.
2.11.4 IMMUNOCYTOCHEMISTRY STAINING.
For immunocytochemistry dewaxed sections were pretreated with 0.1 %
(w/v) trypsin in PBS for 10 minutes at 37°C for antigen retrieval. Endogenous
peroxidase was blocked with 1 % (v/v) hydrogen peroxide. After blocking non¬
specific antibody binding in 5 % (v/v) normal swine serum (Dako, Glostrup,
Denmark) the sections were incubated for 1.5 hours at 37°C with the primary
antibody (anti-NTR) diluted in blocking solution (1:300). After washing in PBS,
sections were incubated with the secondary antibody for 1 hour at R.T. (1:200 swine
anti-rabbit Ig biotinylated antibody (Dako; E0353). Sections were washed in PBS
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and incubated with streptavidin-peroxidase conjugate (Zymed, San Francisco, CA,
USA) at 1:2000 for 30 minutes at R.T. in the dark. The colour was developed by
incubation with a DAB/H2O2 solution for 10 minutes. Sections were counterstained
with haematoxylin, dehydrated and mounted in DPX and visualised by light
microscopy.
2.12 CARCASS ANALYSIS.
Roslin Nutrition carried out the carcass analysis, and basically the protocol consisted
in to dry the carcasses to constant weight at 65°C. Whole body fat was measured by
Soxhlet extraction of the lipids in the dried carcasses using carbon tetrachloride as
solvent. Fat mass is then calculated as the difference between dry weight before and
after chloroform extraction. Lean body mass is carcass weight minus fat mass.
2.13 BLOOD ANALYSIS.
Animals were sacrificed by cervical dislocation between 15.00 and 18.00
hours, and trunk blood was collected. Serum Insulin and plasma leptin levels were
determined by using radioimmunoassay kits with rat insulin and recombinant leptin
respectively, as standards (Linco Research Immunoassay, St. Charles, MO). Plasma
triglycerides, free fatty acids and p-hydroxybutyrate levels were assayed with
commercially available kits (Sigma and Boehringer Mannheim). Whole blood
glucose level was measured by using the One-Touch Profile glucose meter
(Lifescan, Milipitas, CA).
2.14 STATISTICAL ANALYSIS.
ANOVA one way test and Student t test were use for statistical evaluation
using the MINITAB program, with P<0.05 considered as significant. All results
were expressed as means ± S.E.M unless indicated otherwise in the figures.
48
CHAPTER 3
3T3L1: A CELL CULTURE MODEL TO TEST THE EFFICACY OF CB1954
MEDIATED ABLATION IN ADIPOCYTES IN VITRO.
3.1 BACKGROUND.
There are several preadipocyte cell lines reported that differentiate in vitro
and exhibit most of the function of adipocytes in vivo. 3T3L1 is one such cell line
initially isolated by Green and Meuth, (1974) and later by many others. These cells
were chosen in this thesis because they are the best characterised and most widely
used for molecular biological studies. Prior to differentiation, the preadipocyte cell
lines are morphologically similar to fibroblastic preadipose cells in the stroma of the
adipose tissue (Figure 3 .1 A). When appropriately induced with hormonal agents
(e.g. glucocorticoids, insulin-like growth factor-1, and cyclic AMP or factors that
mimic these agents as described in Chapter 2) committed preadipocytes differentiate
into adipocytes in culture. In the process, the cells lose their fibroblastic character,
assume a "rounded-up" appearance and acquire the morphological and biochemical
characteristics of adipocytes. The rounding up of the differentiating preadipocyte is
thought to be due to changes in expression of cytoskeletal and/or extracellular
proteins involved in matrix formation (Spiegelman and Farmer, 1982). Consistent
with this view, the cellular content of the cytoskeletal proteins actin and tubulin
decreases, and a switch in the expression of collagen types occurs, concomitant with
the transition from fibroblast to adipocyte morphology. Soon after the induction of
differentiation (3-4 days), many cytoplasmic triacylglycerol-containing vacuoles
start to appear (Figure 3.1 D) and, after an extended period in culture, coalesce to
form unilocular fat droplets, thus giving rise to the typical "signet ring" appearance
ofmature white adipocytes (Figure 3 .1 F).
A considerable body of evidence shows that differentiated adipocytes
faithfully mimic the metabolism of adipocytes isolated from adipose tissue. Indeed,
extensive biochemical analysis has revealed that the accumulation of cytoplasmic
triacylglycerol is closely correlated with the coordinate expression of virtually every
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enzyme of the pathways of the novo fatty acid and triacylglycerol biosynthesis
(Cornelius et al. 1994). Preadipocytes in culture also acquire the proteins necessary
for lipolysis of triacylglycerol, uptake and intracellular translocation of fatty acids,
and regulation of these processes by lipogenic and lipolytic hormones (Student et al.
1980; Reed and Lane, 1980). Due to the similarities of these cells with adipocytes in
vivo it was considered for this thesis that this in vitro model would provide
important information regarding the behaviour of the system in vivo, both in terms
of the expression of the E.coli nitroreductase gene and in terms of the sensitivity of
the adipose cells to the ablation mediated by the prodrug CB1954.
This chapter describes the generation and characterisation of the
preadipocyte cell line (3T3L1) expressing the E.coli nitroreductase gene under the
control of the adipocyte specific promoter aP2. A series of experiments carried out
with these cells expressing NTR demonstrated the susceptibility of these cells to the
ablation mediated by the prodrug CB1954. Clones of cells stably expressing NTR
were killed after treatment with the prodrug, whereas non-expressing cells were
unaffected. The effect on the cell killing was directly correlated with the levels of
nitroreductase expression. Furthermore, the mechanism of cell killing was found to
involve apoptosis as evidenced by both DNA fragmentation, and Tunel assays. This
is in agreement with the proposed mechanism of toxicity of this system through
DNA-crosslinking and consequent triggering of an apoptotic response. In addition,
the presence of a cell-permeable metabolite that is released to the medium triggering
a bystander effect towards non-expressing adipose cells was demonstrated.
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Figure 3.1. Adipocyte Differentiation in vitro.
Phase-contrast photomicrograph of the preadipocyte cell line 3T3L1 at different
stages of development. A, B, C, D, E and F correspond to different stages of the
adipocyte differentiation. Days after confluent correspond to days after induction to
differentiate with the cocktail of hormones/steroids. Note the dramatic
morphological change that has occurred after 10 days as evidenced by the lipid
accumulation in the cytosol of the cells. Magnification: 100X.
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3.2 TRANSGENE CONSTRUCTS.
3.2.1. GENERATION OF THE aP2-NTR CONSTRUCT.
Figure 3.2 corresponds to a diagram that summarises the cloning steps used
to generate the aP2-nitroreductase (aP2-NTR) construct. A 1.55 kb fragment
containing the E.coli ntr gene and the polyA signal from SV40 was liberated from
the plasmid pWR6 (kindly provided by Dr. Wei Cui), by double digestion Hind
IWXba I (Figure 3.3 A), end filled using Klenow polymerase and ligated into the
unique Sma I site of the aP2 promoter/enhancer plasmid (kindly provided by Dr
Reed Graves). The final construct, designated paP2-NTR, was cut with a number of
restriction enzymes to check for the expected banding pattern (Figure 3.3 B and
Figure 3.4 for details of the expected size bands). Sequencing of the 5' junction
between the NTR gene and the aP2 promoter was carried out to verify the fidelity of
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Figure 3.2. Cloning strategy used to generate the aP2-NTR plasmid.
1.55 kb fragment from the plasmid pWR6 was excised by double digestion Hind









* ,, i, i, ,, ■ .
8.36 kb
1.55 kb
1 234 56 7 89 10
£■§ mm
. ' ""r s > - ••
r
■ ' ';•',•••• • ■' • /' ' ' .
:1§ |i 1I
Figure 3.3: Restriction digest of plasmids used to construct paP2-NTR.
A) The purified 1.55 kb fragment (lane 3) from the plasmid pWR6 was cloned into
the unique Sma I site of the aP2 plasmid (lane 2). Lane 1 is 1 kb marker.
B) A series of restriction digests from one of the putative colonies. Lanes 1 and 10, 1
kb marker. Lane 2 aP2 plasmid Sal I, lane 3 pSK II plasmid Sal I, lane 4 aP2-NTR
plasmid Sal I, lane 5 aP2-NTR plasmid Not I, lane 6 aP2-NTR plasmid Sal I I,
lane 7 aP2-NTR plasmid XIto I/Not I, lane 8 aP2-NTR plasmid EcoR I and lane 9




Figure 3.4: Restriction map of the aP2-NTR plasmid.
Probe 1 (679bp) and probe 2 (850bp) are indicated and X=Xho I, S=Sal I, E=EcoR I,
B=BamHl, N=Not I. aP2 Promoter: 5.4 kb, NTR: 0.7 kb, pA: 0.85 kb and backbone
plasmid 2.96 kb (pSK II).
Sal I digest: 9.91 kb
Not I digest: 9.91 kb
Sal I /NotI digest: 6.95 kb + 2.96 kb
Xho I/Not I digest: 6.95 kb + 2.96 kb
EcoR I digest: 6.21 kb + 3.70 kb
BamH I digest: 5.26 kb + 2.70 kb + 1.1 kb + 0.85 kb
Also in Figure 3.3.B, lanes 2 and 3 correspond to control digestions of the aP2 and
pSK II plasmids, respectively. Thus, in lane 2 Sal I digests 8.36 kb in aP2 plasmid
and in lane 3 Sal I digest 2.96 kb in pSK II plasmid.
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3.2.2. GENERATION OF THE NTR-NEO CONSTRUCT.
Figure 3.5 corresponds to a diagram that summarises the cloning steps that
derived in the construction of the plasmid that was used in the transfection
experiments. 1.8 kb fragment containing the NEO cassette (PGK promoter,
neomycin gene, and pA from SV40) was excised from the NEO plasmid (kindly
provided by Dr. E. Gallagher) by digestion with Xho I (Figure 3.6 panel A). The
aP2-NTR plasmid was also digested with Xho I (Figure 3.6 panel A). The 1.8 kb and
the linearised plasmid fragments were gel purified and ligated to generate the NTR-
NEO plasmid as shown in Figure 3.5. The final construct was cut with a panel of
several restriction enzymes to check that the components of the construct and the
final construct gave the expected banding pattern (Figure 3.6 B and Figure 3.7 for
details of the expected size bands).
Xho I
paP2-NTR 9.96 Kb
Digestion Sma I, CIP i
Xho I Xho I
pNEO 4.76 Kb
i Digestion Xho I
aP2 promoter! NTR! pA 5 NEO cassette
t
NEO cassette | aP2 Promoter !NTR! pA
pNTR-NEO 11.71Kb
Figure 3.5. Cloning strategy used to generate the pNTR-NEO plasmid.
1.8 kb fragment containing the NEO cassette was excised from the plasmid pNEO,
by digestion with Xho I and ligated into the unique Xho I site (CIP treated) of the
aP2-NTR plasmid (described above).
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A) B)
Figure 3.6: Restriction digest of plasmids used to construct pNTR-NEO.
A) The purified 1.8 kb fragment (lane 2) from the NEO plasmid was cloned into the
unique Xho I site of the aP2-NTR plasmid (lane 3). Lanes 1 and 4 are X Hind III and
<|) X-174 markers, respectively.
B) A series of restriction digests from one of the putative colonies. Lanes 1 and 10 1
kb marker. Lane 2 NEO plasmid XhoI, lane 3 aP2-NTR plasmid Xho I, lane 4 NTR-
NEO plasmid Xho I, lane 5 NTR-NEO plasmid Sal I, lane 6 NTR-NEO plasmid Not
I, lane 7 NTR-NEO plasmid EcoR I, lane 8 NTR-NEO plasmid Xho I/Not I and lane
9 NTR-NEO plasmid Sal l/Not I.
X XSE E N
Figure 3.7. Restriction map of the pNTR-NEO plasmid.
NEO cassette: 1.8 kb, aP2 Promoter: 5.4 kb, NTR: 0.7 kb, pA: 0.85 kb and backbone
plasmid 2.96 kb (pSK II).
X=Xho I digest:
E=EcoR I digest:
Xho I/Not I digest:
Sal I/Not I digest:
S =SalI digest:
1.8 kb +9.91 kb
3.7 kb +8.01 kb
1.8 kb +2.96 kb +6.95 kb
4.76 kb + 6.95 kb
11.71 kb
N =NotI digest: 11.71 kb
Also in Figure 3.6.B, lanes 2 and 3 correspond to control digestions of NEO and
aP2-NTR plasmids, respectively. Thus, in lane 2 Xho I digest 1.8 kb (Neo cassette)
and 2.96 kb (backbone plasmid) bands in the NEO plasmid and in lane 3 Xho I
digest 9.91 kb in aP2-NTR plasmid.
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3.3 TRANSFECTION OF 3T3L1 CELLS.
3T3L1 cells were first co-transfected by calcium phosphate using both the
aP2-NTR and NEO plasmids. Pools of approximately 50 colonies were analysed for
the expression of the transgene by either Northern Blot or RT-PCR, after
differentiation of these cells into adipocytes as described in section 2.9.3 in chapter
2. Due to the low levels of expression seen only by the latter approach (data not
shown) it was decided to use a different strategy this time transfecting the cells with
a plasmid containing both the aP2 driven NTR and the selectable marker neomycin.
On this second strategy, cells were transfected with the NTR-NEO plasmid by
calcium phosphate, and kept in 400 pg/ml of neomycin selective medium, as
suggested by Hunt et al. (1986) for approximately 11 days (see Figure 3.8). In this
way, a number of clones were isolated using cloning rings and expanded in
neomycin free medium. Each of these clones was then analysed for nitroreductase
expression (see below) and a stock of each was kept in liquid nitrogen for future
experiments.




Figure 3.8. Stable transfection strategy.
The figure shows the strategy followed to isolate single colonies of 3T3L1 cells
transfected with the plasmid NTR-NEO.
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3.4 EXPRESSION ANALYSIS OF TRANSFECTED 3T3L1 CELLS.
Transfection of the cells by calcium phosphate using the second strategy as
detailed above, allowed the isolation of clones expressing different levels of NTR
after differentiation of these cells into adipocytes. Analysis of RNA carried out by
either Northern blot or semi-quantitative PCR (Figures 3.9 A and B) showed that
two of the clones (A and 10) had relatively high levels of nitroreductase. The rest of
the clones either did not express or expressed NTR at low levels after differentiation.
This data confirmed that both the plasmid and E.coli sequences used in the
transfection are not detrimental to the survival of the cells and do not interfere with
the appropriate differentiation of these cells into adipocytes.
This data also confirm that the sequence of the aP2 promoter used contains
all the necessary elements to drive relatively strong levels of expression in
adipocytes in vitro.
A)
Figure 3.9. RNA expression of NTR transgene in transfected 3T3L1 cells.
A) Northern blot from different clones of cells expressing the ntr gene. lOpg of
total RNA was run on a denaturing agarose gel and Northern blot hybridised with
probe 1 (Figure 3.4) to detect the transgene (superior panel) and GAPDH probe as a
loading control (lower panel).
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B) Semi-quantitative PCR from different clones of cells expressing the ntr gene
as in A. 3pg of total RNA was DNAse treated, reverse transcribed with oligo
(dT)12-18mer (Gibco BRL) and subjected to PCR with primers for NTR and
GAPDH (internal control). Reactions with (+) and without (-) reverse transcriptase
are shown.
Und: Undifferentiated cells
Red 40: Positive control (RNA from a mouse expressing NTR in mammary gland).
-/+ : Negative and positive controls for the PCR reaction respectively.
3.5 TIME COURSE EXPRESSION OF THE TRANSGENE.
The developmental regulation of expression of nitroreductase from the aP2
promoter was studied by following the time course of RNA accumulation.
Transfected cells were differentiated as described in section 2.9.3 in chapter 2 and
RNA was made at different time points of the differentiation protocol. In transfected
cells, both the endogenous aP2 and the exogenous NTR mRNA increased with a
similar time course during differentiation and reached a plateau at the same time
(Figure 3.10). As expected, both mRNA species were undetectable prior to the
differentiation of the cells thus confirming the previous observations that this
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promoter is active only in differentiated cells (Ross et al. 1990). This result indicates
that the aP2 promoter sequences used in the construct contains most of the cis-
regulatory elements needed for an appropriate developmental expression in
adipocytes. Thus, it was concluded from these results that the exogenous gene is
activated and developmentally regulated within adipocytes in a qualitatively similar
fashion to the endogenous aP2 gene.
TIME COURSE OF mRNA EXPRESSION OF BOTH ENDOGENOUS (aP2)
AND EXOGENOUS (NTR) GENES.
Endogenous (aP2) Exogenous (NTR)
P 3days 5days 8days lldays P 3days 5days 8days lldays
Figure 3.10. Time course of appearance of both the endogenous aP2 and the
exogenous aP2 driven NTR transcripts.
Total RNA was collected at different time points as indicated in the figure and a
Northern blot hybridised with probes to detect the endogenous (aP2) and the
exogenous (NTR) genes.
P: Preadipocytes (before differentiation).
3,5,etc: Correspond to days after induction of the cells to differentiate.
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3.6 NITROREDUCTASE-CB1954 MEDIATED ABLATION IN VITRO.
A pilot experiment was carried out where confluent dishes of cells
transfected with the aP2-NTR plasmid (clone 10) and the parental cell line (3T3L1)
were induced to differentiate in the presence of the prodrug CB1954. Cytotoxicity
was observed in cells transfected with the ntr gene after 4 days of induction to
differentiate in the presence of 100 pM of CB1954 but not in the parental cell line
(Figure 3.11 B and E, respectively). The effect was seen as patches or clear areas on
the dish where cells have disappeared (Figure 3.11 E). The effects seen in these cells
are in agreement with the time course of activation of the aP2 promoter, which
normally occurs on day 3 of the differentiation protocol (see Figure 3.1). This
indicates that as soon as the promoter switches on, CB1954 is activated to the
cytotoxic derivatives. The prodrug also caused gross changes in morphology of the
cells, including enlargement of nuclei and multiple nuclei (Figure 3.11 F). These
changes agree with some of the characteristic observed in apoptotic cells although
apoptosis was not studied in this particular experiment. A similar effect was
observed previously by Drabek et al. (1997) working with mouse L cells.
Unlike the cells transfected with ntr gene, parental cell lines (3T3L1 cells)
are not affected when they differentiate in medium containing CB1954, indicating
that NTR/CB1954 system is capable of mediating ablation exclusively in NTR
expressing cells. Furthermore, transfected cells undergoing differentiation in
medium without CB1954 differentiated normally and clusters of adipocytes could be
observed as expected by day 4-5, indicating that the effect is due to the prodrug and
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Figure 3.11 Differentiation of preadipocytes in medium containing 100 pM
CB1954. Phase-contrast photomicrograph of parental 3T3L1 cells (A-C) and
transfected cells (D-F) undergoing differentiation in the presence of 100 pM of the
prodrug CB1954. Panels A and D show the cells at confluence stage when the
hormones and the prodrug were added to the medium. Panels B and E correspond to
the same cells after 4 days of the induction to differentiate and panels C and F after
8 days. Note how the cells have disappeared from the dish and remaining cells failed
to differentiate (E and F) only in transfected cells (clone 10).
Arrows: Enlargement of nuclei and multiple nuclei are shown in cells undergoing
apoptosis. Magnification: 100X.
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3.7 DOES THE NITROREDUCTASE-CB1954 SYSTEM KILL ADIPOCYTES
IN VITRO?
The main purpose of the work in vitro was to demonstrate the feasibility of
the NTR/CB1954 system to kill adipocytes. It was thought that this could give proof
of principle regarding the behaviour of the system in an animal model in terms of
the expression of the bacteria enzyme (NTR) in adipocytes and the susceptibility of
these cells to different concentration of the prodrug. In the previous section it was
shown that the system could kill transfected cells once induced to differentiate in the
presence of the prodrug. However, a different situation could have been expected
from fully differentiated adipocytes due to the possibility of these cells being
intrinsically more resistant to CB1954.
In order to demonstrate this, experiments were carried out this time applying
the prodrug CB1954 once differentiation had proceeded to term, typically after 10
days of the induction with hormones. Differentiated cells expressing nitroreductase
and parental cell lines were tested for their ability to survive after treatment with the
prodrug at various concentrations. It was found that adipocytes are indeed
susceptible to the killing by the prodrug CB1954 while parental cell lines were not
affected. Both cells were grown in medium with the prodrug for 12 days and the
number of cells were counted with an hematocytometer at different time points
(days 0, 3, 5, 7, and 12). Transfected cells expressing NTR (clone 10) begun to die
soon after 3 days of treatment and by 12 days around 80% of the cells had
disappeared from the dish, leaving a few remaining cells that did not differentiate
and presumably are not expressing the nitroreductase (see Figure 3.12). By contrast,
parental cell lines were not affected by the prodrug and the cell number remained
relatively constant, despite a slight reduction as a natural process of cellular death in
culture (same effect was seen in 3T3L1 grown with and without the prodrug in the
medium (see Figure 3.13 B).
The first signs of toxicity corresponded to a change in the phenotype of the
cells (cell shrinkage) and membrane blebbing which is evident under these
conditions after 3 days, concomitant with the cell detachment. By day 6 many cells
have disappeared from the dish and this effect of the prodrug is irreversible after 4
days of treatment, since returning the cells to normal culture conditions did not lead
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to their recovery. Optimal cytotoxicity was found with 200 pM leading to a 100%
killing of the nitroreductase expressing cells with no apparent effect on the control
cells (Figure 3.13 B). Here, the time required for maximum toxicity was half of the
time to kill similar number of cells with 100 pM of the prodrug. This suggests that at
lower doses of CB1954 the cells are still capable of repairing the DNA adducts
formed as result of the bioactivation of CB1954 but above a certain concentration
they are no longer capable of doing so. This threshold of toxicity will have critical
implications for the survival of the cells as above certain concentration of the
prodrug the cells will trigger a self-destructive response known as apoptosis.
Before Prodrug After 3 Days After 6 Days
lOOpM lOOpM
Figure 3.12 Effect of CB1954 in adipocytes stably expressing NTR (clone 10)
and the parental 3T3L1 cells.
Phase-contrast photomicrograph to show that CB1954 treatment does not produce
any toxic effect in parental 3T3L1 cells, however one of the clones (clone 10) stably
expressing NTR show signs of toxicity after 3 days of treatment and after 6 days
most of the cells have disappeared from the dish (see also Figure 3.13 A and B for
quantitative analysis). Magnification 100X except middle panel 40X.
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EFFECT OF DIFFERENT DOSES OF CB1954 ON THE SURVIVING RATE
OF THE ADIPOCYTES IN VITRO.
A) lOOpM
Figure 3.13 Quantitative effect of CB1954 in the survival rate of adipocytes
expressing NTR. Differentiated parental cells (3T3L1) and one of the clones
expressing NTR (clone 10) were incubated in medium containing the prodrug
CB1954 at a final concentration of 100 and 200pM (panels A and B respectively).
The number of cells was counted at different time points, as indicated in the graph.
Each point represents the mean ± SD of duplicates.
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The results showed above demonstrate the ability of the NTR/CB1954
system to kill non-dividing fully differentiated cells thus confirming that this system
is a convenient way to eliminate terminal differentiated cells and might well work to
eliminate other such as neurons and non-dividing neoplastic cells, a not infrequent
component of any solid tumour. This is in contrast to the tklGCV system, which
requires cells to be in S phase for cytotoxicity. Thus, NTR/CB1954 system can
prove a better alternative for the generation of transgenic animal models lacking of a
specific cell type.
3.8 INCREASED EXPRESSION LEVEL LEADS TO A GREATER
CYTOTOXICITY.
Section 3.4 characterised the expression of NTR transgene by Northern Blot
and RT-PCR in different clones of 3T3L1 cells stably expressing NTR upon
differentiation. Different levels of expression were observed (Figures 3.9 A and B)
with some of clones expressing high levels (clone A and 10), while others at very
low only detectable by the more sensitive RT-PCR assay (clone 3). Thus, it was
decided to test the effect that CB1954 would have in the survival of these cells
expressing different levels ofNTR.
Increasing levels of enzyme expression in cell populations were found to
correlate with their sensitivity to CB1954 (Figure 3.14). In this way, clones of cells
expressing lower levels of NTR were more resistant to the killing by the prodrug
when grown in similar conditions with clones expressing higher levels. These results
suggest that those clones with the highest levels of NTR expression are more
sensitive to the killing by the prodrug CB1954 because of the higher concentration
of the E.coli nitroreductase enzyme available to metabolise the prodrug.
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DEGREE OF CELL KILLING CORRELATESWITH LEVELS OF NTR
EXPRESSION.
Figure 3.14 Clones of cells 3T3L1 expressing different levels of the NTR enzyme
were grown in medium containing 200pM of CB1954 and the cell number
determined with an hematocytometer at different time points. Values correspond to
single determinations.
3.9 DOSE-DEPENDENCE OF IN VITRO CYTOTOXICITY OF THE
NTR/CB1954 SYSTEM.
The therapeutic index (toxicity in parental cells versus toxicity in transfected
cells) of this suicide gene/prodrug system was determined by analysing the LD50 or
the concentration of prodrug required to kill 50% of the cells. As shown in Figure
3.15, the LD50 in the parental cells was 2.500 pM and in NTR expressing cells
(clone 10) was 150 pM resulting in the therapeutic index of 17. A vast increase in its
cytotoxicity of up to 100.000 fold was originally found vitro in the extremely
sensitive Walker cells compared to more resistant Chinese hamster V79 cells
(Roberts et al. 1986). Despite this high potency, CB1954 was not effective in a
range of animal and human tumours (Workman et al. 1986). This lack of antitumour
response in humans was due to species differences in CB1954 reduction, catalysed
by the nitroreductase enzyme DT-diaphorase (Knox et al. 1993). Nevertheless, in
several human and murine cells, following delivery of the E.coli NTR gene, which
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can also catalyse CB1954 reduction, differential toxicity between cells expressing
the NTR gene and non-expressing control cells has reached 10-100 fold
(Bridgewater et al.1995; Clark et al.1997; Drabek 1997), therefore making
this system as remarkable as that observed with tkJGCV. Furthermore, from the
experiments already described in section 3.8 is clear that the cytotoxicity of
nitroreductase-expressing cells is directly correlated to the levels of enzyme
produced from these cells. Thus, it is possible that this therapeutic index could be
even greater if a clone expressing higher levels ofNTR is selected for this analysis.
Most of the experiments carried out to date with NTR/CB1954 have used
actively dividing cells rather than fully differentiated. This therapeutic index
observed in differentiated adipocytes thus confirms the feasibility of this system to
be used in a transgenic animal model to kill fully differentiated cells.
72 HOURS KILLING CURVE
Figure 3.15 Dose-dependence of in vitro cytotoxicity of the NTR/CB1954
system.
3T3L1 cells stably expressing NTR (clone 10) and parental cell lines (3T3L1) were
incubated with increasing concentrations of the prodrug CB1954 and the number of
surviving cells counted after 72 hours of incubation. Each point represents the mean
± SD of duplicates. X axis is logarithmic. Open and closed symbols represent the
data obtained with parental and transfected cells, respectively.
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3.10 THE MECHANISM OF NTR/CB1954 MEDIATED ABLATION IS
APOPTOSIS.
Apoptosis or programmed cell death represents a physiological form of cell
death that occurs during development and in the mature animal. Cell culture
provides many advantages to studying apoptosis, including the availability of large
quantities of homogeneous cells, the ability to examine the morphological,
biochemical and genetic properties of cells undergoing apoptosis throughout the
course of experiments, and the ability to precisely regulate the cellular environment.
This section describes two approaches that were used to measure apoptotic
cell death of adipocytes undergoing NTR/CB1954 mediated ablation. The first
method used was a commercial Tunel assay (Figure 3.16) which takes advantage of
the biochemical hallmark of apoptosis, namely internucleosomal DNA
fragmentation, to chemically label and visualise apoptotic nuclei. This method
(described in Chapter 2) utilises the activity of terminal deoxynucletidyl transferase
(TdT) enzyme to incorporate biotinylated dUTP onto 3' ends of fragmented DNA.
The incorporated biotinylated-dUTP is commonly visualised after incubation of the
labeled cells with avidin-biotin-conjugated horseradish peroxidase followed by
staining with 3,3'-diaminobenzidine tetrahydrocholoride (DAB). Figure 3.16 shows
the result of the Tunel assay carried out on adipocytes after treatment with 200pM of
CB1954 for 4 days. Note the specific brown colour staining indicative of apoptosis
mediated DNA strand breaks only in NTR expressing cells treated with the prodrug,
thus confirming apoptosis of these cells.
A second method (DNA laddering) was also used to confirm the results
obtained with the Tunel assay. Cleavage of genomic DNA into oligonucleosome-
length fragments by endogenous nucleases is the biochemical hallmark of apoptosis
in nearly all systems examined to date (Bortner et al. 1995). As can be seen from the
Figure 3.17 a characteristic DNA laddering could only be observed in NTR-
expressing cells that had been treated with the prodrug (lane 9 in Figure 3.17).
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Figure 3.16 Tunel Assay.
The Figure shows the result of the Tunel assay carried out in cells expressing the
nitroreductase (clone 10) and the parental cell lines (3T3L1). Cells were treated with
100pM of CB1954 for 4 days. Note the characteristic brown colour (arrows)
indicative of apoptotic nuclei only seen in those cells expressing NTR and treated
with CB1954 (Clone 10). Magnification 200X.
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Although a number of protocols were used to detect this DNA laddering, the
one that gave the best results is the described by Sellins and Cohen, (1987) as shown
in Figure 3.17. This protocol (described in detail in Chapter 2) contains a
preliminary centrifugation step that allows the recovery of fragmented DNA
contained in the supernatant fraction. This DNA is later precipitated with
isopropanol in the presence of salts. The pellets obtained in the first centrifugation
contain the remaining genomic DNA, which is later digested with buffer and
proteinase K and finally precipitated. These two fractions, genomic and supernatant
DNA respectively, were then loaded onto 1.5% agarose gels.
3T3L1 3T3L1 Clone 10 Clone 10
OfaM 200|itM O^iM 200|uM
#v #v
^ c? N<f ^
^ e>° ^ o° ^ ^
1 23456789
Figure 3.17 DNA fragmentation assays.
Lane 1 lkb marker. Lanes 2 and 3 correspond to genomic and supernatant DNAs of
the parental cell line (3T3L1) without treatment. Lanes 4 and 5 correspond to
genomic and supernatant DNA of the parental cell line (3T3L1) treated with 200pM
of CB1954. Lanes 6 and 7 correspond to genomic and supernatant DNA of the
nitroreductase expressing cells (clone 10) without treatment. Lanes 8 and 9
correspond to genomic and supernatant DNA of the nitroreductase expressing cells
(clone 10) treated with 200pM of CB1954. Note the effect (DNA laddering) seen
only in those cells expressing NTR that were treated with the prodrug.
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The results shown above confirmed that the mechanism of ablation is
mediated by apoptosis, which is in agreement with the proposed cytotoxic role of the
DNA adducts formed after activation of the prodrug (Friedlos et 1992).
3.11 NTR/CB1954 HAS A BYSTANDER EFFECT THAT IS MEDIATED
THROUGH A METABOLITE RELEASED INTO THE MEDIUM.
The ability of the NTR/CB1954 system to kill NTR non-expressing cells was
assayed by mixing the parental cell lines (3T3L1) with different proportions of one
of the clones stably expressing the NTR enzyme (clone 10). Cells were mixed at the
following proportions: (parental 3T3Ll:Clone 10) 100%:0%, 50%:50%, 30%:70%,
10%:90%, and 0%;100%. Upon differentiation of the cells to adipocytes, 200pM of
the CB1954 was added and the cells incubated for 96 hours after which time,
surviving cell numbers were counted with the help of an hematocytometer. Figure
3.18 confirmed that killing by this bystander effect is also observed in adipocytes
expressing the NTR enzyme. 50% ofNTR expressing cells were enough to kill over
70% of the cell population under the conditions used in this experiment. It is
noteworthy that this number may not reflect the real potential of the bystander effect
of these cells as 100% conversion to the adipocyte estate it is unlikely to be obtained
in culture conditions (3T3L1 can only differentiate with a 90-95% efficiency). This
might imply that the 50% ofNTR expressing cells used might only have contained a
40-45% of cells expressing the NTR.
Another situation that might underestimate this potential bystander effect is
the possibility of variegated transgene expression in these cells expressing the NTR,
a not uncommon phenomenon in culture systems. Some effort was devoted to assess
for the possibility of variegated transgene expression in one of these clones stably
expressing the NTR. Immunocytochemistry analysis with antiserum to NTR was
used to estimate the proportion of cells that were expressing the NTR within the
clone. Unfortunately, due to cross-reactivity of the antibody it was not possible to
distinguish between expressing and not expressing cells since both showed
immunostaining (data not shown). No further attempts were made to address this
point.
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Figure 3.18 In vitro bystander effect of the NTR/CB1954 system.
Parental 3T3L1 cells were mixed with various proportions of the 3T3L1 cell line
stably expressing the NTR (clone 10) and exposed to 200pM of CB1954 for 96
hours. After the incubation period cell number were counted as described above.
Each bar represents the mean ± SD of duplicates.
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3.12 CYTOTOXICITY CAN BE TRANSFERRED IN THE CONDITIONED
MEDIUM (CMED) OF 3T3L1 CELLS EXPRESSING NTR WHEN
TREATED WITH CB1954.
NTR expressing and non-expressing (parental cell lines) were treated with
media alone or media in the presence of 200pM of the prodrug for 96 hour. After
this time CMED was collected from each of these dishes and transferred (after being
filtered with 0.2pm filters) to parental 3T3L1 cells and left for 96 hours. When
conditioned medium (CMED) from one of the clones expressing nitroreductase
(clone 10) treated with CB1954 was transferred to 3T3L1 cells (Figures 3.19 and
3.20 D), cell survival was reduced to 50% when compared to CMED from clone 10
without CB1954, and CMED from parental cells with or without CB1954. This data
confirmed the presence of a diffusable active metabolite of CB1954 that passed into
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Figure 3.19 Toxicity of CMED from NTR expressing cells.
3T3L1 stably expressing NTR (clone 10) and parental cell lines (3T3L1) were
treated with media alone or media in the presence of the prodrug. The CMED was
transferred after being filtered to 3T3L1 cells and the number of surviving cells
counted after 96 hours. The y axis shows the following conditions: 3T3L1 CMED
alone, 3T3L1 CMED with prodrug, clone 10 CMED alone, clone 10 CMED with
prodrug. Each bar represents the mean ± SD of triplicates.
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fepi
Clone 10 CMED CB1954
Figure 3.20 Conditioned medium toxicity on parental 3T3L1 cells.
Phase-contrast photomicrograph of the effects of supernatant derived from 3T3L1
either untreated or CB1954-treated (A and B) or NTR expressing (clone 10)
untreated or CB1954-treated, on the wild-type 3T3L1 cells.
A, B and C show the 3T3L1 cells growing well in CMED derived from parental
3T3L1 cells untreated (A) and treated with CB1954 (B) and CMED derived from
NTR expressing cells untreated (C). In contrast, when CMED was derived from
NTR expressing cells that had been treated with CB1954 a considerable cell death
could be observed. Magnification 100X.
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These results indicate the presence of a toxic metabolite of CB1954 that is
relatively stable and more importantly that can freely cross the cellular membrane
into the culture medium to mediate a bystander effect, in agreement with previous
observations of Bridgewater et al. (1995). This mechanism of bystander effect
differs from the classical mechanism of intercellular gap junctional communication
observed with tk/GCV system. Nevertheless, due to the proximity of one cell each
other, as it is the case in confluent adipocytes, it can not be rule out the possibility of
other mechanisms acting synergistically to enhance this bystander effect.
A number of studies attempting gene delivery to tumours in vivo have shown
that a proportion of cells remains unmodified. Thus, a desirable feature of any
enzyme/prodrug combination for use in GDEPT is that activation and bystander
effects of the modified cells could also kill adjacent unmodified cells. Here it was
further confirmed that a bystander effect, as observed with tk/GCV, is also present
with NTR/CB1954 system. This bystander effect may have important implications
in the killing of surrounding non-infected tumour cells in the case of gene therapy or
non-expressing cells when used to ablate specific cells in transgenic animal models
(Knox et al. 1988; Clark et al. 1997; Drabek et al. 1997).
3.13 CONCLUSION.
3T3L1 cells were successfully transfected with the E.coli ntr gene driven by
the adipocyte specific promoter aP2. Activation of the transgene by the promoter
sequences used indicates that E.coli NTR is not detrimental for the survival of the
cells and more importantly for an appropriate differentiation of these cells into
adipocytes. The aP2 promoter sequences used contain the necessary regulatory
elements to drive the expression of exogenous genes into adipocytes in vitro in a
temporal developmental manner similar to the endogenous gene.
CB1954 is converted by nitroreduction from a monofunctional to a
difunctional alkylating agent capable of reacting with DNA to produce interstrand
crosslinks. The results described above showed that differentiated eukaryotic cells
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are able to express the E.coli nitroreductase gene and judging for the end result (cell
death), are capable of reducing this substrate, inducing DNA interstrand crosslink
formation leading to cell death.
The degree of cytotoxicity correlates with the level of nitroreductase activity
in these cells, presumably due to a more efficient conversion of the prodrug to the
active metabolites, in agreement with previous work in murine fibroblast and other
human tumour cell lines (Bridgewater et al. 1995; Green et al. 1997; McNeish et al.
1998). In the same way, low concentration of the prodrug rendered these cells more
resistant to the killing, requiring longer time exposure to the prodrug to achieve a
similar toxic effect. One possible explanation for this effect is that at lower
concentrations the cells are still capable of repairing the DNA adducts formed as a
result of the bioactivation of the prodrug and over certain concentration they are no
longer capable of doing so. As a consequence of these lesions it has been suggested
that cells react triggering a self destructive response known as apoptosis. Here, it
was confirmed that apoptosis is involved in the mechanism of cell killing of
adipocytes. Both morphological and cellular data are consistent with this
observation. TdT-mediated dUTP nick end labeling (Tunel) showed specific staining
indicative of apoptosis-mediated DNA strand breaks in cells expressing NTR treated
with the prodrug. Furthermore, DNA fragmentation and morphological analysis
confirmed the apoptosis-mediated cell death.
In trials of gene therapy using HSV-tk, it has been shown that tumours
regress even when only a fraction of the tumour mass contains the viral gene
(Freeman et al. 1993). Furthermore, a few cells transfected with the HSV-tk gene
without retroviral infectious capabilities were also able to cause tumour regression
(Ram et al. 1993). This implies that in the presence of ganciclovir, cells that produce
HSV-tk are able to cause the death of neighbouring cells that do not themselves
produce the enzyme. This phenomenon has been termed the "bystander effect"
(Kolberg R. 1992). A similar bystander effect has been previously observed with the
NTR/CB1954 system by some authors (Knox et al. 1988), although the same effect
could not be observed by others (Clark et al. 1997). Here, it was further confirmed
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the ability of a minority of nitroreductase expressing cells to cause prodrug-
dependent death of surrounding nitroreductase non-expressing cells. An efficient
bystander effect is widely acknowledged to be an essential feature of
enzyme/prodrug systems for potential applications in GDEPT, or VDEPT as gene
transfer to 100% of tumour cells in vivo is unlikely to be achieved. In the same way,
this bystander effect is especially useful with transgenes affected of variegated
expression; a not uncommon problem in transgenesis thus enabling the killing of
surrounding silenced cells.
These studies allow to conclude the feasibility of the NTR/CB1954 system to
kill adipocytes in vitro. However, these studies do not guarantee that the system
would work in an animal model where the levels of transgene expression are more
likely to be affected by environmental factors and external cues. CB1954 can also
have a major role for the success of the experiments in vivo since it must be
administered to such concentration that can reach the organ target to levels high
enough to kill the NTR expressing cells. Therefore, in order to confirm that the
system works in vivo and specifically in the target tissues, it is necessary to create a
mouse model expressing NTR in the adipose tissue and assess the susceptibility of
these cells to the prodrug as it will be described next.
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CHAPTER 4
4. TRANSGENIC MICE HARBOURING E.COLI NITROREDUCTASE
GENE DRIVEN BY THE aP2 PROMOTER ENHANCER: GENERATION
AND ANALYSIS.
4.1 BACKGROUND.
Transgenic animal technology has become one of the most fascinating
technologies developed in the last two decades. The introduction of foreign genes
termed "transgenes" into the germline of animals is achieved by microinjection of
multiple copies of the transgene into the pronucleus of a fertilised one-cell embryo.
The transgene randomly integrates into the genome (usually at a single site) and the
cleaved embryos (two-cell stage) are transferred to pseudopregnant females (females
mated with vasectomised males). The live births can then be screened for the
presence of the transgene either by PCR or Southern Blot analysis ofDNA from tail
biopsies. These transgenic animals exhibit unique phenotypes and these
characteristics are inherited by their offspring in a Mendelian fashion. The
mechanisms involved in the integration event are largely unknown but result in the
insertion of different copy numbers of the transgene, usually in a direct head to tail
array. In many cases the transgene is susceptible to "position effects", resulting in
aberrant or different expression levels between lines carrying the same construct
(Palmiter and Brinster, 1986).
One of the main drawbacks of this technique has been the low efficiency. Of
the embryos that survive the injection procedure only -10% produce offspring, of
which -20% are transgenic (Boyd and Samid 1993). Other problems associated with
pronuclear injection are that neither the site of integration nor the number of copies
of foreign DNA can be controlled precisely, which means that not infrequently some
transgenes are silenced. In spite of the low efficiency, pronuclear injection is
currently the most commonly used technique for the generation of transgenic
animals and transgenic animals still provide unique opportunities to address
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fundamental questions on development, gene regulation, cell biology, disease
pathology and genetic engineering of animals to improve their health status.
This chapter describes the generation of transgenic mice harbouring the
E.coli nitroreductase gene under the control of the adipocyte specific promoter aP2.
The establishment of transgenic lines of mice and the analysis of transgene
expression are also described.
4.2 TRANSGENE CONSTRUCT.
The nucleotide sequence of the E.coli ntr gene has been determined (Michael
et al. 1994). The enzyme is a monomeric FMN-containing flavoprotein with a
molecular mass of 24.000 Da and requires either NADH or NADPH as a cofactor.
From comparison of partial aminoacid sequence the enzyme appears homologous to
the classical nitroreductase of Salmonella typhimurium (Watanabe et al. 1990). The
generation of the construct aP2-NTR has been described in section 3.2.1 in chapter
3. The same construct that was used to transfect cells in the previous section was
used in the generation of transgenic mice as described next.
4.3 TRANSGENE MICROINJECTION.
Approximately 10 pg of the aP2-NTR plasmid was double digested with Sal
\/Not I (Figure 4.1) and the transgene purified free of any plasmid sequences, which
are thought to interfere with the stable integration of the transgene (Palmiter and
Brinster, 1986). The concentration of the transgene DNA was determined by agarose
gel analysis comparing with a standard of known concentration and aliquots of 60
ng/pl stock prepared in TE-buffer. The DNA was microinjected at a concentration of
1.5 ng/ml into pronuclear stage eggs from superovulated (C57Bl/6xCBA Fl)
females by Roberta Wallace.
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probe1 probe2
Sal I Not I
aP2 Promoter/Enhancer pA
Figure 4.1 Map of the 6.95 kb aP2-NTR transgene.
Probe 1 (679 bp) and probe 2 (850 bp) are indicated.
4.4 ANALYSIS OF THE FOUNDERS AND THE ESTABLISHMENT OF
TRANSGENIC LINES OF MICE.
Transgenic founders were identified by PCR and Southern Blot analysis of
mouse tail DNA. PCR analysis was carried out using a pair of primers that amplify a
471 bp fragment of the NTR gene. Figure 4.2 illustrates the result of a typical PCR
reaction where the positive and negative mice are clearly seen. The control included
in the PCR reaction corresponded to DNA from a transgenic and non-transgenic
mouse (positive and negative controls, respectively), conditions of the PCR reaction
were as described in chapter 2.
Southern Blot analysis was routinely used to confirm the results of the PCR
reactions. Figure 4.3 is a Southern blot of all the founder mice that were positive by
the PCR. 10 pg of mouse tail genomic DNA was digested with EcoR I, which cut
once in the transgene, and Southern blot hybridised with probe 1 (Figure 4.1). This
probe detects a 6.95 kb band corresponding to the transgene in a head to tail array.
Thus, the presence of this fragment confirmed the integration of the transgene into
the founder mice. The different intensities of the band indicate the variation in copy
numbers of the transgene although a more accurately study of the copy number is
shown later in this chapter. Out of 97 live births, 12 mice were positive by PCR and
Southern blotting, an efficiency of 13%.
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— NTR product
Figure 4.2 Screening of genomic mouse tail DNA for transgenic mice carrying
the transgene.
Positive and negative control DNA samples are loaded on the right of the gel.
6 25 30 34 38 39 40 42 47 48 55 64 67 74 81 87
6.95 kb y * - pr
Figure 4.3 Southern Blot of genomic tail DNA from different transgenic
founders carrying the transgene.
10 pg of genomic DNA was digested with EcoR I and Southern blot hybridised with
probe 1 (Figure 4.1).
4.5 ANALYSIS OF THE TRANSGENE COPY NUMBER IN THE LINES OF
MICE.
The copy number of the transgene in each line of mice was estimated by
Southern blot analysis (Figure 4.4). Genomic DNA was prepared from liver tissue
from 2 G1 sisters of each transgenic line. Copy number control was prepared by
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adding different amounts of the transgene DNA (equivalent to 1, 5 and 25 copies) to
a liver DNA sample known to be negative for the transgene. The DNA (10 pg) was
digested with Kpnl, which cuts once in the transgene and the Southern blot
hybridised with a 850 bp probe corresponding to the pA fragment (probe 2 in Figure
4.1). This probe detects a 6.95 kb band corresponding to the transgene in a head to
tail array (Figure 4.5). The same Figure also shows other possible rearrangements.
DNA loading was corrected by reprobing the blot with the murine cystic fibrosis
transmembrane-conductance regulator (CFTR) probe, a single copy rodent gene
(kindly provided by Dr. W. Cui). Figure 4.4 shows that the transgene is present in
various copy numbers ranging from 1 (line 64) to over 25 (line 87). Please note that
Figure 4.4 was overexposed to allow detection of the single copy control and the
single copy signal from line 64. Also from the figure note that line 30-2 is
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Figure 4.4 Transgene copy number in the lines of mice.
Southern blot with 10 pg of Kpn I digested genomic liver DNA from 5 independent
transgenic lines of mice carrying the 6.95 kb transgene (two mice from each line).
The blot was hybridised with probe 2 (Figure 4.1), then stripped and rehybridised
with a murine cystic fibrosis transmembrane-conductanse regulator (CFTR) probe as




Figure 4.5 Possible transgene arrays.
Diagram showing the 6.95 kb band detected when transgene is inserted in a head to
tail array and other possible rearrangements.
4.6 ANALYSIS OF TRANSGENE EXPRESSION IN THE LINES OF MICE.
4.6.1 NORTHERN BLOT ANALYSIS.
Northern Blot analysis was routinely used to determine the expression of the
transgene in the different lines of mice. Total mRNA was prepared from epididymal
fat pads of male mice and inguinal fat pads of female as in these sites the fat is
plentiful and easily accessible. Figure 4.6 shows the result of a Northern blot carried
out to some of the transgenic lines that were generated, confirming expression of the
transgene in this tissue. Note that an overexposure of the film allows seeing more
clearly the low signal from line 64 and 55. NTR mRNA expression was not detected
in other transgenic lines generated e.g. lines 34, 39, 42, 47, 67, and 74 (data not
shown), which presumably was due to position effects of the transgene.
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Figure 4.6 Transgene expression in the different lines of mice.
Northern blot with 10 pg of RNA from 5 individual samples of each transgenic line.
The blot was hybridised with probe 1 (Figure 4.1) in the upper panel and then
stripped and re-hybridised with an adipocyte specific probe (aP2) as loading control
(lower panel).
4.6.2 WESTERN BLOT ANALYSIS.
Levels of protein were also examined in the lines of mice that had shown
expression at the mRNA level. Protein extracts were prepared from epididymal fat
pads of male and inguinal fat pads of female (as described in chapter 2), run on a
12.5% SDS-PAGE gel, and transferred to nitrocellulose. The Western blot was
probed with a polyclonal antibody to NTR. Figure 4.7 shows a single band of
approximately 24 kDa (the expected size of NTR) in all 5 lines analysed, which
confirm an appropriate translation of the NTR transcript. The same Figure
confirmed highest expression of the NTR protein in line 87 followed by lines 30 and
81 and with lower expression lines 55 and 64. A correlation is also observed when
the RNA levels of the different lines are compared with their respective protein
levels.
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Figure 4.7 Western blot analysis.
Total protein tissue extracts (20pg) were prepared from adipose tissue of one
member of each of the transgenic lines that showed expression by Northern blot
(above). The blot was probed with a polyclonal antibody directed to the E.coli NTR.
+: corresponds to a positive control sample (NTR extract ofmammary gland from a
mouse expressing NTR in this tissue (Clark et al. 1997).
corresponds to a non-transgenic sample loaded as a negative control.
Table 4.1 Transgenic Lines Generated.
Transgenic Line F1 offspring Transgene Copy Number Expression levels
30 8/17(47%) 5-10 Medium/High
34 8/17(47%) N/A N/D
39 8/19 (42%) N/A N/D
40 0/25 (0)% N/A N/A
42 4/24(17%) N/A N/D
47 3/22 (47%) N/A N/D
55 4/27 (15%) -5 Medium
64 13/20 (65%) 1 Low
67 10/19(53%) N/A N/D
74 10/31 (32%) N/A N/D
81 3/19(16%) 10-15 Medium/High
87 3/38 (8%) >25 High
Number in bold represent the lines that were kept for future experiments.
N/A: Non-analysed; N/D: Non-detected.
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4.6.3 ANALYSIS OF ECTOPIC EXPRESSION.
The promoter sequences used in this thesis have been demonstrated
previously to confer specific expression to the adipose tissue (Ross et al. 1990).
However, due to the random integration of transgenes is not uncommon to observe
aberrant expression in tissues where endogenous genes are not normally expressed.
This possibility was assessed by analysing RNA from several tissues including
heart, kidney, liver, testis and spleen of one of the transgenic lines that showed high
expression levels (line 87) and hybridising this RNA with a probe that detects 1.4 kb
band of the NTR transcript (probe 1 in Figure 4.1). As expected, the adipose tissue
(as represented by the epididymal fat pad) expresses high levels of the NTR mRNA,
however ectopic expression was also observed in some of the other tissues analysed
as confirmed by the weak signal that could also be observed in these tissues (Figure
4.8 upper panel). Nevertheless, more detailed analysis of these tissues demonstrated
that the hybridisation signal from the kidney RNA is due to the presence of
contaminating adipose tissue, since a probe to the endogenous aP2 mRNA also
hybridised to this tissue (middle panel in Figure 4.8). However, no such signal could
be observed for the spleen, thus suggesting that the signal observed with NTR in this
tissue is due to some leaky expression. The nature of this leaky expression is not
clear but it might involve effects of the copy number of the transgene, which for this
line is >25 (see Figure 4.4 above) or it might be due to effects of the integration site
of the transgene.
Another possibility is that the promoter sequences used lack a negative
regulatory element that suppresses transcription in the inappropriate tissue. In any
case, the former possibilities are more likely since the same promoter sequences
have been previously used in a number of transgenic models without ectopic
expression in other tissues being reported (Ross et al. 1993; Lowell et al. 1993;



























Figure 4.8 Ectopic expression ofNTR mRNA in a high expressing line of mice.
The blot was hybridised with a NTR probe (probe 1 in Figure 4.1) in the upper panel
and then stripped and re-hybridised with an adipocyte specific probe (aP2) as
control for fat contamination of tissues (lower panel), stripped again and re-
hybridised with a 7 S probe as loading control.
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4.6.4 TRANSGENE EXPRESSION IN DIFFERENT FAT DEPOTS.
Interestingly, from the previous Figure it is possible to observe a strong
signal in the heart when the membrane was hybridised with the adipose specific
marker aP2 which, indicates that some remaining fat was adhered to this organ
(middle panel in Figure 4.8). However, no signal was observed in this tissue when a
probe to detect the NTR transgene was used (upper panel in the same Figure). This
observation might suggest that different adipose depots express different levels of
the transgene. To assess more directly this possibility, a number of adipose depots
were chosen to measure the expression levels of the transgene, some of these depots
included retroperitoneal, epididymal, subcutaneous and interscapular brown fat.
Since endogenous aP2 is expressed in both WAT and BAT it was expected that
brown adipose tissue would also express the transgene. Figure 4.9 shows the results
of this study confirming expression of the transgene in the brown adipose tissue.
The same Figure shows different intensities of the NTR signal in the different
adipose depots. In order to assess more accurately the levels of expression from each
of these tissues, the radioactivity in the gels was quantified using a phosphorimager,
normalised to the aP2 signal and expressed as the fold intensity relative to the
mRNA level of the lowest expressing tissue. In this way, it was found that different
fat depots have indeed different levels of expression of the transgene, as suggested
by the intensity of the NTR signal, with the epididymal fat pads showing the highest
levels (1.8 fold) compared to the retroperitoneal that had the lowest. Although one
might expect that these subtle differences may fall within experimental error it has
long been suggested that different adipose depots may have indeed different
functions according to the anatomical location where they are situated. The capacity
of inguinal cells to accumulate more triglycerides than adipose cells in the
parametrial or retroperitoneal depots is a confirmation of this statement.
Another possibility for this difference might be in the metabolic state of each
adipose depot and/or due to effects of the integration of the transgene. Experiments
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Figure 4.9 Expression of NTR mRNA in different fat depots.
The blot was hybridised with a NTR probe (probe 1 in Figure 4.1) in the upper panel
and then stripped and re-hybridised with an adipocyte specific probe (aP2) as
loading control (lower panel). Epididymal, retroperitoneal, subcutaneous and
interscapular brown fat (BAT) are represented.
Intensity of the signal was normalised to the aP2 and expressed as the fold intensity
relative to the mRNA level of the lowest expressing tissue.
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4.6.5 IMMUNOCYTOCHEMISTRY ANALYSIS OF THE TRANSGENE
EXPRESSION IN ADIPOSE TISSUE OF TRANSGENIC MICE.
As suggested from the previous experiment different adipose depots were
found to express the transgene at different levels, one possibility for this effect was
suggested to be due to variegated transgene expression where not all the cells in a
tissue express the transgene. Unstable transgene expression has been described
previously among progeny of the same founder mouse (Palmiter et al. 1984) and it
has been suggested that this effect is a property of the transgene integration locus
(Dobie et al. 1996). Immunohistochemistry analysis was carried out in paraffin
embedded sections of epididymal fat pads of two transgenic lines (line 30 and line
87) to assess whether levels of NTR expression were reflected in differential
expression of the transgene. Figure 4.10 illustrates the result of this assay in two of
the transgenic lines analysed. Adipose tissue sections from these two lines showed
clusters of cells strongly expressing the NTR protein, surrounded by non-expressing
(silenced) cells (Figure 4.10 B and C) confirming a patchy expression of the NTR.
Variegated transgene expression has been previously observed between
individuals of the same transgenic line and it has been suggested that this effect is a
consequence of the integration site of the transgene and the number of transgene
copies (Dobie et al. 1996). In fact, both lines studied in these experiments that
showed mosaic expression had a high copy number of the transgene (>10 and >25
for lines 30 and 87, respectively). This mosaic expression may have important
implications as suggested by Dobie et al, (1996) in biotechnological applications,
such as the production of proteins of biomedical interest in the milk of transgenic
livestock. Similarly, this mosaic expression may have an important role in gene
addition experiments, such as the experiments proposed in this thesis, because
variegated transgene expression in these experiments may prevent 100% ablation of
adipose cells and therefore result in variable numbers of cells remaining in the
tissue.
90
Wild Type Transgenic line 87
Transgenic line 30
Figure 4.10 Variegated expression of NTR in the adipose tissue.
Immunocitochemistry of sections of adipose tissue from control (A) and two
different transgenic lines (line 87 B and line 30 C).
Paraffin embedded sections were hybridised with anti serum to NTR. Note the
patchy staining of the transgenic sections. Magnification: 200X A-C.
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4.7 CONCLUSION.
Microinjection of the aP2-NTR transgene (by Roberta Wallace) into single
cell mouse embryos resulted in the generation of 12 transgenic founder mice from a
total of 96 analysed, an efficiency of 13%, which compares favourably with the
efficiency observed by other groups (Boyd and Samid, 1993). All founders showed
variable copy numbers of the transgene. 11 founders transmitted the transgene into
the offspring albeit the variable rate and one did not generate transgenic offspring
presumably due to mosaic effects (Whitelaw et al. 1993). All 11 lines of mice had
approximately normal litter sizes (i.e. 8-12 pups per litter), and no obvious
phenotype was observed as result of the transgene integration.
Expression of the NTR transgene could be observed in 5 out of 11 F1 lines
generated, thus indicating that aP2 promoter used contain all the necessary
regulatory elements to drive expression of exogenous genes into adipocytes in vivo.
High levels of expression were observed in some of the lines generated (lines 87, 81
and 30) and these levels were correlated to the protein level. Expression levels of the
transgene were far from the levels observed for the endogenous aP2, which might
suggest that the promoter sequences used still lack of one or more regulatory
sequences necessary for a stronger level of expression in this tissue. Another
possibility is some silencing effects from neighbouring chromatin, which might also
explain the complete absence of expression in other transgenic lines generated.
Appropriate translation of this prokaryotic protein was also demonstrated
thus indicating that eukaryotic cells (adipocytes) have no major problems in
processing this E.coli NTR sequence. However, a mosaic pattern of transgene
expression was observed in the transgenic lines analysed, which may have some
important consequences in the proposed ablation experiments with CB1954 as
described in the next chapter.
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CHAPTER 5
5. A MOUSE MODEL TO TEST THE EFFICACY OF CB1954 MEDIATED
ABLATION IN VIVO.
5.1 BACKGROUND.
White adipose tissue (WAT) is the principal site in the body for energy
storage, using triglycerides as a remarkably efficient storage mechanism. WAT also
helps to regulate energy homeostasis (including food intake, metabolic efficiency,
and energy expenditure) via its secreted hormone, leptin and additional hormones.
The large variation in fat mass is unlike that of other tissues in the body and is
determined both by an individual's genetic background and by environmental
factors including diet and physical activity (Comuzzie and Allison, 1998). Excess of
body fat, or obesity, is a major health problem, particularly in Western societies,
increasing the risk of Type 2 diabetes, hypertension, hyperlipidemia, and coronary
artery diseases (Pi-Sunyer FX, 1993). Genetically fat mice exist and have
contributed greatly to the understanding of obesity. However, the mechanisms by
which obesity causes the associated disorders are unknown. Thus, whole animal
models are required for the understanding of these questions because obesity and
diabetes are the integrated results of signalling and metabolism in brain, liver,
muscle and pancreas, in addition to adipose tissue. Although a number of mouse
models with either increased or decreased amounts of adipose tissue have been
reported, no mouse model from either knockout or transgenic technologies had been
described, at the time of the start of this thesis, that were devoid of fat throughout
development, which may imply that fat was essential for life. Thus, the availability
of a mouse model where adipose cells could be removed at different stages ofmouse
development would undoubtedly serve to better understand the physiology of this
tissue and more importantly for the study of the associated disorders of obesity.
Chapter 3 showed that differentiated 3T3L1 cells stably expressing the NTR
gene can be successfully killed in the presence of the prodrug CB1954. Having
assessed the susceptibility of these cells to the prodrug, the next step in this project
was to demonstrate that the NTR/CB1954 system works in an animal model in vivo.
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The previous chapter described the generation and characterization of a number of
transgenic lines expressing NTR in adipose tissue, thus confirming the appropriate
expression and translation of this prokaryotic protein. This chapter now describes
the use of this novel approach of ablation to genetically remove specific cells in an
animal. This system was used to ablate adipose tissue cells in an inducible manner
through different stages of the mouse development. Upon prodrug treatment,
depletion of adipose cells in transgenic mice was observed whereas other tissues
were normal and comparable with non-transgenic treated or untreated control mice.
The effects and the consequences of the treatment with the prodrug are described.
5.2 NTR MEDIATED ABLATION OF ADIPOCYTES IN VIVO.
5.2.1 PRELIMINARY EXPERIMENTS.
Preliminary ablation experiments were carried out with one of the transgenic
lines (line 64), which had showed high levels of NTR in the adipose tissue.
Unfortunately, it was later found that this line contained double integration site of
the transgene (data not shown). This meant that the offspring had two different
patterns of transgene expression, one group with low expression and another group
with high expression, depending on the integration site of the transgene. By the time
this was discovered, one of the males with low expression levels had already been
used to propagate the line and thus all the subsequent generations of this mating had
low expression. This was discovered just after ablation experiments had been carried
out with this line, thus explaining what little effect that CB1954 had, in terms of
ablation of the adipose tissue, in this transgenic line. Northern and Western blot
analysis carried out with this line (Figures 4.6 and 4.7 in previous chapter),
suggested that this line turned out to be the lowest expressing line from all 5 lines
chosen to propagate. Therefore, subsequent ablation experiments most of which will
be described in this chapter, were carried out with line 87, which showed high
expression levels ofNTR by both assays.
Ablation experiments were normally carried out with mice housed at 20°C in
individual cages with free access to food and lights on for 12 h/day. Transgenic and
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non-transgenic littermates were injected intra-peritoneal (i.p.) with the prodrug
CB1954 suspended in arachis oil containing 10% acetone. Toxicity studies on
CB1954 carried out by Workman et al. (1986) established acceptable doses for
single and multiple doses administration in BALB/c and C3H/He mouse strains.
Therefore, preliminary studies were undertaken using multiple dose regimens of 40
mg/kg of body weight that were somewhere between the LDio of BALB/c and
C3H/He mice. This multiple dose regimen included, most typically, daily injections
for 3 days although 5 injections were also used in other experiments.
To characterise the mice, a number of tissues were dissected to assess
whether ablation had occurred. These tissues included the gonadal fat pad since it is
plentiful and can be dissected easily from surrounding tissues. The skin was also
assayed since this contains a well-defined structure and white adipose tissue begins
to appear soon after birth; liver was analysed to control for any secondary toxic
effect of the prodrug. Organ weights were also taken to monitor the effects of the
ablation of adipocytes or indirect effects of the prodrug in other tissues.
5.2.2 ABLATION EXPERIMENTS WITH LINE 87.
Ablation experiments with this line involved transgenic and non-transgenic
littermate mice of 7 weeks old that were injected intraperitoneally with CB1954 for
3 days. Another group of mice was left untreated to serve as control. An example of
a dose regimen of 40 mg/kg of body weight used is shown below in Table 5.1. The
weight of the mice was routinely monitored daily starting on injection day until the
mice were sacrificed. The first experiment was carried out with males that received
a dose regimen of 40 mg/kg of body weight. At this dose, transgenic mice, but not
non-transgenic control mice, showed loss of condition. These mice were observed to
be cold, hunched and reluctant to move immediately after the second injection.
Unfortunately, no device was available, at that time, to measure body temperature.
Therefore these mice were humanly sacrificed on the second day in conformity with
the Animals (Scientific Procedures) Act 1986, and the carcasses sent to Roslin
Nutrition for analysis of the total body lipid content, which was carried out as
described in chapter 2. Unfortunately, this analysis showed no major difference in
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the content of fat, presumably due to the short time that the mice were kept alive,
thus not giving enough time to the prodrug to act. These experiments suggested the
need of heated pads to keep the mice warm, for which the necessary amendments to
the Project License were made to allow the execution of these experiments.
Table 5.1 Dose-regimen of injections
Injections: FEMALE CB1954 (4mg/ml)





After approval of the amendments to the Project License, a different
experiment was carried out this time with females that received a similar dose-
regimen of 40 mg/kg of body weight. A drop in the body weight of mice that have
received treatment with CB1954 was observed (transgenic and non-transgenic mice
injected with the prodrug). More than half of the experimental mice started to lose
weight on day 2 of the experiments, and after withdrawal of the injections they
showed a reduction of 10-15%, suggesting that the threshold of toxicity was reached
(Figure 5.1 A), although this effect was more pronounced in transgenic mice with
some of them losing as much as 23% of body weight towards the end of the
regimen.
A reduction in the body weight was also observed in a different experiment
with males and females that received a lower dose of 20 mg/kg of body weight.
With this regimen, transgenic and non-transgenic mice treated with the prodrug lost
approximately 4 and 8% of body weight, respectively (Figures 5.2 A and B), a much
smaller reduction compared to the regimen of 40 mg/kg of body weight used with
females.
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In general, weight loss due to enteritis would be the first sign of toxicity, as
previously described in rats (Cobb LM 1970) and mice (Workman 1986). A
loss of body weight has also been observed in other experiments involving mice that
have been injected with CB1954 (Drabeck 1997; Cui personal communication)
and it has been suggested that this effect is partly due to the effects on NTR positive


















Figure 5.1 Measurement of body weight during treatmentwith CB1954.
7 week old transgenic (T) and non-transgenic (NT) littermate mice were injected (T)
with CB1954 at doses of 40 mg/ kg of body weight for 3 days. Another non-
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Figure 5.2 Measurement of body weight during treatment with CB1954.
7 weeks old transgenic (T) and non-transgenic (NT) littermate mice were injected
(T) with CB1954 at doses of 20 mg/ kg of body weight for 3 days. Another non-
transgenic group was left untreated (NT-UT)
A) Male, B) Female.
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There was another effect of the treatment with the prodrug, which was
observed only in the transgenic group that received this higher dose of 40 mg/kg of
body weight (females). These mice were found to be hunched, cold and reluctant to
move after treatment with the prodrug. When body temperature was measured, this
time with a rectal thermometer, a considerable drop in approximately 5°C
(32°C±0.5) compared to the control groups (37°C±0.6) was observed. A drop in the
body temperature has also been observed previously in mice devoid of fat (Moitra et
al. 1998). This drop in body temperature was suggested to be due to the effects of
the loss of fat, which is needed for heat production. This group described that
husbandry of fat depleted mice was not trivial and they required heated pads to keep
the mice warm. Nevertheless, mortality of approximately 60% was observed at
weaning of these mice.
A similar device was used in these transgenic mice treated with CB1954.
Unfortunately, heated pads did not improve the conditions of the mice, albeit a slight
recovery in the body temperature that was observed, which meant that these mice
were humanly sacrificed at the end of the day (day 3 of the injections for this
experiment). A similar effect was observed in other two transgenic mice in this
group although this effect was observed later than the first group (day 5 and 6).
Another transgenic mouse was found dead on day 6 and was not included in the
analysis. The cause of death is unclear but it might be a direct consequence of the
ablation of adipose cells or a secondary toxic effect of the prodrug. In contrast to
transgenic mice, non-transgenic mice injected with the prodrug did not show this
effect and the only effect of the prodrug observed in these mice was a drop in the
body weight as already discussed above.
Earlier toxicology experiments carried out by Workman et al. (1986) also
showed a marked reduction in the body weight of up to 30% at non-lethal doses of
CB1954. At higher doses, toxic symptoms developed towards the end of the regimen
as described by these authors. These symptoms included shaking, splaying of the
hindlimbs, and walking on tiptoe, all indicative of neurotoxicity. In the experiments
described in this section neither transgenic nor non-transgenic mice treated with
CB1954 showed these symptoms.
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Transgenic mice that received a lower dose of 20 mg/kg of body weight
showed no signs of morbidity with this regimen and there was no need to sacrifice
them earlier than planned. Despite the lost in body weight, these mice (transgenic
and non-transgenic injected with CB1954) tended to recover their body weight
almost immediately after withdrawal of the injections with this effect being more
pronounced in the transgenic group that had lost more weight than non-transgenic
group injected with the prodrug (Figure 5.2 A). The same effect was also observed
in another experiment involving females that had received this lower dose of 20
mg/kg of body weight (Figure 5.2 B). Interestingly, despite having lost more weight
than the control group (-6%), transgenic females recovered their weight and
eventually weighed more after these 7 days of prodrug free period. It might be
suggested that this recovery in the body weight has a major component in leptin
levels falling down in parallel to the adipose stores. This would derive in an
increased food intake and decreased energy expenditure as leptin acts as a feedback
loop to maintain constant stores of fat (Flier, J.S 1997). Although food intake was
not measured in these experiments, confirmation of a possible involvement of leptin
will come from another experiment were leptin levels where directly measured in
the plasma of transgenic mice after the treatment with CB1954, as will be described
in the next chapter.
5.2.3 ANATOMICAL CHARACTERISTICS OF TRANSGENIC MICE
AFTER TREATMENT WITH CB1954.
Autopsy of these mice revealed a considerable reduction in the size of the
adipose stores in the transgenic groups, with this effect being more pronounced in
the group of females that received the higher dose of 40 mg/kg of body weight. In
fact, three of these mice that were sacrificed earlier after been in the heated pads,
showed no visible adipose mass in any of the fat depots analysed, including
parametrial (gonadal), retroperitoneal and inguinal. The inguinal and paramesial fat
pads of two other mice that were sacrificed later (day 4 and day 5 in Fig 5.1) were
significantly reduced (PO.OOl), weighing only 20 and 40% of control mice,
respectively (Figure 5.3 A and Table 5.2 A). The interscapular brown adipose tissue
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(BAT) in transgenic mice were also reduced in size, although this effect was not
significant due to the high variation that was observed between individuals of this
group. In contrast, non-transgenic mice injected with CB1954 had comparable levels
of adipose mass to the control untreated group albeit a slight reduction that was
observed in the inguinal fat mass of this group that might indicate an indirect effect
of the prodrug concomitant with the reduction in body weight.
Transgenic males that received a lower dose of 20 mg/kg of body weight also
showed a considerable reduction of the adipose stores (Table 5.2 B) although this
effect was not as marked as in the female group that received 40 mg/kg of body
weight. The epididymal fat pads of transgenic mice weighed on average 60% less
(P=0.01) than the control untreated group (Figure 5.3 B and Table 5.2 B). A small
reduction was also observed in the non-transgenic treated group but this reduction
was not significant when compared by a Student t test with the untreated group (data
not shown). A small reduction of fat was also observed in the inguinal fat pads of
females in the experiment described above. This effect might be due to normal
variation that may be observed between mice in whose case it should disappear if a
larger population is included in the analysis. Another possibility is an indirect effect
of the prodrug concomitant with the reduction in body weight that is observed in
these mice after treatment with CB1954. Retroperitoneal fat pads of transgenic mice
were also significantly reduced by 50% (P=0.01) compared to the levels of the other
two control groups (Table 5.2 B).
Comparison of the other organs showed a reduction in the size of the spleens
for both groups (transgenic and non-transgenic) injected with CB1954 at this higher
dose of 40 mg/kg of body weight. A possible explanation for this effect has been
previously suggested by Drabeck et al. (1997). Since the prodrug is administrated
intraperitoneally, the spleen is accessible almost immediately after injection and will
experience a much higher local concentration of prodrug than other organs. Another
possible explanation is some leaky expression of the transgene in the spleen, thus
explaining the smaller size in the transgenic group compared with the non-
transgenic group treated with the prodrug (Table 5.2 A).
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T-T 15.6+0.6 0.07±0.01 0.08+0.01 0.18±0.05 4.50±0.1 0.77±0.03 0.20±0.01 0.52+0.05
(n=4) * ¥ ¥ *
NT-T 15.1±0.3 0.17+0.01 0.32+0.05 0.27±0.01 4.70+0.7 0.70±0.05 0.25±0.01 0.56+0.02
(n=2) * *
NT-UT 18.0±0.4 0.15±0.01 0.42±0.02 0.23+0.04 4.60±0.2 0.71±0.06 0.3410.05 0.5810.02
(n=3)
P Value *=<0.05 ¥=<0.0001


















T-T 24.5+1.1 0.2710.01 0.0710.01 0.1910.03 5.45+0.1 0.69+0.03 0.24+0.02 0.52+0.02
(n=3) * * ¥ ¥
NT-T 23.8+0.7 0.5110.07 0.13+0.01 0.1510.01 4.8610.2 0.7810.01 0.2710.02 0.4910.01
(n=3)
NT-UT 26.011.3 0.6410.04 0.1310.01 0.1510.05 4.7010.1 0.8110.04 0.2910.03 0.54+0.03
(n=2)
P Value *=<0.01 ¥=0.06
Data are mean ± S.E.M. Animals were transgenic and non-transgenic littermate of 7
weeks old. The organ weights were measured as a percentage of the animal's body
weight. Probabilities (P) are from ANOVA one way. Groups with significant
differences are shown.
T-T: Transgenic mice treated with CB1954, NT-T: Non-transgenic mice treated with
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Figure 5.3 Appearance of fat depots in wild type and transgenic mice treated
with CB1954.
A) Peritoneal cavity showing the different fat depots of a wild type (left) and
transgenic littermate (right), age 7 weeks old, after treatment with CB1954.
B) Photomicrograph of testes showing the reduction of fat in the epididymal fat
deposits of the transgenic mouse, compared to the wild type control.
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Interestingly, toxic effects in the spleen was not observed at this lower dose
of 20 mg/kg of body weight (Table 5.2 B), as the size of the organ was comparable
to the size of control groups. Visual inspection of other tissues showed no great
difference suggesting a specific effect in the adipocytes. Although, small and large
intestines were found distended, possibly confirming the enteritis described by Cobb
L. M. (1970) (Figure 5.3 A) with this effect being also correlated to the dose of
CB1954 used. This would explain the lack in gain of body weight experienced by
the mice while treated with the prodrug.
5.2.4 HISTOLOGICAL CHANGES IN THE FAT OF TRANSGENIC MICE
TREATED WITH CB1954.
The white adipocyte is characterised by a single large lipid droplet that
occupies most of the cytoplasmic space pushing the nucleus to the cell periphery. In
contrast, the brown adipocyte has a dense cytoplasm, with multilocular lipid
droplets, caused by its high content of mitochondria. Histologic sections of the
inguinal fat pads in control mice, stained with hematoxylin and eosin, showed
mature adipocytes of uniform size each of which contained a characteristic
unilocular fat droplet (Figure 5.4 A). In contrast, remaining inguinal fat pads of
transgenic female that received a dose of 40 mg/kg of body weight contained a
mixture of mature and immature adipocytes with some empty spaces occupied by
stroma where adipocytes have disappeared (Figure 5.4 B). Epididymal fat pads of
male that received this lower dose of 20 mg/kg of body weight did not show this
marked disappearance of adipocytes as was observed with females (not shown) in
part due maybe to the lower dose of CB1954 that was used in this group and
presumably due to the rapid removal of death cells by the phagocytic machinery, as
these mice were sacrificed 7 days after the beginning of the experiments, which is in
contrast to the female group that was sacrificed much earlier.
In contrast to wild type WAT, BAT of control mice contained large areas of
typical mitochondria rich eosinophilic cells with multiple lipid droplets as well as
regions of white fat (Figure 5.4 C). Histological examination of the brown fat in
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transgenic females, at this high dose of CB1954 showed some atrophic cells, which
were palely stained with the eosin, presumably indicating reduction in the
mitochondrial content, and the white fat that covers the brown fat as the mice ages
was virtually absent (compare Figures 5.4 C and D). This atrophy of the brown
adipose tissue might explain the impaired ability to thermoregulate the body
temperature that was observed in these mice, since it is well known the function of
BAT in non-shivering thermogenesis, in which fuel oxidation is uncoupled from
ATP synthesis to generate heat. One way to demonstrate whether BAT was
functional could have been by exposing these mice to cold and measuring the UCP
content. It is predicted that ifBAT thermogenesis was indeed impaired, the levels of
UCP would not increase. Although due to the lowered body temperature that was
observed in these mice they may have not been able to withstand the cold.
Unfortunately, cold exposure experiments were not permitted in the Project licence.
Analysis of sections of brown adipose tissue in mice that received the lower
dose of the prodrug, showed no major histological difference with control groups,
which confirms the ability of these mice to cope with this regimen of CB1954 (nor
was a reduction of body temperature observed in these mice). Although in sections
of some transgenic mice it was possible to observe less eosinophilic staining
(compare Figures 5.5 C and D).
Since the aP2 promoter/enhancer is expressed in both WAT and BAT
adipose tissues, one might have expected that the BAT would also be ablated. In
fact, Northern blot analysis described in section 4.6.4 in previous chapter confirmed
expression of the transgene (NTR) in this tissue. Nevertheless, from the histology
studies carried out in these mice it seems that only white adipocytes were ablated,
although definitive proof of this should come from analysis of the cellular and total
protein content of this tissue.
It is possible that a selection exists against BAT ablation, although viable,
partially BAT-ablated mice have been produced (Lowell et al. 1993). Other two
mouse models showed a similar resistance of the brown adipose tissue to the
ablation (Shimomura et al. 1998; Moitra et al. 1998). Both teams genetically
blocked the growth of fat cells by altering transcriptions factors that are crucial to
cell growth and differentiation. The changes produced by these two teams have
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similar effects: The mice were born with little or no white adipose tissue, while the
brown adipose tissue was only reduced in size in one case and enlarge with the
appearance of inactive brown cells in the other. It is not clear the partial resistance
of brown adipocytes to the ablation since the same aP2 promoter/enhancer was used
in these studies, but a suggestion given by one of the authors pointed to a
homeostatic response of the brown adipocyte to an altered metabolic status of these
mice (Moitra et al. 1998).
Haematoxylin and eosin staining of sections of the skin showed a
considerable reduction of the adipose cells in the sections of transgenic mice and in
some occasions there was a complete disappearance of the adipocytes. This effect
was especially evident, in transgenic females that received the higher dose of
CB1954 (Figures 5.4 E and F). Transgenic male with the lower dose also showed a
reduction in the adipocytes (Figure 5.5 A and B), although this effect was not as
marked as with females at the higher dose. This might be in part due to the lower
dose of CB1954 used with males although the control groups showed in general
lower number of adipocytes (compare Figures 5.4 E and 5.5 A). This effect might be
due to sex differences with female having more fat than male as both group of mice
were of the same age. Thus, these results confirmed that ablation of adipocytes was
not restricted to a specific fat deposits.
Histological analysis of the livers in transgenic mice showed some diffuse
swelling of hepatocytes with disorganization of the hepatic cords and most blood
vessels were congested with blood (Figure 5.4 H). This effect was observed with
both regimens of CB1954 (20 or 40 mg/kg of body weight) although it was not
observed in all mice. This might explain the larger size of the livers that was
observed in especially transgenic male with the dose of 20 mg/kg of body weight
which, might indicate the effects of the toxic metabolites of CB1954 being
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Figure 5.4 Histology of different tissues after treatment with CB1954.
Histological sections ofwhite fat (A and B), interscapular brown fat (C and D), skin
(E and F), and liver (G and H) from 7 weeks old female transgenic (B, D, F and H)
and non-transgenic (A, C, E and G) littermates.
Tissues were fixed in NBF and paraffin-embedded sections stained with
hematoxylin and eosin. Magnification: 100X A,B>C, D, E and F; 40X G and H.
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Wild Type Transgenic
Figure 5.5 Histology of different tissues after treatment with CB1954.
Histological sections of skin (A and B) and interscapular brown fat (C and D) of
wild type and transgenic mice are shown.
Tissues were fixed in NBF and paraffin-embedded sections stained with
haematoxylin and eosin. Magnification: 100X A and B, 200X C and D.
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To confirm the insitu death of adipocytes after treatment with the prodrug,
paraffin embedded sections of remaining inguinal adipose tissue was analysed by the
Tunel assay as described in section 3.10 in chapter 3. Figure 5.6 shows the result of
this assay demonstrating the presence of some apoptotic cells only in sections of
transgenic mice that were treated with the prodrug (panel B), while the control
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Figure 5.6 In situ Tunel Assay.
The Figure shows the result of the Tunel assay carried out in paraffin embedded
sections of inguinal fat pads of females treated with CB1954 at doses of 40mg/kg of
weight. Control non-transgenic treated (A) and transgenic treated (B) are shown.
Magnification: 40X
The results shown in the last two sections clearly demonstrate selective
killing of adipocytes in transgenic mice expressing NTR in these cells. The
magnitude of adipose tissue ablation also correlated to the morbidity effects
observed in these mice. While a lower dose of 20 mg/kg of body weight produced a
partial reduction of adipocytes without any signs ofmorbidity. A higher dose of 40
mg/kg of body weight resulted in a complete disappearance of any visible adipose
depots in some transgenic mice. This reduction of adipose tissue had important
implications especially in the ability to thermoregulate body temperature. Some
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morbidity effects could be observed after 72 hours of the treatment with mice
showing signs of cold and inactivity. More severe cases included the death of some
mice, which although is not clear at this stage, this might be the direct result of the
loss of fat thus confirming that fat is important for life or an indirect effect of the
toxic metabolites of CB1954. Previous experiments using transgenic technology
failed to generate transgenic mice devoid of fat throughout development, which
suggested that WAT was essential for life (Ross et al. 1993; Wang et al. 1995;
Burant et al. 1997). Nevertheless, the work of Moitra et al (1998) and Gavrilova et
al. (1998), confirmed the survival of mice devoid ofWAT, although these two teams
observed mortality of 60% and 20%, respectively, which corroborates the
importance of adipose tissue for normal development of life.
The morbidity shown only by transgenic mice after treatment with the
prodrug resembles a torpor-like state. Torpor, corresponds to a hibernation-like state
that is characterised by inactivity, a lowered body temperature (Tb), and a low
metabolic rate (Webb et al. 1982). Although metabolic rate was not measured in
these mice, they did show inactivity and a low body temperature. Furthermore,
histological examination of the brown adipose tissue confirmed some atrophy of this
tissue thus, suggesting that non-shivering thermogenesis may have been impaired.
The magnitude of the ablation correlated directly with this effect. Thus, females that
received the higher dose of 40 mg/kg of body weight showed extensive depletion of
the adipose stores, which was also correlated with a lower body temperature. This
effect was not observed when a lower dose of 20 mg/kg of body weight was used
although the ablation in these mice was not as marked as the former group.
It has been suggested that some birds and small mammals routinely use daily
torpor to conserve energy, although the drop in Tb may be only a few degrees. In
contrast, hibernation corresponds to a state of deep torpor that can last for days to
even months. Although mice and other small mammals do not use hibernation,
possibly because they can not store enough fuel, it has been documented that mice
can enter torpor when there is a quiet environment, reduced food availability, and a
low ambient temperature (Webb et al. 1982).
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The ob/ob mice are an exception, entering deep torpor upon fasting and
occasionally entering torpor when well fed and housed at room temperature
(Himms-Hagen, J. 1985). It has been recently reported that leptin treatment not only
prevents deep torpor in these mice, but also the modest 4°C fall in the body
temperature, thus suggesting that leptin has an important role in regulating Tb and
torpor (Gravilova et al. 1999). The same team also demonstrated that another
mechanism (leptin-independent) is responsible for entry into torpor in a different
mouse model (A-ZIP/F1 mice). This mouse model is characterised for an almost
complete lack of adipose stores and undetectable levels of leptin. Interestingly,
leptin treatment did not prevent these mice from entering into torpor. Thus,
Uravilova et al. (1999), suggested that this second mechanism (leptin-independent)
might be provided by a signal(s) from adipose tissue besides leptin.
In the light of these results it might be suggested that transgenic mice treated
with CB1954 could enter to a torpor-like state judging by the reduced body
temperature and inactivity that was observed, with this effect being the direct result
of a decreased in the levels of leptin (see section 6.3 in chapter 6) or a secondary
effect of the loss of fat, as was shown above. Non-transgenic mice injected with
CB1954 showed no such phenotype as described with the transgenic group, nor was
a drop in the body temperature observed in these mice, which suggests that the
effect seen in transgenic mice treated with the prodrug is a direct effect of the
activation ofCB1954 with the end result being the ablation of the adipocytes.
Experiments described with females that received a dose of 40 mg/kg of
body weight confirmed a reduction in the wet weight of the spleens when compared
to the non-transgenic group also injected with the prodrug (Table 5.2 above).
Therefore, it might be suggested that some of this variability observed in response to
the prodrug is due to ectopic expression in tissues other than the adipose. In fact,
section 4.6.3 in chapter 4 suggested ectopic expression in the spleen, with the
possibility of ectopic expression in other tissues that were not included in that
analysis. In any case, it is more likely that the ectopic expression observed in the
spleen is the result of the integration site of the transgene, as the regulatory
sequences used to direct the expression of NTR have been previously used by other
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groups demonstrating tissue-specific expression to the adipocytes (Ross et al. 1990;
Ross et al. 1992; Moitra et al. 1998, Gravilova et al. 1998).
Another potential effect of the prodrug is the possibility of a bystander effect
of the toxic metabolite. As was confirmed earlier in chapter 3, NTR/CB1954
mediates a bystander effect in cells through the released of a toxic metabolite that
can migrate and kill neighbouring cells. It must be underlined the fact that this is the
first time a transgenic model has been created expressing NTR in different deposits
of the body, as other studies have localised expression to a particular area or tissue.
Thus, if produced, one might expect that this toxic metabolite diffuses to the
bloodstream with the potential of causing some toxic effects elsewhere. One way to
confirm this could be measuring the toxic metabolite directly in the blood of
transgenic mice after treatment with CB1954.
5.3 CONCLUSION.
Treatment of transgenic mice with the prodrug CB1954 resulted in the
selective ablation of the adipose cells whereas other tissues were normal and
comparable with non-transgenic treated or untreated control mice, confirming the
efficacy of this system to kill terminally differentiated (non-dividing) cells in an
animal model.
Histological analysis of paraffin-embedded tissues stained with hematoxylin
and eosin provided direct evidence of the change in tissue morphology.
Furthermore, this analysis indicated that ablation of adipocytes was not restricted to
specific adipose depots, as all major adipose depots analysed showed reduction or
disappearance of the adipose cells.
The magnitude of cell ablation was correlated to the dose of CB1954 used
with a much stronger effect at doses of 40 mg/ kg of body weight. This higher dose
produced complete disappearance of any visible adipose depot in some transgenic
mice, thus suggesting that a bystander effect may have occurred in vivo, since
immunohistochemical analysis in sections of adipose tissue confirmed variegated
transgene expression in these cells. The lack of adipocytes, at this higher dose of
CB1954, had also dramatic consequences in some transgenic mice especially in their
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ability to thermoregulate the body temperature. More extreme cases included the
death of some mice indicating that fat is an important organ for life.
A lower dose of 20 mg/kg of body weight was also shown to be effective in
ablating adipose cells of transgenic mice. Although the extent of the ablation was
not as marked as with higher doses, as seen with females, these mice responded
better and could be kept alive until the end of the proposed experiment, thus
enabling the use of this model for studies related to the consequences of fat ablation
and fatty acid metabolism. Importantly, toxic effect were not observed in the spleen
of these mice although liver and kidneys were found slightly increase and decrease
respectively, which might suggest an effect of the prodrug and its metabolites in
these two likely routes of excretion.
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CHAPTER 6
6 CONSEQUENCES OF ADIPOSE TISSUE ABLATION USING
NTR/CB1954 SYSTEM.
6.1 BACKGROUND.
The last chapter described the use of this novel approach NTR/CB1954
system to remove adipocytes in an animal model. Upon prodrug treatment, depletion
of adipose cells in.transgenic mice was observed whereas other tissues were normal
and comparable with non-transgenic treated or untreated control mice. While higher
doses of CB1954 produced a marked reduction in the adipose tissue of transgenic
mice, these mice showed a deterioration of the condition possibly by an impaired
ability to thermoregulate body temperature. This led to the premature killing ofmost
of the experimental animals. When lower doses of CB1954 were used, a smaller
effect in terms of ablation of the adipose tissue was observed, although these mice
responded better and could be kept alive until the end of the proposed experiments,
thus enabling the use of this model for studies related to the consequences of
adipose tissue ablation.
This chapter describes some of the physiological and metabolic
consequences of the ablation of adipose tissue in mice treated with the prodrug
CB1954 and describes the experiments carried out to assess whether regeneration of
adipose tissue occurs after ablation with CB1954.
6.2 DOES THE FAT REGENERATE AFTER TREATMENT WITH CB1954.
Previous experiments have shown that treatment with CB1954 lead
invariably to a reduction in the body weight in a dose dependent fashion. Thus, mice
injected with 40 mg/kg of body weight showed a reduction of approximately 15%
and mice injected with 20 mg/kg of body weight showed a reduction of
approximately 8%. The cause of this reduction has been already explained in
previous chapter. Interestingly, withdrawal of the injections led to the recovery in
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the body weight with this effect being more pronounced in the transgenic treated
group (Figures 5.2 A and B in previous chapter and Figure 6.1 later). Thus, the
question arose as whether the gain in body weight is in parallel to a gain
(regeneration) of the adipose tissue lost after ablation with CB1954.
Two different approaches were designed to address this question. A direct
measurement of the wet weight of some of the adipose stores after a short ablation
period of 5 days and after similar ablation schedule but with a prodrug free period of
30 days. The second approach used was to measure the total body lipid content in
the carcasses of these mice after similar periods as described above. The next two
sections describe the results obtained in these two approaches.
6.2.1 DIRECT MEASUREMENT OF THE WET WEIGHT OF FAT DEPOTS
AS AN INDICATOR OF ADIPOSE TISSUE REGENERATION.
For this experiment two groups of male mice (7 weeks old) were injected
with CB1954 at doses of 20 mg/kg of body weight but with a regimen of 5 injections
instead of 3 that had been previously used. The extension of the ablation was
assessed by monitoring the change in wet weight of the epididymal fat pad (as a
percentage of body weight) as these traits have been shown previously to be highly
correlated to total body fat percentage in mice (Rogers and Webb, 1980). Two
different groups of mice were injected with CB1954 for 5 days and sacrificed after 5
days (first group) and after a recovery period of 30 days (second group). Weight of
the mice was monitored as described before starting on injection day until the mice
were sacrificed.
With this regimen, 6 out of 20 transgenic mice (2 in the first group and 4 in
the second group) showed loss of condition (mice hunched) and were sacrificed
earlier. These mice were not included in the final analysis. Non-transgenic mice
injected with the prodrug were not affected. Figures 6.1 A and B show first the
effect in the total body weight of the mice after treatment with the prodrug.
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Figure 6.1 Measurement of body weight during treatment with CB1954.
Groups of transgenic (T) and non-transgenic (NT) mice at the age of 7 weeks were
injected with the prodrug and sacrificed at day 5 (A) or after a 30 days recover





of body weight in the group sacrificed at day 5 (Figure 6.1 A). In the second group,
the loss in body weight was more pronounced in the transgenic group with a drop of
approximately 12% compared to non-transgenic group that lost on average 4%.
Withdrawal of the prodrug led to the recovery in the body weight of both groups.
Interestingly, despite having lost more weight, transgenic group recovered their
body weight and eventually weighed more toward the end of the experiment (Figure
6.1 B).
Comparison of the different adipose deposits and organ weights showed a
significant reduction of the adipose stores especially in the epididymal fat pads of
transgenic mice (Table 6.1 and Figure 6.2) that weighed on average 40% less than
the non-transgenic treated group (P=0.02). A smaller effect was observed in the
retroperitoneal fat pads, presumably due to the lower levels of NTR expression that
has been observed in this tissue (section 4.6.4 in chapter 4), and/or due to inaccurate
measurement of this small deposit. No major differences were observed with the
other organs with the exception of the liver that increased significantly (P=0.002) in
the transgenic group compared to the non-transgenic group. The experiment
described already in previous section shows a similar effect in the liver of transgenic
mice that had received 3 injection of CB1954, although the effect was not as marked
as in this group.
Table 6.1 Body composition after 5 days of prodrug treatment.
Body Weight Epididymal Retro Interscap. Liver Kidney Spleen Heart
Grams (WAT) (WAT) (BAT)
(%) (%) (%) (%) (%) (%) (%)
T-T 24.7±0.8 0.40+0.06 0.08+0.01 0.19+0.01 4.61±0.1 0.74+0.04 0.17+0.01 0.53+0.02
(n=8) * ¥
NT-T 25.8+0.8 0.69±0.1 0.10±0.02 0.17+0.01 4.00±0.1 0.76+0.04 0.19+0.01 0.54+0.03
(n=5)
P Value *=0.02 ¥=0.002
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29.5+0.8 0.75+0.05 0.21+0.02 0.16+0.01 4.36+0.1 0.87+0.03 0.21+0.02 0.47+0.02
P Value *=0.001
Data are mean ± S.E.M. Animals were transgenic and non-transgenic littermate of
10 weeks old (first group) and 14 weeks old (second group). The organ weights were
measured as a percentage of the animal's body weight. Non-transgenic mice
untreated were not included in this experiment due to the little number of mice
available.
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Figure 6.2 Analysis of the fat pad weight.
Fat pad weight was compared in transgenic (T) and non-transgenic (NT) mice
treated with CB1954 at 5 days and after a recover period of 30 days, as a measured
of adipose tissue regeneration.
A two-tailed unpaired Student's t Test was used for statistical analysis showing
significance (P=0.02) in the transgenic group sacrificed at day 5, but not in the group
sacrificed after 30 days.
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After 30 days of prodrug free period, the second group of transgenic mice
have increased the mass of adipose tissue, as represented by the wet weight of the
epididymal (Table 6.4 and Figure 6.2) from 0.40% to 0.58% a total increased of
18%. A small increased of 8% was also observed in the non-transgenic group (from
0.69% to 0.75%). As result, the significant difference that was observed in the first
group (P=0.02) disappeared in the second group (P=0.14), thus suggesting a greater
degree of regeneration of the adipose tissue in the transgenic group.
It is necessary however, to point out that the regrowth of adipose mass
observed in the second transgenic group may be underestimated by the lag time at
which experiments were terminated. Thus, while mice in the first group were
sacrificed at day 5, the mice in the second group were sacrificed much later giving
longer time to the prodrug to act and consequently for the cells to die. This might
then suggest that those mice in the second group had a more marked ablation
compared to the first group, which in principle would indicate that the transgenic
mice in the second group have in fact recovered more fat than the data suggests in
Figure 6.2. The fact that 4 transgenic mice in this group showed loss of condition
and had to be sacrificed earlier confirm a stronger ablation beyond 5 days (two of
these mice were sacrificed on day 7 and other 2 on day 8). Experiments carried out
with cells in vitro (described in section 3.7 in chapter 3) showed cytotoxicity in cells
stably expressing NTR that were treated with a lower dose of lOOpM of the prodrug,
nevertheless these cells required longer time to show similar toxicity compared to a
higher dose of 200pM. A similar rationale may help us understand the stronger
ablation effect that was observed in transgenic male that received a regimen of 3
injections of 20 mg/kg of body weight (as described in previous chapter). These
mice showed a reduction of 50% of fat mass (as represented by the epididymal fat
deposit), compared to the non-transgenic treated group, however these mice were
sacrificed after 8 days of the first injection compared to the 5 days of the mice in the
first group of this experiment.
In order to confirm the previous suggestion that cells may require longer
time to die it was decided to carry out immunocytochemical analysis with the hope
that this assay would show in situ the effects of the prodrug on the nitroreductase-
expressing cells. Figure 6.3 A, shows the results of this assay in sections of adipose
119
tissue (epididymal fat pads) of transgenic mice that were killed after 5 days of
treatment with the prodrug. This Figure confirms that after 5 days of treatment there
is a small number of NTR-expressing cells still in the section. It is also possible to
see immunostaining between the cells, which would indicate that these cells are
dying or disappearing from the tissue (presumably these cells are being removed by
the phagocytic machinery). Another interesting observation from this section is the
large number of NTR-nonexpressing cells thus confirming the variegated transgene
expression previously shown in section 4.6.5 (chapter 4). Thus, this result confirms
the previous observation that 5 days may not be enough time to kill all NTR-
expressing cells. On the other hand, the pattern of variegated transgene expression
that is observed in these sections might also help to explain the variation that has
been found, in terms of ablation of adipose tissue, in some of the transgenic mice.
After 30 days of prodrug free period, immunostaining of sections of
transgenic mice have disappeared which suggest that all NTR-expressing cells have
been killed. (Figure 6.3 B). Interestingly, this result indicates that NTR-expressing
cells do not have the ability to regenerate after ablation. At first impression this
might suggest that regeneration of the adipose tissue might be accomplished mainly
by hypertrophy of remaining NTR-nonexpressing cells. Nevertheless, after a closer
examination of these sections it is evident that there is a large variation in the size of
the cells, with some small (immature) adipocytes growing alongside the mature
adipocytes. Because the age of these mice is approximately 14 weeks, one should
expect to see a very regular appearance, in terms of the size of the cells, in these
sections. This might suggest then that hyperplasia (increase in the number) is also
involved, and more intriguingly this hyperplasia did not include newly formed
transgenic cells.
It is not clear at this point why NTR-expressing cells do not have the ability
to repopulate after ablation with CB1954. One possibility is that stem cells are more
sensitive to CB1954 itself. Another possibility is that ablation of NTR-expressing
cells may have killed stem cells or preadipocytes by a bystander effect as observed
in vitro (section 3.11 in chapter 3). Furthermore, this bystander effect could be
enhanced by toxic cellular debris that is generated from dying cells.
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CB1954 5 days
Sacrificed at day 5
CB1954 5 days
Sacrificed at day 30
CB1954 5 days
Sacrificed at day 30
Figure 6.3 In situ killing of NTR expressing cells after prodrug treatment.
Immunohistochemistry of sections of adipose tissue from transgenic mice treated
and sacrificed at day 5 (A) and treated and sacrificed at day 30 (B).
Paraffin-embedded sections were hybridised with anti serum to NTR. Magnification:
200X A and B, 100X C.
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Due to the developmental expression of the aP2-driven NTR transgene,
direct ablation of preadipocytes would not be expected under these conditions (aP2
is expressed only in differentiated adipocytes). Further experiments are required to
confirm whether these NTR-expressing cells can repopulate after a longer time than
used in these experiments.
Analysis of the other organs showed that the kidneys of transgenic mice were
significantly decreased in size after this 30 days recovery period (Table 6.2). This
effect in the kidney might be attributed to the excretion of CB1954 itself and the
toxic metabolites of this, after activation with CB1954 in the adipose tissue ofNTR-
expressing cells. In fact, earlier experiments carried out by Cobb, (1970) using
CB1954 at toxic doses, showed similar effects in the urinary tract of rats with an
increased frequency ofmicturition especially in females. Other effects observed by
this author were histopathological changes in the liver and lung. Although lungs
were not examined, livers were significantly increased in size in the transgenic
group sacrificed at day 5. This difference disappeared in the second group
(sacrificed at day 30), which may indicate the effects of the toxic metabolites of
CB1954 being metabolised and excreted by the liver.
Histological examination of the livers showed some localised hypertrophy of
hepatocytes and in some occasions the liver was congested with blood thus
confirming the above observation. Experiments described in the previous chapter
showed a similar tendency (although not statistically significant) in livers and
kidneys of transgenic male mice that were treated with 3 injections of 20 mg/kg of
body weight thus, confirming the indirect effects of the prodrug in these tissues.
CB1954 induced toxicity in mice (except in those tissues expressing NTR as
a transgene) was not observed in a previous study using 50 mg/ kg of body weight,
although in this study CB1954 was given for 3 days and the mice sacrificed shortly
after the last injection (Clark et al 1997). However, in a different study mice
receiving 20 mg/ kg of body weight of CB1954 for 5 days had 15% weight loss and
mice receiving 50 mg/ kg of body weight experienced severe multiorgan toxicity
(Drabeck et al. 1997). In a more recently performed study Westphal et al. (2000),
observed hair loss using CB1954 dose of 20 mg/ kg of body weight in SCID mice,
which indicates that certain mammalian cells may be able to metabolise CB1954
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into a toxic form or may be more susceptible to the prodrug itself even if it remains
unmodified.
6.2.2 ANALYSIS OF THE TOTAL BODY LIPID CONTENT (CARCASS).
Due to the possibility of variegated transgene expression that was observed
in the transgenic mice (section 4.6.5 in chapter 4), the experiments described above
might have underestimated the total effect in the ablation of adipose tissue as only
few selected adipose deposits were used for the analysis. To overcome this effect, it
was decided to carry out an analysis of the total body lipid content with the rationale
that this assay would not only demonstrate the overall reduction in the adipose tissue
but also confirm whether regrowth of this tissue occurs after a recovery period
without the prodrug.
Bearing in mind the loss of condition observed with doses of 40 mg/kg of
body weight and with 20 mg/kg of body weight in the regimen already described of
5 injections, it was decided to use a regimen of only 3 injections of 20 mg/kg of
body weight. Thus, two groups of female mice were treated with the prodrug and
sacrificed at day 7 (first group) and after 30 days of prodrug free period (second
group). Carcasses of these mice were frozen and sent to Roslin Nutrition for the
analysis of the total body lipid content, which was carried out as described in
chapter 2.
The mice used for this experiment included transgenic mice injected with
CB1954, transgenic mice injected only with the vehicle solution (arachis oil), and
non-transgenic mice injected with CB1954. Figures 6.4 A and B show similar
effects of the prodrug in the body weight as in the previous experiment, although a
less marked reduction was observed with this regimen. Transgenic and non-
transgenic mice treated with the prodrug lost approximately 5-6%, respectively and










Figure 6.4 Measurement of the body weight during treatment with CB1954.
Transgenic (T) and non-transgenic (NT) mice were injected with the prodrug and
sacrificed at day 7 (A) or after a 30 days recover period (B). T-Mock represents mice
injected with the solvent solution. The mean body weights ± SD are plotted.
124
The results of the carcass analysis carried out in these mice allowed to
confirm an effect of a lower dose of CB1954, in terms of ablation of adipose tissue
(Table 6.3). Absolute fat mass was decreased in the transgenic treated group by 30%
compared to the other two groups. This reduction of fat mass was significant to 94%
(P=0.06) when fat was expressed as relative to body weight. As expected, relative
lean body mass increased in this group. Interestingly, a second group of mice that
was treated in a similar way but left to recover for 30 days showed no such
difference. As shown in table 6.4, transgenic mice after a 30 days period have
normalised all parameters and the significant differences that were observed in the
first group are not evident any more in the second group. Thus, taken together these
results suggest that after ablation of adipose tissue remaining cells are able to
regenerate. The mechanism on how this happens is not clear at this point but it
might involve hyperthropy or hyperplasia of the remaining cells in the tissue, as was
described in previous section.
Table 6.3 Body lipid content analysis (7 days).
Transg. CB1954 Transg. Mock Non-T CB1954 P Value
Body weight (g) 18.5±1.0 21.011.0 21.211.2 0.22
Lean Body mass (g) 17.3±1.0 19.210.9 19.510.9 0.30
Lean body mass % BW 93.5±0.2 91.610.2 91.810.6 0.06
Fat mass (g) 1.2±0.1 1.810.1 1.810.2 0.06
Fat mass % of BW 6.4±0.2 8.410.2 8.210.6 0.06
Table 6.4 Body lipid content analysis ([28 days).
Transg. CB1954 Transg. Mock Non-T CB1954 P Value
Body weight (g) 23.2±0.7 23.210.9 23.310.7 0.99
Lean Body mass (g) 20.410.5 20.710.8 20.610.6 0.96
Lean body mass % BW 88.210.8 89.011.0 88.110.2 0.72
Fat mass (g) 2.710.2 2.510.2 2.810.1 0.75
Fat mass % of BW 11.810.8 11.011.0 11.910.2 0.72
Values are means ± SEM; n=3.
Probabilities (P) are from ANOVA one-way.
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6.3 LEPTIN LEVELS DECREASE AFTER ABLATION OF ADIPOCYTES.
Leptin is a hormone secreted by both white and brown adipose tissue cells in
proportion to fat mass. It regulates energy homeostasis by decreasing food intake
and increasing activity, sympathetic tone, energy expenditure, and insulin sensitivity
(Flier, J.S 1997).
It was suggested in a previous chapter that the greater recovery in the body
weight of transgenic mice might have its cause in leptin levels falling down in
parallel to adipose stores after ablation with CB1954. To address the question of
whether leptin levels decrease during ablation of adipose cells and more importantly
if regeneration of adipose tissue, as suggested from previous sections, leads to an
increase in leptin levels, it was decided to measure the plasma leptin levels in these
mice after ablation and after this prodrug free period of 30 days.
Circulating leptin levels were measured with a monoclonal anti-mouse leptin
radioimmunoassay by the use of the Mouse Leptin RIA Kit (Linco Research, St.
Charles, MO). Individual and pooled samples of plasma were used from transgenic
and control mice from the experiment described in section 6.2. It was found that
after this regimen of 5 injections, levels of leptin in plasma decreased significantly
by 55% in the transgenic group and slightly by 28% in the non-transgenic group
compared to a control age matched untreated group (Figure 6.5). This decreased in
the plasma leptin levels concomitant with the decrease in adipose stores
corroborates the proposed role of leptin as an adiposity indicator (Zhang et al.
1994). Non-transgenic mice injected with the prodrug also showed a small
reduction. The reduction observed with this group might account for the small
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Figure 6.5 Leptin analysis.
Plasma leptin levels were measured in transgenic (T) and non-transgenic (NT) mice
at 5 days and after a recover period of 30 days. Non transgenic mice untreated serve
as control for basal levels.
Interestingly, when mice were treated as above but left to recover for
approximately 30 days (second group of mice) plasma leptin levels markedly
increased to levels comparable to the control group, although large variation was
observed between individuals of the transgenic group. In contrast to the first group,
analysis of this second group was carried out with plasma from each individual, thus
the large variation observed represents the effects of each individual in this group.
Although not clear, this variation between some mice in this group, one might
speculate that this effect is due in part to variegated transgene expression (as
demonstrated in chapter 4). Thus, for those mice with more penetrance of the
transgene, ablation with CB1954 would be more effective and the possibility of a
127
bystander effect that would kill adipoblast or precursor cells would be enhanced. As
expected, regeneration of the adipose tissue in this case would depend very much on
the extension of the ablation.
It would also be interesting to observe the response of transgenic females
that received a dose of 40 mg/kg of body weight (some mice showing complete
disappearance of adipose tissue) over the recovery period of 30 days. One might
expect from the above that these mice would not recover adipose tissue, the
consequences from which could be as dramatic as those observed in the lipoatrophic
models described by Moitra et al (1998) and Gavrilova et al. (1998), where the lack
of adipose tissue led to diabetes in these mice. Although interesting to test, this
experiment would require to have the mice in a warmer room and/or the use of
heated pads continuously for 24 hours something that was not possible to carry out
in previous experiments.
The results described in the last three sections strongly suggest that after
ablation of the adipose tissue, remaining cells have the ability to regenerate or
repopulate the tissue ablated. Tissue regeneration following toxigene ablation has
been previously observed in mice and possible mechanisms have been discussed
(Bernstein and Breitman, 1989). Lowel et al. (1993) described the generation of two
transgenic mice with primary deficiency of brown adipose tissue. They used
regulatory sequences of the uncoupling protein (UCP) to direct the expression of
both DT-A and an attenuated form (176), as described in chapter 1, to generate mice
with deficiencies in the brown adipose tissue. What these authors observed was that
at an early age both lines of mice have markedly reduced brown fat and increased
total body lipid content. Surprisingly, while UCP-DTA line developed marked
obesity with age, in UCP-176 line brown adipose tissue regenerates later in life and
total body lipid content returned to normal. A similar regeneration effect was
observed in a different approach, more relevant to this thesis. Drabek et al. (1997)
directed the expression of nitroreductase specifically in T cells using control
elements of the CD2 locus. After CB1954 treatment they observed specific cell
ablation in thymus and spleens. However, in a different experiment where the mice
were killed after 5 days of the last injection it was observed that thymuses and
spleens returned to their normal size. Therefore, the authors concluded that
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progenitor cells, which did not express the transgene, are able to repopulate these
tissues. In a different study where adipocytes were depleted by the use of polyclonal
antibodies raised against plasma membranes of adipocytes, a compensatory increase
in volume of remaining adipocytes was observed in genetically obese rats, although
the same effect was not observed in diet induced obese rats (Flint, D. 1998) thus
illustrating the differences between genetic- and diet-induced obesity models.
Most information regarding regeneration of adipose tissue mass comes from
experiments involving direct surgical removal of adipose tissue or better known as
lipectomy. Most lipectomy experiments have involved the extirpation of gonadal
and/or subcutaneous-inguinal fat pads. Four possible responses have been observed
to lipectomy: 1) adipose tissue may regenerate, which in the strictest sense means
that adipose mass is restored at the site from which it was removed and the cells in
this new tissue are newly formed, 2) there may be compensatory growth of non-
excised deposits, 3) the adipose mass may diminish even further, 4) there may be no
response.
Although the mechanism of regeneration observed in the adipose tissue of
transgenic mice treated with CB1954 is unknown it is more likely that corresponds
to hypertrophy or hyperplasia of remaining cells as suggested by the
immunohistochemistry in Figure 6.3. In fact, experiments in rats that have had
removed some portions of the epididymal fat pads showed regrowth after lipectomy
by a mechanism of hypertrophy of remaining cells (Faust et al. 1977). In other
experiments were the subcutaneous inguinal fat pad has been removed it has been
observed regrowth of adipose tissue that is in part regenerative, with some
compensatory hyperplasia of neighbouring fat (Roth et al. 1981).
One way to truly confirm the exact mechanism of regeneration of the adipose
tissue after treatment with CB1954 involves the measuring of the tissue cellularity
for which special equipment (Coulter Counter) and procedures are required which
were not available at the moment that these experiments were carried out.
Nevertheless, it is also important to highlight the fact that 30 days may not be
enough time for this tissue to recover fully, and experiments should be considered
extending this time substantially to measure the longer term effects of the ablation of
the adipose tissue.
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6.4 PHYSIOLOGICAL ANALYSIS OF MICE AFTER CB1954 MEDIATED
ABLATION.
The physiological consequences of adipose tissue ablation might be
anticipated from the work of clinical scientists who have studied lipodystrophic
patients, a condition characterised by a marked reduction of the adipose tissue.
Humans suffering from congenital or acquired lipodistrophy become severely
diabetic, have voracious appetites, are hypermetabolic, and display an anabolic
syndrome that includes enlargement of the liver, spleen, pancreas, and kidney
(Foster D.W. 1994). Recently, two mice models have been created that are devoid of
fat (Moitra et al. 1998; Shimomura et al. 1998). These models resemble many of the
features observed in lipodistrophic patients, thus indicating that the lack of adipose
tissue may have profound physiological consequences.
In order to investigate the physiological consequences of the ablation of
adipose tissue in transgenic mice treated with CB1954, a number of parameters were
measured in the plasma of these mice after treatment with the prodrug. These
parameters included total blood glucose levels, and plasma triglycerides, free fatty
acids (FFA) and P-hydroxybutyrate levels (Figure 6.6). Pooled samples of plasma
were used from transgenic and control mice from the experiment described in
section 6.3.1, except for glucose that corresponds to individual determinations. After
this regimen of 5 injections, blood glucose levels are preserved and remained
comparable to the controls indicating no major problem in withstanding the
reduction of adipose tissue. Triglycerides, which are carried in the circulation as
lipoprotein particles, were slightly elevated although this difference was not
significant with any of the control groups. Similarly, plasma free fatty acids (FFA),
which are a circulating energy source were slightly elevated in the transgenic group
however due to the high variation observed in this group this difference was not
significant. One possible explanation for this slight increase might be due to start the
experiments relatively late during the light cycle. Another possible explanation
might be the oxidation of triglycerides from ablated adipose cells, thus indicating a
possible destination for the ablated fat. P-hydroxybutyrate is a ketone produced by
the liver from free fatty acids at times of low glucose, low insulin and high glucagon







































Figure 6.6 Physiology of mice after treatment with CB1954.
Male mice transgenic and non-transgenic control were injected with CB1954 for 5
days and sacrificed at day 5 (first group) and at day 30 (second group).
T-T: Transgenic treated, NT-T: Non-transgenic treated, NT-NT: Non-transgenic
non-treated.
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Plasma levels of (3-hydroxybutirate were unchanged in the transgenic group
compared to the controls, thus suggesting no increased production of ketones bodies
by the liver.
Taken together these results suggest no major metabolic consequences of the
ablation of adipose tissue at least as described in this regimen of 5 injections of 20
mg/kg of body weight, with blood glucose, triglycerides, FFA and [3-
hydroxybutirate levels remaining normal or at levels comparable to the control
groups. This does not rule out of course the possibility that other parameters that
were not included in this analysis may have been altered, such as hormones involved
in fatty acids metabolism and glucose homeostasis (e.g. leptin as was shown in
previous section).
After a recovery period of 30 days blood glucose levels and triglycerides
remained normal, which tend to confirm the ability of the adipose tissue to
regenerate in these conditions. This hypothesis is based in the fact that without an
appropriate amount of adipose tissue to take up and store free fatty
acids/triglycerides derived mainly from diet and hepatic production, blood levels
would have become elevated. Increased levels of FFA in turn would have increased
the glucose levels via the glucose fatty acid cycle, in which muscle burns FFA in
preference to glucose (Randel et al. 1963; Gavrilova et al. 2000) and increased
levels of triglycerides in the circulation would have finished with a marked
increased in hepatic triglycerides, a condition known as steatosis, that was not
observed in hematoxylin and eosin sections of livers of these mice. Nevertheless,
one might speculate that a different situation would have been observed if
regeneration of adipose tissue does not occur. This would be true especially in those
mice that showed a dramatic ablation of the adipose tissue after they received an
injection of 40 mg/kg of body weight with some mice showing complete
disappearance of visible adipose tissue. In that case, some possible scenarios
expected to be observed in these mice are like those described in the literature for
transgenic models devoid of fat.
Burant et al. (1997) for instance, described a delayed-onset form of
lipodistrophy that appeared when adipose tissue of a mouse was genetically ablated
by targeted expression of the diphtheria toxin A (DT-A) transgene under control of
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the aP2 promoter/enhancer. These mice were phenotypically normal at birth and
showed no signs of lipodistrophy until 5-6 months of age, at which time the adipose
tissue begun to disappear. Two other models of lipodistrophy showed very similar
physiological consequences of the ablation of adipose tissue although the magnitude
of adipose tissue depletion was much higher -99% and -70% Moitra et al. (1998)
and Shimomura et al. (1998), respectively. Many of the animals died before they
reached adulthood, but those that survived developed diabetes. Their cells no longer
responded properly to insulin, as a result insulin levels in the bloodstream were
increased up to 442 times normal levels for some mice and glucose levels at least
tripled. Like human diabetics, the animals also had high levels of triglycerides and
other fat building blocks in their circulation, and their organs became enlarged with
the liver showing the presence of triglycerides.
6.5 CONCLUSION
Ablation of adipose tissue with a lower dose of CB1954 resulted in a partial
reduction of this tissue leaving some remaining cells that do not express the
transgene and thus escaped the ablation with the prodrug. Partially ablated adipose
tissue showed the ability to regenerate after a prodrug free period of 30 days. This
observation is based on the results carried out measuring the content of the total
lipid in the carcasses of the mice as well as by measuring the wet weight of the fat
depots. Interestingly, immunohistochemistry analysis showed that the compensatory
growth of adipose tissue did not include newly formed transgenic cells. The reason
for this is not clear but a possible scenario might be that preadipocytes or stem cells
died as result of a bystander effect. Although the mechanism of regeneration of the
adipose cells is not clear it might involve hyperplasia and/or hypertrophy of the
remaining cells. This observation is based on the results of the
immunohistochemistry that showed a number of small adipocytes growing alongside
some much larger fat cells.
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No major physiological consequences were observed from the ablation of
adipose cells with a lower dose of CB1954. Blood glucose, and plasma triglycerides,
FFA and P-hydroxybutirate levels remained normal or at levels comparable to the
control groups after a short ablation period of 5 days. After 30 days, blood glucose
levels and triglycerides were comparable to controls thus indicating no longer term
effects at least for these two parameters. Nevertheless, analysis of leptin showed that
this hormone decreased significantly after ablation of adipose tissue thus,
corroborating the proposed role of this hormone as an adiposity indicator, the levels
ofwhich returned to normal after this recovery period of 30 days.
Inducible ablation of adipocytes in this transgenic model provides unique
opportunities to study the effects of decreasing the number of adipocytes at different
stages of the mouse development, allowing the investigation of the interrelationship
between excessive adipose tissue mass and the disorders associated (diabetes,
hypertension, hyperlipidemia) through manipulation of the target cell population.
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CHAPTER 7
7. EXPLOTING OTHER POSSIBILITIES OF THIS INDUCIBLE SYSTEM
NTR/CB1954.
The present chapter describes two approaches exploiting the potential use of
this inducible system NTR/CB1954. In the first approach CB1954 was tested for its
ability to cross the transplacental barrier to act directly in the ablation of adipose
cells (brown fat) in the fetuses. In the second approach, the ntr transgene was
introgressed into an obese line by mating one of the transgenic lines with
heterozygous Lepobl+ mice. These mice were then treated with CB1954 and the
effects of the prodrug on adipocytes and physiology of the mice assessed.
7.1 IN UTERO ABLATION.
An interesting property of the NTR/CB1954 system is the ability of the
prodrug to cross different cellular membranes. Such property has been already
exploited by Cui et al (unpublished results) to show the feasibility of this system to
induce ablation of astrocytes in the central nervous system, for which CB1954 had
to cross the haematoenchephalic barrier. Therefore, it was envisaged that such
property could be further exploited by attempting ablation experiments in utero.
This should allow the killing of different cellular types before birth, something that
is not possible to carry out with other gene suicide systems such as Diphtheria toxin
or Ricin A.
Because brown adipose tissue is formed at day 15 of gestation (Houstek et
al. 1988), it was expected that injections of CB1954 to a 14 days pregnant female
could result in the specific ablation of this tissue in transgenic offspring. On the
other hand, white adipose tissue should not be affected as it has been shown that its
development is postnatal (Ailaud and Hauner, 1998), although it could not be ruled
out the possibility that committed preadipocytes were affected. It was envisaged that
these experiments could provide a new model to study the consequences of brown
adipose tissue ablation. Because of the capacity of BAT to uncouple mitochondrial
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respiration, it has been implicated as an important site of facultative energy
expenditure. Therefore, BAT deficiency might be expected to cause reduced energy
expenditure and obesity.
7.2 CB1954 DOSAGE.
Preliminary experiments were carried out to determine optimum levels of
CB1954 for the generation of live-born pups, because results for such experiments
were largely unanticipated. Transgenic males were crossed to non-transgenic
females to avoid the effects of the prodrug in ablating the adipose tissue of the dam.
This maternal injection protocol should result in the generation of fetuses that are
transgenic and non-transgenic, the latter of which provides an internal control for
the ablation effects of the prodrug in the transgenic siblings. Six F1 females were
mated to transgenic male of the line 87 (group A). As control, the same number of
F1 females was mated to F1 males (group B). 3 females from each group (A and B)
received 5 injections of 20 mg/kg of body weight, starting on day 14 of gestation
until day 18. Remaining 3 females from each group (A and B) received 5 injections
of 30 mg/kg of body weight.
At doses of 30 mg/kg of body weight, all pups generated from F1 females
mated to transgenic males (group A) were found dead. A similar effect was also
observed with the control non-transgenic group (group B) which had only one litter
that survived. On the other hand, a lower dose of 20 mg/kg of body weight allowed
the live birth of 16 pups from the three dams in the group A however, PCR analysis
after weaning of these mice showed that no transgenic offspring had been generated
from these mice thus, indicating no survival of transgenic pups. The control group
(group B) had only 11 pups generated from 2 dams as the remaining litter from the
third dam in this group was found dead. These results established that CB1954 at
doses of 30 mg/kg of body weight results in toxicity to either the pups or the dam's
ability to nourish the offspring. Visual inspection of the dead pups showed some
milky fluid in their stomachs, which might suggest that these pups were born alive
but they died due to inappropriate care from the dams. Experiments with 20 mg/kg
of body weight generated no-transgenic pups alive, which might indicate a direct
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effect of the prodrug activating the transgene in those mice. Although is not clear
whether these transgenic pups were born alive and died as consequence of the loss
of brown adipose tissue. Nevertheless, the fact that 1 litter was found dead in the
control group still suggests some effects in the female's ability to nourish the pups.
Therefore, a second experiment was set up this time with a regimen of only 3
injections of 20 mg/kg of body weight, starting on day 14 of gestation until day 16.
Six F1 females were mated with transgenic males of the line 87. Three of these
females were injected with CB1954 and the other three were left untreated to serve
as a control for the number of transgenic pups generated. Three F1 females were
also mated with F1 males and were injected with CB1954. With this regimen, all
dams gave birth to live offspring. Nevertheless, the number of pups per litter was
largely decrease for those dams mated with a transgenic male that had been treated
with the prodrug, which suggested an effect of the prodrug in the transgenic
offspring. Confirmation of this came after analysis of the transgenic status of these
mice, which was carried out after weaning (approximately 21 days). This analysis
was done as usual from tail-tip DNA as described in chapter 2. PCR analysis
confirmed a significant decrease in the number of transgenic pups generated from
the 3 dams that had received the prodrug. Only two transgenic pups were found
positive for the transgene (13%), which is in marked contrast with the control
untreated group that had 14 transgenic pups (58%). In fact, the number of pups from
these 3 dams treated with the prodrug accounted for only 15, which is in contrast to
the other transgenic non-injected and control F1 injected dams that had 24 and 23
pups, respectively thus indicating no lethality in these control groups (Table 7.1).
Although difficult to assess, it is possible that transgenic pups may have been
born alive and then succumbed due to the deficiency of brown adipose tissue. A
more direct observation of pups born from these dams should be exercised in future
experiments to confirm this suggestion.
Birth weight and length of pups born from these dams showed a significant
difference in both parameters (P=<0.0001, P=<0.0001, respectively) when compared
to the control untreated group by the criterion of Student's t test. However, this
effect was also observed for the control group (FlxFl) whose dam had been injected
with the prodrug (P=<0.0001, P=<0.0001, respectively), which at first impression
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might indicate an indirect effect of the prodrug in the normal development of the
pups. Nevertheless, all dams injected with CB1954 had delivered earlier than
expected (day 18 of gestation), which suggests that induction of parturition, due to
stress-manipulation during the injections, may have occurred. This could explain the
smaller size and weight that was observed in these pups since this effect was not
observed in the control untreated group that gave birth as expected at day 21±1.
Table 7.1 Effect of the administration of CB1954 to pregnant dams on weight and
length of pups at birth.
Offspring from: F1 x Tg (CB1954) F1 xFl (CB1954) F1 xTg (No-CB1954)
Total Births observed 15 23 24





Length at birth (cm) 29.1110.44 29.2±0.37 32.810.40
* *
Data are mean ± S.E.M.
Each group was compared independently with the control untreated group by the
criterion of Student t test.
*P<0.0001
The remaining two transgenic pups (males) were studied in more detail to
assess the consequences of the in utero ablation with the prodrug in the brown
adipose tissue of these mice. Body weight of these 2 pups was monitored in a
weekly base together with 2 male siblings of the same litter (FlxTg CB1954) until
the mice were sacrificed (~8 weeks). Also, two male pups that were born from a
dam crossed to a non-transgenic male (FlxFl) and two other male pups from a dam
that was crossed with a transgenic male but that was not injected (FlxTg No-
CB1954) were included as control groups.
Analysis of the body weight of these mice showed a slight decrease in the
size of the siblings, transgenic and non-transgenic, of approximately 10% when
138
compared to the control groups, with this effect being more pronounced in the two
transgenic mice of this litter (Figure 7.1 and Table 7.2). The two non-transgenic
mice that were born from a dam that was also treated with the prodrug (FlxFl
CB1954) showed similar body weight to the control untreated group (FlxTg No-
CB1954).
1 2 3 4 5 6 7 8
Weeks
Figure 7.1 Effects of CB1954 administration during gestation on the growth of
transgenic and non-transgenic pups.
Body weight ofmale pups from each of the respective groups was monitored once a
week for 8 weeks.
Tg-L and NT-L are transgenic and non-transgenic mice (siblings) from the dam
injected with CB1954 (FlxTg CB1954).
NT: mice from FlxTg NoCB1954 group.
Fl: mice from FlxFl CB1954 group.
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Dissection of these mice after this 8 weeks period showed a large reduction
in the brown adipose tissue of both transgenic mice in comparison with that one of
siblings brothers and remaining mice of the other groups (Table 7.2). This was
especially evident in one of the transgenic mice that had a very small adipose depot
(Figure 7.2). However, when compared statistically with the other groups, there was
not significant differences due to the large variation that was observed in this
transgenic group and one of the control groups (P=0.09). Another difference
observed in the transgenic group was a marked increased in the size of the heart
(P=0.02). Although it is not clear this effect in the heart one might speculate that this
effect corresponds to an homeostatic response due to secondary effects of the
ablation of the brown fat, although further analysis are required to assess this
hypothesis more directly. The white adipose tissue of these mice was comparable to
that one of control mice thus suggesting no effect in this tissue.
Figure 7,2 Photomicrograph of interscapular brown adipose tissue (BAT).
Photomicrograph of brown adipose tissue (interscapular deposit) of two brother mice
whose dam was injected with CB1954 at day 14 of gestation. On the right side of the
picture it is possible to observe the large decrease of this organ compared with the
non-transgenic littermate.
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A large decrease in the size of the testes was also observed. Intriguingly, this
effect was observed in all mice whose dam had been injected with CB1954,
regardless of transgenic status or genetic background (Figure 7.3). This effect was
highly significant (PO.OOOl) when all mice were compared by ANOYA (Table
7.2), which confirms the ability of CB1954 to cross the transplacental barrier.
Nevertheless, this indirect effect in the testes was not anticipated, since previous
experiments where CB1954 was administered via i.p. in mice (as described in
chapter 5 and 6) showed no such effect, even at the higher doses of 40 mg/kg of
body weight (chapter 5). It is possible that this corresponds to a longer-term effect of
the prodrug, which future experiments should confirm whether this effect is
observed immediately after birth of these mice or if it corresponds to a much longer
residual effect of the prodrug in this organ. It is not clear from toxicology
experiments carried out by Cobb, (1970) whether this effect was observed in the
testis since there is no reference of it, nevertheless this author observed
histopathological changes in the urinary tract, liver and lungs in experiments with
CB1954 at the minimum toxic dose. A similar effect was also described, although
increased in magnitude, when CB1954 was administered at maximum tolerated
doses. As previously mentioned in chapter 5, these results confirm the need of
further studies with CB1954 to asses the longer term effects of the treatment with
this prodrug.
It would have been interesting to asses the fertility of these males simply by
housing these mice with 2 or 3 females and counting the number of plugs after a
couple of weeks. As well as direct measurements of testosterone levels should
provide evidence to confirm whether this reduction in the size of testes correlates
with a reduction of the reproductive capacity of these mice.
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Figure 7.3 Photomicrograph of testes.
Photomicrograph of testes showing the reduction in size that was observed in all
mice whose dam was treated with the prodrug.
Table 7.2 Body composition ofmice born from dams treated with the prodrug.
Body Weight Gonadal Retro Intersc. Liver Kidney Spleen Heart Testis
Grams (WAT) (WAT) (BAT)
(%) (%) (%) (%) (%) (%) (%) (%)
Tg-T-L 24.4±1.0 0.83+0.15 0.25+0.01 0.11+0.03 4.41+0.1 0.73+0.14 0.29+0.03 0.64+0.01 0.01±0.002
(n=2) * §
NT-T-L 25.8±0.5 1.26±0.11 0.35+0.03 0.20+0.01 4.21+0.1 0.80+0.04 0.22+0.02 0.45+0.02 0.02±0.005
(n=2) : §
NT-T 28.3±1.0 0.92±0.01 ©o+lCNO 0.19+0.01 4.31+0.2 "3-•o+l00o 0.21+0.01 0.48+0.04 0.10+0.005
(n=2)
Fl-T 27.7±1.1 0.91+0.13 0.24+0.05 0.18+0.03 3.10+0.4 0.76+0.01 0.29+0.03 0.52+0.03 0.01±0.002
(n=2) §_
P Value * <0.05 §<0.0001
Body composition of the two male pups from each of the respective groups at the
age of 8 weeks. CB1954 was administered to the dams of T-L, NT-L and F1 groups.
Tg-L and NT-L are transgenic and non-transgenic mice (siblings) from the dam
injected with CB1954 (FlxTg CB1954).
NT: mice from FlxTg NoCB1954 group.
Fl: mice from FlxFl CB1954 group.
Data are means ± S.E.M. Groups were compared by ANOVA one way.
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The work of Lowell et al.(1993) indicated that brown adipose tissue-ablated
mice become obese due to a reduced metabolic rate. It was later confirmed (Klaus
al. 1998) that these mice had a downshift of Tb level of 1°C when compared with
the control group and therefore it was suggested that this could significantly have an
effect on the overall energy budget of these mice.
A similar effect in the body temperature of these mice whose dam had been
treated with CBI954 was expected to observe. However, no such effect was
observed with rectal body temperature being actually slightly higher than control
groups (Figure 7.4). Furthermore, histological examination of the brown adipose
tissue in these mice showed no signs of atrophy, which suggests that thermogenesis,
was essentially not impaired (Figure 7.5).
A main difference observed in this model compared to the model of Lowell
et al. (1993) which might help to explain the discrepancy in the response observed
to the ablation of brown fat (BAT), is precisely the appearance of this tissue. While
the mice whose dam was treated with CB1954 showed small deposits of BAT,
histological examination of these deposits confirmed the appearance of a normal
rich-eosinophilic tissue without any signs of atrophy. In marked contrast, the BAT
in the models of Lowell and coworkers was largely increased in size being almost 3
times heavier than control group with this effect being mainly due to increased lipid
deposition because the protein content was not different from the controls.
Furthermore, the thermogenic capacity of this tissue, as assessed by measurement of
the cytochrome oxidase activity (COX), an indicator of the total respiratory
capacity, was largely reduced in the transgenic mice of Lowell and coworkers being
only 21% of controls and the content ofUCP was reduced to 15% of control.
These observations suggest a different response to the ablation of brown
adipose tissue with these two approaches. While diphtheria toxin A, as used in the
model of Lowell and coworkes, produced transgenic mice with primary deficiency
of brown adipose tissue, CB1954/NTR produced only a partial reduction of this
tissue without, apparently, affecting its overall function.
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Figure 7.4 Measurement of body temperature.
Core body temperature was measured in the morning with a rectal thermometer.
Tg-L and NT-L are transgenic and non-transgenic mice (siblings) from the dam
injected with CB1954 (FlxTg CB1954).
NT: mice from FlxTg NoCB1954 group.
Fl: mice from FlxFl CB1954 group.
Figure 7.5 Histology of brown adipose tissue (BAT).
Histological sections of the brown fat of a transgenic (B) and a littermate non-
transgenic mouse (A) whose dam was injected with CB1954 at day 14 of gestation.
Tissues were fixed in NBF and paraffin-embedded sections stained with
haematoxylin and eosin. Magnification: 200X A and B.
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Nevertheless, these conclusions must be taken with caution since it is
possible that a similar effect would have been observed in those transgenic mice that
died possibly due to the deficiency of BAT. Therefore, future experiments should
consider more detailed analysis of these mice especially to assess the magnitude of
BAT ablation at birth. In this way, immunoblotting with UCP antiserum to
determine the interscapular BAT content of UCP should confirm the magnitude of
the BAT ablation, as well as tissue cellularity and protein content of this deposit.
Thermogenic activity of this tissue could be assessed by measurement of the COX
activity and basal metabolic rate (resting oxygen consumption). Also, continuous
telemetric recording of core body temperature with temperature-sensitive radio
transmitters should clarify whether brown fat thermogenesis is indeed increased as
suggested by the slight increased in rectal body temperature and smaller size of
these mice that was observed. Finally, cold acclimation experiments should also
provide important information regarding the ability of the remaining brown fat to
respond to cold.
Another possibility is that these mice had indeed an increased metabolic rate
as result of the partial reduction in the brown adipose tissue that was observed. This
would suggest that remaining brown adipose tissue would be more active, which
would explain the higher body temperature and the leanness observed in these mice.
This could also explain the significantly increased size of the heart in these mice.
Although provocative, this theory needs to be confirmed with further studies and a
much larger population of mice. Studies carried out by Cummings et al. (1996)
confirmed that higher body temperature could increase metabolic rate in mice.
These authors created genetically lean mice by targeted disruption of the RIip
subunit of the protein kinase A. These mice are resistant to dietary induced obesity
due to chronic activation of BAT thermogenesis, resulting in elevated body
temperature (0.8°C) compared with the control groups and thus increased metabolic
rate. In a different experiment Erickson et al. (1996) created ob/ob mice deficient for
neuropetide Y. These mice showed an attenuation of their obesity syndrome partly
due to enhanced energy expenditure by maintenance of a higher body temperature.
Therefore, if ablation of brown fat in these mice whose dam was treated with
CB1954 is producing an increase metabolic rate, experiments should be attempted to
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clarify this and to assess whether these mice could be resistant to diet induced
obesity as the mice ofCummings and co-workers are.
Previous attempts to ablate or denervate brown adipose tissue surgically
were uninformative because it exists in diffuse deposits and has substantial capacity
for regeneration and hypertrophy (Rothwell and Stock, 1989). This capacity for
hypertrophy also suggests the need to analyse these mice soon after birth, because it
is possible that these two transgenic mice were born with much smaller deposits of
brown fat enough to allow them to survive and then this tissue had regenerated.
Future experiments should consider the analysis of these fat deposits at birth to
clarify this point.
Physiological studies of these mice showed no major differences in any of
the parameters measured with blood sugar levels and plasma triglycerides and FFA
within normal ranges for all groups (Table 7.3), although the low number of mice
makes statistic analysis difficult. These results suggest that a partial reduction of the
brown adipose tissue has no major physiological effect in these mice.



















Data are mean ± S.D. Animals were males 8 weeks old.
Tg-T-L and NT-T-L are transgenic and non-transgenic mice (siblings) from the dam
injected with CB1954 (FlxTg CB1954).
NT: mice from FlxTg NoCB1954 group.
F1: mice from F1 xF 1 CB1954 group.
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It was anticipated from previous work studies (Lowell et al. 1993) that
brown adipose tissue deficiency might have profound effects in the physiology of
these mice, specifically in their ability to thermoregulate body temperature and
energy expenditure. However, most of the effects described by Lowell et al. (1993)
in their mice were after 22-26 weeks of age. Before this period, transgenic and non-
transgenic mice had similar food intake, and body weight although the latter had
increased body lipids content. However, after 22-26 weeks of age, transgenic mice
developed a marked hyperphagia with significantly high body weight, total body
lipid content and increased lean body mass, which suggests that future experiments
with CB1954 should also consider the analysis of these mice at a much older age.
7.3 CONCLUSION.
Experiments described in this section confirmed the ability of CB1954 to
cross the transplacental barrier and more importantly confirmed the feasibility of in
utero ablation of NTR expressing cells. Higher doses of CB1954 were found to
cause toxicity to either the pups or the dam's ability to nourish the offspring.
Nevertheless, lower doses of CB1954 decreased only the number of transgenic pups
generated, which suggests a direct effect of the prodrug in those mice expressing the
NTR. This lower dose of CB1954 produced two transgenic pups alive from a total
expected of 14, as compared with the control untreated group. These two pups had a
large reduction in the size of the brown adipose tissue, which was histologically
active.
Decreased size and weight of pups born from dams that had been injected
with the prodrug was also observed. It is believed that this effect corresponded to a
premature delivery of the dams caused by stress produced during the injections since
this effect was not observed in the control untreated dams.
CB1954 also caused a large decrease in the size of the testes in all mice
whose dam had been treated with the prodrug, which might indicate a secondary
longer-term effect of the prodrug in this organ. This effect may have important
implications in the establishment of pedigrees from these mice since it is possible
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that the reproductive capacity may have been affected, something that need to be
addressed in future experiments.
No major physiological consequences were observed in any of the
parameters measured with blood sugar levels and plasma triglycerides and FFA
within normal ranges for all groups, which suggests that a partial ablation of brown
adipose tissue has no major physiological consequence at least at this young age (8
weeks). This should not rule out the possibility of a longer-term effect, which
remain to be determined.
These experiments encourage the belief that ablation of embryonic cells can
be accomplished with this approach, which expand substantially the spectrum of
opportunities of this system.
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7.4 GENETIC ABLATION OF AN OBESE MOUSE: A POTENTIAL MODEL
TO STUDY THE MORBID CONSEQUENCES OF DIABETES?
One of the diseases that can be best approached using transgenic models is
obesity. Obesity refers to a heterogeneous group of disorders in which there is an
excess of adipocyte cell mass and/or increased adipocyte cell number. This increase
leads to a perturbation in the general metabolic state, and as a result, obesity is a
major risk factor for a number of clinical diseases such as diabetes (NIDDM),
cardiovascular disease, hyperlipidemia, and hypertension. In mice that inherit genes
that cause them to become obese, triglycerides storage in adipose tissue is more
efficient and catabolism of these stores is slower than in normal, non-obese
counterparts. The phenotype of the obese mice is consistent with the hypothesis that
metabolic abnormalities in diabetes are the result of an excess of adipose mass.
It was envisaged that incorporating the ntr transgene in the genetic
background of an obese mouse could provide a novel approach to study the role of
the WAT in the aetiology of diabetes. For this study it was decided to cross one of
this transgenic lines expressing NTR in adipose tissue with the well characterised
ob/ob model, since these mice do not have detectable levels of leptin and therefore
any effect observed as result of the ablation of the adipose tissue could be attributed
to the direct consequence of the reduction in fat mass. Thus, this could prove that the
excess of fat is causing the metabolic abnormalities in these mice.
The obese mice {ob/ob) are characterised by a marked obesity, increased
food intake (hyperphagia), a low body temperature and low physical activity thus,
abnormalities in both energy intake and energy expenditure combine to produce the
obese phenotype. Other characteristic of these mice includes hyperglycaemia, and
markedly elevated plasma insulin levels associated with an increase in number and
size of the islets of Langerhams (Coleman et al. 1978). Therefore, these mice
represent a good model for the study of Type II diabetes mellitus, a principal cause
ofmorbidity and mortality in human populations.
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7.5 GENERATION OF LEPOB/LEPOB, Tg/+ MICE.
The mutation in the obese mouse is autosomal recessive and homozygous
mutants are infertile. Therefore, mutant homozygous mice are obtained by mating
known heterozygous mice. Breeding of these mice involved two generation crosses.
In the first generation three males heterozygous for the obese gene, Lepob/+
(C57B1/6J Harlan UK Limited) were crossed to transgenic females of the line 87
(tg/+) to produce double-heterozygous (Lepob/+, tg/+) mice. The same males
(Lepob/+) were also crossed to F1 females (C57BLxCBA) mice to produce non-
transgenic heterozygous (Lepob/+, +/+) offspring. In the second generation males
and females from each group were intercrossed with the respective males and
females of the other group. Intercrossed of these mice generated homozygous
mutant for the obese genotype and heterozygous for the transgene (Lepoh/Lepoh,
Tg/+) thus avoiding the generation of obese mice homozygous for the transgene, for
which the effects of the ablation were unknown. The mice were first genotyped for
the transgene locus using specific primers that detect a 492 bp band corresponding
to the ntr transgene (as described in chapter 4) and then for the Lep locus. Lep
genotyping involved two separates PCR reactions (primer sequences and PCR
conditions are described in section 2.8.1 in chapter 2), one mutant-specific and one
wild-type specific according to the method described by Anand and Chada, (2000).
The mutant specific PCR generated a 295 bp band from the Lep allele, but no
product from the wild-type allele, and vice versa for the wild type-specific PCR
(Figure 7.6). The frequencies observed in the first and second generation crosses are
shown in tables 7.4 and 7.5, respectively. Frequencies of transgenic mice in the first
and second generations were at the expected Mendelian ratio, 47% in each case
(Tables 7.4 and 7.5). However, the observed ratio for the heterozygous mutant
genotype was much lower than expected. The percentage of (Lep°b/+, tg/+) mice
was 11.3% from an expected Mendelian ratio of 25% (Table 7.4). The same effect
was observed in the second group from the cross (Lepob/+ x +/+) x (+/+, +/+) with a
frequency observed for the (Lepob/+, +/+) mice of only 35% from a total expected of
50% (Table 7.4). It was later found that one of the Lepob/+ males used in the
breeding had not transmitted the mutant gene to any of the offsprings in the first
group of matings and to only 2 of the offsprings in the second group, therefore
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explaining the differences in the expected frequencies that were observed. In the
second generation however, observed frequencies were very close to the expected
Mendelian ratio for each of the groups (Table 7.5), thus indicating no embryonic or
neonatal lethality as result of these crosses.
Table 7.4 Observed frequencies for the crosses (Lepobl+, +/+ x +/+, tg/+) and
(Lepob!+, +/+ x +/+, +/+).
(Lepob/+, +/+) x (+/+, tg/+) Expected Frequency Observed Frequency Total
Lepob/+, tg/+ 25.0% 11.3% 7
Lep°b/+, +/+ 25.0% 21.0% 13
+/+, tg/+ 25.0% 35.5% 22
+/+,+/+ 25.0% 32.2% 20
Transgenic 50% 47% 62
(Lepobl+ x +/+) x (+/+, +/+) Expected Frequency Observed Frequency Total
Lepob/+, +/+ 50% 35% 26
+/+, +/+ 50% 65% 49
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Table 7.5 Observed frequencies of the cross (Lep"h/+, tg/+) x (Lepob/+, +/+) mice.
Expected Frequency Observed Frequency Total
LepobILep°b, tg/+ 12.5% 13.5% 13
Lepob/Lep"h, +/+ 12.5% 8.4% 8
Lepob/+, tg/+ 25.0% 28.1% 27
Lep°b/+, +/+ 25.0% 30.2% 29
+/+,tg/+ 12.5% 9.4% 9
+/+, +/+ 12.5% 10.4% 10
Transgenic 50% 47% 96
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Figure 7.6 Genotyping of obese mice from genomic tail DNA.
1.5% agarose gel showing the results of a PCR reaction carried out with two set of
primers to distinguish the obese genotype (Lepob/Lepob) from heterozygous (Lep"b/+)
or wild type (+/+).
Ablation experiments were carried out with mice housed at 23°C instead of
20°C as used in previous experiments since these mice have already a lower body
temperature (Coleman et al. 1978). It was decided to use a dose of 20 mg/kg of body
weight as mice injected previously with this dose showed no problems in
withstanding the effects of the prodrug and the reduction of adipose tissue. With this
regimen, transgenic male and female injected with the prodrug lost approximately
8% of body weight (Figures 7.7A and B, respectively) while control mice injected
with the prodrug showed a reduction of only 4%. This data are quite similar to the
reduction in body weight that was observed in previous experiments using similar
dose-regimen in non-obese mice as described in chapter 5. Nevertheless, transgenic
obese mice were more sensitive to the effects of the prodrug. These mice were
observed hunched, cold and reluctant to move after the third day of the treatments
with this regimen. A considerable reduction in the body temperature below the limit
of detection of the instrument (<32°C) was observed in these mice, which is in
contrast to the other control mice that had a body temperature of 35°C±0.5 (obese
mice have already a lower body temperature). Despite the use of heated pads these
mice did not recover and were sacrificed as soon as these signs were evident. Four
out of 6 females and 2 out 3 males were sacrificed earlier (day 5 and 6) and one










































Figure 7.7 Measurement of the body weight during treatment of obese mice
with CB1954.
10 weeks old obese-transgenic (O-T) and obese non-transgenic (O-NT) littermates
were injected (T) with CB1954 at doses of 20 mg/kg of body weight for 3 days.
Another obese non-transgenic group was left untreated (O-UT).
A and B females and males, respectively.
153
Dissection of these mice revealed some of the typical features of the obese
mice. All major adipose deposits including subcutaneous, inguinal, retroperitoneal
and gonadal were massively large. The livers were also large occupying most of the
abdominal cavity and were pale indicating the massive accumulation of
triglycerides. Analysis of transgenic mice injected with CB1954 also showed a large
accumulation of adipose tissue in all different deposits. Nevertheless, analysis of the
wet weight of these deposits showed a reduction of 20% in the gonadal and
retroperitoneal fad pads of transgenic male compared with the control groups (Table
7.6). Transgenic females injected with the prodrug also showed a reduction of
approximately 15% in the inguinal fat pad but this effect was not observed in the
retroperitoneal fat pad (Table 7.7), which might be due to the fact that this deposit
was dissected as one large deposit with the parametrial fat due to the complexity to
separate both cleanly. Despite this reduction in fat mass, no significance difference
could be observed when these deposits were analysed with the other groups, in part
due to the large variation that was observed between individuals in each group. This
large variation was also reflected in the size of each mouse, which despite being all
littermates born during the same week, some of them were markedly heavier than
others. This effect is more notorious for instance in the transgenic male group
treated with the prodrug, which despite the loss of ~8% of body weight, these mice
were still much heavier than the other two groups (Table 7.6). This effect might
correspond to the different response of these mice to the developing disorders
associated with their obesity or it might be due to some variation due to the genetic
background (Coleman and Hummel, 1973).
The brown fat, as represented by the interscapular fat mass (BAT), was
slightly decreased in both transgenic males and females, although this effect was not
significant.
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Table 7.6 Body composition of male obese mice.
Body Weight Gonadal Retro Intersc. Liver Kidney Spleen Heart
Grams (WAT) (WAT) (BAT)
(%) (%) (%) (%) (%) (%) (%)




47.1+2.1 4.6±0.87 2.1+0.27 0.42±0.03 5.9+1.2 0.52+0.01 0.14+0.02 0.35+0.02
(n=2)
O-UT 45.0+0.8 4.4±0.20 2.2+0.35 0.36±0.02 7.6+0.4 0.63+0.13 0.17+0.01 0.38+0.01
(n=2)
Table 7.7 Body composition of female obese mice.
Body Weight Gonadal Retro Intersc. Liver Kidney Spleen Heart
Grams (WAT) (WAT) (BAT)
(%) (%) (%) (%) (%) (%) (%)
O-T-T 45.2+0.8 3.6+0.27 2.4+0.14 0.27+0.04 7.6+0.4 0.55+0.03 0.11+0.01 0.35+0.01
(n=6) *
O-NT-3 45.4+1.5 4.2+0.22 2.5+0.08 0.32+0.04 5.8+0.4 0.52+0.02 0.18+0.01 0.35+0.02
(n=4) *
O-UT 51.2+1.7 4.2+0.31 2.6+0.53 0.27+0.04 7.8+1.1 0.45+0.01 0.14+0.06 0.29+0.04
(n=2)
P Value *=0.05
Data are mean ± S.E.M. Animals were obese transgenic and non-transgenic
littermates of 14 weeks old. The organ weights were measured as a percentage of the
animal's body weight. Probabilities (P) are from a ANOVA one way.
O-T-T: Obese transgenic treated.
O-NT-T: Obese non-transgenic treated.
O-UT: Obese untreated.
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Histological analysis of this tissue in control mice showed sparse
eosinophilic staining, a single lipid droplet per cell, and peripheral nuclei,
resembling the appearance of white adipose tissue (Figure 7.8 A). This is the typical
appearance of inactive brown adipose tissue (BAT) as seen in most of the obese
models (Trayhurn P, 1986), which indicates that BAT of these mice is atrophied and
thermogenically quiescent. This atrophy includes selective losses of uncoupling
protein (UCP) and lipoprotein lipase, which explain the lower body temperature that
is observed in these mice (Himms-Hagen, 1990). This is in marked contrast to the
appearance of active BAT as seen in wild type mice (Figure 7.5 as an example in
this chapter). The appearance of the brown fat in transgenic mice treated with the
prodrug was similar to that of control mice, nevertheless in these sections there was
a marked disappearance of adipose cells leaving some empty spaces that were
occupied by stroma (Figure 7.8 B).
Histological analysis of the white adipose tissue showed no major difference
between the groups (not shown) possibly due to the less defined structure of this
deposit and/or due to the higher capacity of hyperplasia and hypertrophy of these
cells in the obesity condition. Nevertheless, histological analysis of the skin
confirmed a considerable reduction in the adipose cells of some of the transgenic
mice that were treated with the prodrug (Figures 7.8 C and D). This effect was again
more notable in females than in males thus confirming the previous observation




Figure 7.8 Histology of different tissues in obese mice after treatment with
CB1954.
Histological sections of the interscapular brown fat (A and B), liver (C and D) and
skin (E and F) from 7 weeks old female transgenic (B, D, F and H) and non-
transgenic (A, C, E and G) littermates.
Tissues were fixed in NBF and paraffin-embedded sections stained with
haematoxylin and eosin. Magnification: 100X A,B»C, and D; 40X E and F.
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Comparison of the other organ weights showed no major difference with the
other groups, although a decrease in the steatosis of some of the transgenic mice that
had been treated with the prodrug was observed (Figure 7.9). Histological analysis of
sections of these livers confirmed this observation. The liver of obese control mice,
showed hepatocytes that were swollen, stained palely eosinophilic and contained
numerous vacuoles, which coalesced to form distinct unilocular vacuoles displacing
the nucleus to the cell periphery (Figure 7.8 C). The livers of some obese transgenic
mice injected with the prodrug, showed a marked reduction of vacuoles, which
stained more eosinophilic and there were some areas with better organised hepatic
cords (see arrows in Figure 7.8 D). It has been described that excessive caloric intake
might play a role in the genesis of fatty liver disease observed in obese mice (Sheth
et al. 1997). Therefore it is important to determine if CB1954 beneficial effect on
fatty liver disease is the direct result of a decrease in adipose tissue or the indirect
effect of the prodrug in reducing the excessive caloric intake (hyperphagia) normally
observed in these mice. Food intake analysis of these mice while treated with the




Figure 7.9 Photomicrograph of livers.
Photomicrograph of livers that show the marked decrease in fatty acids accumulation
in one of the transgenic mice that was injected with the prodrug (right side),
compared to the control obese mouse (middle in picture). Although both livers of the
obese mice show hepatomegaly as compared with the wild-type control on the left
side.
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One of the main objectives with these experiments was to assess the
consequences of the ablation of adipose tissue in the physiological parameters
already altered in obese mice. Unfortunately, this could not be established due to a
problem that arose three days before remaining transgenic and control mice were
going to be sacrificed (day 8). The temperature of the room, where the mice were
normally located dropped to 14°C due to a failure in the system. This problem was
not detected until all mice were sacrificed and blood glucose analysis carried out,
otherwise the termination of the experiments could have been postponed for a few
days later thus allowing these mice to settle down again. The first indication that
something was seriously wrong came from the results of the blood glucose analysis
carried out in these mice that plummeted in all mice to levels similar to those
observed in wild type mice (90 mg/dl) although there were a few mice which still
had relatively high glucose levels (>200 mg/dl). This is in marked contrast to the
non-fasting values expected for obese mice that are around 500mg/dl. In fact, blood
glucose levels in those transgenic mice that were sacrificed earlier (day 5 and day 6)
showed values in this order of magnitude (-500 mg/dl) although some of them
showed a reduction in blood glucose levels (280-3OOmg/dl). Nevertheless, these
values are still much higher than those observed at day 8 when all the control mice
were sacrificed.
This failure in the heat system of the room also had implications with other
parameters such as insulin. Insulin was also decreased in these mice although there
was more variation in this parameter with some mice having low levels (~12ng/ml)
and others high (>70ng/ml). This is in marked contrast to what is normally observed
in obese mice, which are characterised by high insulin and glucose levels.
The drop in these physiological parameters that was observed in these mice
suggests that due to the low temperature of the room these mice may have been
starving or unable to feed properly. Both glucose and insulin levels are consistent
with this observation. A drop in insulin drives the metabolic adaptation to fasting
and adipose tissue triglycerides are hydrolysed which releases free fatty acids that
are metabolised by the liver to produce ketone bodies constituting the main fuel for
the brain. Although it would have been interesting to measure the levels of ketones,
unfortunately no more blood was available to carry out this assay. Nevertheless,
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analysis of free fatty acids in pooled samples of plasma confirmed a slight increase
in these levels (Table 7.8).
Table 7.8 Physiological characteristic of obese mice.
Glucose Triglycerides Insulin FFA
mg/dl mg/dl ng/ml mM
O-T-T 383±217 (88-612) 285±330 (69-929) 58.3±49.5 (4.7-120) 0.58±0.02
O-NT-T 153±48 (110-235) 57±14 (41-67) 40±41 (10-69) 0.81±0.21
O-UT 168±76 (83-234) 72±18 (58-98) 27±19 (12-55) 1.12±0.07
Data are means ± SD. Animals were 14 weeks old males and females. Glucose,
triglycerides and insulin analyses were carried out with plasma from each animal.
Free fatty acid analysis was carried out with pooled samples from 3-5 mice.
O-T-T: Obese transgenic treated.
O-NT-T: Obese non-transgenic treated.
O-UT: Obese untreated.
Although a reduction in both glucose and insulin levels could be observed in
some transgenic mice treated with the prodrug that had been sacrificed earlier, it is
impossible to confirm whether this effect was the direct result of the decrease in
adipose tissue, since no possible comparison can be made with any of the control
mice. If ablation of adipose tissue really improved glucose homeostasis in these
mice will have to be confirmed with further experiments.
Another effect observed only in those transgenic mice treated with the
prodrug was a large increase in the levels of triglycerides of up to 10 fold
(900mg/dl), although this effect was not observed in all mice, since others showed
levels similar to those observed in the control groups (80mg/dl). This high level of
plasma triglycerides could indicate a destination for the fat in the ablated adipocytes.
Although previous experiments, as described in chapter 6, showed only a slight
increase in the levels of plasma triglycerides in non-obese transgenic mice, the
difference might be in the higher content of fat in the adipocytes of obese mice.
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Another possibility for this difference is that fatty acid are oxidised more efficiently
in or near adipocytes in wild type mice thus preventing them from reaching the liver,
the site of ketogenesis. If so, one might expect increased expression of enzymes of
fatty acid oxidation such as CPT-1 and ACO in adipose tissue during the
disappearance of fat (Zhou et al. 1999). Future experiments measuring the
expression of these enzymes should clarify this observation.
7.6 CONCLUSION.
To understand better the contribution of the adipose tissue to diabetes and
metabolism, it would be valuable to examine a mouse in which the adipose tissue
has been removed at defined time points in the life of the animal. Such a mouse
model would allow a functional dissection of obesity and its metabolic sequel to be
studied. These preliminary experiments showed the feasibility to genetically ablate
adipose cells in obese mice expressing the E.coli ntr gene in the adipose tissue.
Histological analysis of paraffin-embedded tissues stained with haematoxylin and
eosin provided direct evidence of the change in tissue morphology, with a more
marked effect being observed in the adipocytes of the skin. Although the magnitude
of cell ablation was not as marked as in previous experiments involving wild-type
mice, this may reflect the higher capacity of hypertrophy and hyperplasia of
adipocytes observed in the obesity condition.
A decrease in the levels of glucose and insulin was observed in transgenic
mice treated with the prodrug, which could suggest an improvement in the glucose
homeostasis and hence in the diabetes of these mice. Nevertheless, a similar effect
observed in control mice, due presumably to starvation caused by a decreased in the
temperature of the room spoils any comparison with these mice and preclude any
reliable conclusion. That the effect in transgenic mice was the direct result of the
reduction of adipose tissue mass will remain to be determined.
A decreased in the steatosis was also observed in some transgenic mice after
treatment with the prodrug. That this effect corresponds to a direct result of the
decrease in the adipose tissue or an indirect effect of the prodrug, reducing the food
intake of these animals, also remains to be determined. As well is yet to be
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demonstrated whether reducing the fat content of obese mice would lead to a
reestablishment of the metabolic parameters and disappearance of some of the
morbidity consequences of obesity. Nevertheless, these preliminary results




8. ALTERNATIVE SYSTEM OF CELL ABLATION MEDIATED BY RAIDD.
8.1 BACKGROUND.
Control of cell number depends primarily on the balance between processes
of proliferation and apoptosis. In mammals, apoptosis begins at the blastula stage
and continues throughout life and can be as equal important in controlling cell
numbers, as is cell proliferation. The RAIDD/CRADD gene, a protein that serves as
an adapter for death proteases in the apoptotic signalling pathway, was recently
isolated (Horvat and Medrano, 1998) as a potential candidate for the hg (high
growth) gene in the mouse. The hg gene was identified in a selection experiment for
rapid growth. It produces a 30-50% increase in weight gain of homozygous
individuals without resulting in obesity. The human death adapter molecule
RAIDD/CRADD, which share very high homology with the mouse, was recently
tested in MCF-7 cell lines (a human breast carcinoma cell) to address the function of
RAIDD in apoptosis. MCF-7 cells transiently transfected with a RAIDD construct
underwent apoptosis, which was inhibited by the inclusion of several known
inhibitors of apoptosis, thus confirming the role of this gene in the apoptotic
pathway (Duan and Dixit, 1997). RAIDD (RIP-associated ICH-1 homologous
protein with a death domain) is an adapter molecule that contains an amino-terminal
CARD (Caspase Recruitment Domain) region and a carboxy-terminal "death
domain". It mediates the action of cystein proteases involved in the apoptosis
pathway (Duan and Dixit 1997). The carboxy-terminal domain combines with the
homologous death domain region in RIP, a serine/threonine kinase component of the
TNFRI signaling complex, and the Caspase-2 (ICH-1) molecule associates with the
homologous amino-region ofRAIDD (Cohen G, 1997).
This chapter describes preliminary experiments carried out with a
preadipocyte cell line (3T3L1) overexpressing the murine RAIDD cDNA in an
attempt to test the feasibility of the RAIDD-mediated ablation in these cells. A range
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of phenotypes was observed after a number of individual clones transfected with the
RAIDD cDNA were exposed to the cocktail of hormones that induce the conversion
of these cells into adipocytes.
The most consistent effect was a complete blockage of the differentiation of
these cells into adipocytes, which was observed with a number of independently
isolated clones. This effect was judged by the absence of lipid accumulation, a lack
of expression of adipocytes-specific genes and a fibroblastic morphological
appearance. Others clones showed impaired differentiation, as judged by the partial
accumulation of lipid and the death of differentiated adipocytes that escaped the
initial blockage. A possible mechanism for this RAIDD-mediated effect is
discussed.
8.2 TRANSGENE CONSTRUCTS.
8.2.1 GENERATION OF THE aP2-pA CONSTRUCT.
Figure 8.1 corresponds to a diagram that summarises the two cloning steps
used to generate the aP2-driven RAIDD plasmid. In the first step, a 0.85 kb
fragment containing the pA signal from SV40 was excised from the pA plasmid
(kindly provided by Dr. Wei Cui) by double digestion with Sma \/Not I and gel
purified ligated to the aP2 Promoter plasmid also digested with Sma I/Not I. For the
confirmation of the appropriate clone, minipreps were made of DNA from several
colonies and the aP2-pA fragment liberated from the backbone vector by double
digestion Sal I/Not I. In this way, two bands were expected for those clones that had
incorporated the pA fragment, a 6.25 kb band containing the aP2 plus pA fragments
and a 2.9 kb band corresponding to the backbone vector (Figure 8.2 B).
8.2.2 GENERATION OF THE aP2-RAIDD-pA CONSTRUCT.
The second step of this cloning (Figure 8.1 B) consisted in the incorporation
of a 0.88 kb fragment of the RAIDD cDNA. This fragment was excised from the
plasmid pB308 (kindly provided by Dr. Simon Horvat) by double digestion with
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Sma l/Cla I (Figure 8.3 A) replacing the pA signal for that of SV40, which has been
observed to work well in our lab and end filled ligated into the unique Sma I (CIP
treated) site of the newly generated aP2-pA plasmid. Confirmation of the
appropriate integration of this DNA came from minipreps of DNA from colonies
digested with Sal I/Not I. In this way, two bands were expected for those clones that
had incorporated the RAIDD fragment, a 7.1 kb band corresponding to the aP2-
RAIDD-pA fragment and a 2.9 kb band of the backbone vector (Figure 8.3 B).
Further analysis was necessary to confirm for the right orientation of the RAIDD
fragment, which had been incorporated as a blunt end. Confirmation of the right
orientation came from a series of restriction digest of 5 clones that were chosen at
random from Figure 8.3 B. Digestion of these clones with Sma 1/EcoR I would have
generated three fragments of 1.7 kb, 3.7 kb and 4.69 kb if RAIDD was in the right
orientation (see lanes 12 and 14 in Figure 8.4) or three fragments of 2.58 kb, 3.7 kb
and 3.81 kb if it was in the wrong orientation. Apa I also served to look for the
appropriate orientation although due to the poor quality of the DNA (minipreps
DNA), it was not as good as with Sma 1/ Eco R I.
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Figure 8.1 Two steps strategy used to generate the aP2-RAIDD plasmid.
A) First Step: 0.85 kb fragment containing the pA signal was excised from the
plasmid pSV40-pA by double digestion with Sma I I and ligated into the aP2
promoter plasmid also digested Sma I/Not I.
B) Second Step: 0.88 kb fragment of the RAIDD cDNA was excised from the
plasmid pB308 by double digestion with Sma l/Cla I and end filled ligated into the
aP2-pA plasmid also digested Sma I.
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1) First Step: Cloning aP2-pA.
A) B)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Figure 8.2 Restriction digest of plasmids used to generate the aP2-pA plasmid.
A) Lanes 1 and 2 correspond to (j>—X 174 Hae III and A, Hind III markers,
respectively. Lane 3 corresponds to the 8.36 kb fragment of the linearised aP2
promoter plasmid digested Sma l/Not I. Lane 4 corresponds to the 0.85 kb fragment
of the SV40 plasmid digested Sma l/Not I.
B) Lane 1 corresponds to the 1 kb marker. Lanes 2-18 correspond to DNA from
different putative colonies digested Sal l/Not I. A number of clones seem to have
incorporated the pA fragment as evidenced for the 2 different bands of the expected
size (6.25 kb aP2-pA+2.9 kb plasmid band).
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2) Second Step: Cloning aP2-RAIDD-pA.
A) B)
1 2 3
Figure 8.3 Restriction digest of plasmids used to generate the aP2-RAIDD-pA.
A) Lane 1 corresponds to X Hind III marker. Lane 2 correspond to the 9.2 kb
fragment of the linearised aP2-pA plasmid (generated above) digested Sma I. Lane 3
corresponds to the 0.88 kb fragment of the B308 plasmid digested Sma l/Cla I.
B) Lanes 1 and 20 correspond to 1 kb marker. Lanes 2-19 correspond to DNA from
different putative colonies digested Sal I/Not I. A number of clones seem to have
incorporated the insert (RAIDD fragment) as evidenced for the size of the two
expected bands (7.1 kb aP2-RAIDD-pA+2.9 kb plasmid bands). Confirmation of the
orientation of the RAIDD fragment (blunt end ligated) came from the digests in
Figure 8.4.
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Figure 8.4 Restriction digest of 5 putative clones.
Lanes 1 and 18 1 kb marker. Lanes 2 and 17 X Hind III marker. Lane 3 aP2 Promoter
plasmid Sal I/Not I. Lane 4 aP2-pA plasmid Sma l/Not I. Lane 5 aP2-pA plasmid
Apa I. Lanes 6, 7, 8, 9 and 10 correspond to putative clones 2, 1,9, 10 and 12
digested Apa I, respectively. Lane 11 aP2-pA Sma l/Eco R I, lanes 12, 13,14, 15 and
16 correspond to putative clones 2, 7, 9, 10 and 12 digested Sma l/Eco R I,
respectively.
ASa E S A N
aP2 Promoter Enh. pA
Figure 8.5 Restriction map of the paP2-RAIDD plasmid.
A=Apa I, Sa=Sal I, E=EcoR I, S=Sma I, N—Not I.
Sma I digest: 10.09 kb
Sal I digest: 10.09 kb
Not I digest: 10.09 kb
Sma VEcoR I 1.7 kb + 3.7 kb + 4.69 kb
Apa I digest: 4.04 kb + 6.04 kb
aP2 Promoter: 5.4 kb, RAIDD: 0.88 kb pA: 0.85 kb and backbone plasmid 2.96 kb
(pSK II).
Also in Figure 8.4 lanes 3, 4, 5 and 11 correspond to control digestions. Thus, in
lane 3 Sal l/Not I digest 5.4 kb and 2.96 kb bands in aP2 Promoter plasmid. Lane 4
Sma l/Not I digest 0.85 kb and 8.36 kb bands in aP2-pA plasmid. Lane 5 Apa I
digests 9.21 kb in aP2-pA plasmid and lanell Sma l/Eco R I digest 1.7 kb, 3.7 kb
and 3.81 kb bands in aP2-pA plasmid.
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8.3 OVEREXPRESSION OF MURINE RAIDD cDNA BLOCKS
DIFFERENTIATION OF TRANSFECTED 3T3L1 CELLS INTO
ADIPOCYTES.
Microscopic examination showed that when 3T3L1 cells are induced to
differentiate in the presence of agents that promotes differentiation (dexamethasone,
insulin, methylisobutylxanthine) these cells undergo a dramatic morphological
change that ends with the massive accumulation of cytosolic triglycerides (Figure
3.1 in chapter 3 and Figure 8.6 E below). In marked contrast, different clones of
3T3L1 cells stably transfected with a plasmid containing the murine RAIDD cDNA,
failed to accumulate cytosolic triglycerides when treated under identical conditions
as the parental cells. The effect on these cells was evidenced by light microscopy
(Figure 8.6) and oil Red O staining, which stains specifically the lipid droplets
(Figure 8.7). Similar results were obtained in a second transfection experiment with
4 other independent clones. This was true even when these cells were left for over 2
weeks after induction to differentiate or when induced to differentiate after 4 or 6
days postconfluence instead of 2 days recommended in the differentiation protocol
(Student et al. 1980).
Two clones of 3T3L1 cells transfected only with the backbone plasmid
containing the antibiotic resistance marker neomycin, differentiated normally (data
not shown). Furthermore, the same backbone plasmid had been used before in the
experiments described in chapter 3 where more than 12 independent clones
transfected with the NTR gene were expanded and differentiated showing no
problem in their ability to convert into adipocytes, thus arguing against an indirect
effect of the plasmid sequences in this blockage.
Other effects observed with some of the clones were a partial differentiation
into adipocytes as judged by the reduction in the accumulation of cytoplasmic
triglycerides (Figure 8.6 A), although these cells underwent a morphological change
from fibroblast-like to rounded up cells. Another clone showed a similar reduction
in the accumulation of triglycerides but partially differentiated adipocytes that have
escaped the initial blockage begun to die by a mechanism which, although was not
studied, it is believed to have corresponded to apoptosis due to the proposed role of
this gene in the apoptotic pathway (Duan and Dixit, 1997).
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Figure 8.6 Effects of the overexpression of RAIDD on the differentiation of
3T3L1 cells under optimal hormonal conditions.
Phase-contrast photomicrograph of different clones of 3T3L1 cells transfected with
RAIDD. Cells were subjected to differentiation with standard differentiation
medium as described earlier on chapter 3. Panel A shows a clone that differentiated
into adipocytes but has accumulated less triglycerides. Panels B, C, and D show
some of the clones that were completely blocked and thus, did not differentiate.
Panel E corresponds to the control parental cells. Magnification: 100X A, B, C and
E; 40X D.
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Control Clone 2 clone 6
Figure 8.7 Lipid Staining.
At 8 days following differentiation, cultures of two different clones (clones 2 and 6)
transfected with RAIDD and untransfected parental cells (control) were fixed with
10% paraformaldehyde in PBS, stained for lipid content by Oil Red O, and
photographed.
Red dish corresponds to cells that show substantive accumulation of triglycerides
indicating appropriate differentiation into adipocytes. No staining is observed in the
two clones shown in this figure.
8.4 PRELIMINARY ANALYSIS BY RT-PCR OF THE EXPRESSION OF
mRNAs FOR TARGET GENES IN THE DIFFERENTIATION OF
ADIPOCYTES.
Expression of exogenous and endogenous RAIDD and a number of genes
involved in the differentiation of 3T3L1 into adipocytes were assessed by RT-PCR
from total RNA made of 6 of these clones transfected with RAIDD after 8 days of
the induction to differentiate with the cocktail of hormones. Four of these clones did
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not differentiate into adipocytes (clones 2, 3, 5 and 6 in Figure 8.8). Two other
clones differentiated into adipocytes but they accumulated less cytosolic
triglycerides (clone 1 see Figure 8.6 A above) and/or once differentiated, adipocytes
begun to die (not shown). As control, total RNA from parental cells before
differentiation (P) and after 8 days of differentiation (A) was also included. Five pg
of total RNA (DNase-treated) was reverse transcribed as described in chapter 2, and
expression of these genes assessed by amplification of the respective cDNA using
two specific primers that were selected from the published sequence (Pub Med)
using the public domain software Primer Design.
In order to distinguish expression of exogenous from endogenous RAIDD, a
pair of primers was designed to amplify a region containing the transcribed +21 bp
sequence of the aP2 promoter (5' primer) and a reverse primer corresponding to an
internal sequence ofRAIDD (3' primer). Amplification of endogenous RAIDD with
an internal 5' primer and the reverse primer as above detects both endogenous and
exogenous RAIDD (primer sequences and PCR conditions are described in chapter
2). Thus, expression of exogenous RAIDD would yield a band of approximately 620
bp with the first set of primers and expression of both endogenous and exogenous
RAIDD would yield a band of approximately 502 bp with the second set of primers.
Figure 8.8 A confirmed expression of the exogenous RAIDD in all clones
transfected with the RAIDD cDNA. As expected, control parental cells before
differentiation (P) and after differentiation into adipocytes (A) showed no signal for
the exogenous RAIDD. Analysis with the set of primers that detects the endogenous
and exogenous RAIDD shows lower expression of some clones, which might simply
indicate lower yield of the transcription from total RNA to cDNA (Figure 8.8 B).
This observation is further confirmed from the semi-quantitative PCR analysis
carried out with GAPDH as an internal control and endogenous/exogenous set of
primers (Figure 8.8 C).
The inability of 3T3L1 cells transfected with the murine RAIDD cDNA to
express the differentiated phenotype was further substantiated by analysing the
expression of the differentiation-specific marker adipsin. Adipsin is a serine protease
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whose cDNA was isolated by differential screening of preconfluent and
differentiated 3T3L1 cells (Cook et al. 1987). It is found in vivo in the circulation of
both animals and humans and is produced and secreted in vitro by differentiated
3T3L1 cells thus, making this gene a marker for terminally differentiated
adipocytes. RT-PCR analysis carried out from total mRNA transcribed from these
clones showed a strong signal only in those clones that differentiated into adipocytes
(clones 1 and 4) and in the control parental cells (3T3L1) after differentiation into
adipocytes (A) (Figure 8.8 D). In contrast, no induction of the expression of this
gene was observed for the clones 2, 3, 5 and 6 thus confirming the block in the
differentiation of these clones.
While a number of mRNAs, whose levels increase during adipocytes
differentiation have been well characterised and their regulation has been studied in
detail, very few have been identified that are down-regulated during adipocyte
differentiation. Preadipocyte factor 1 (Pref-1) corresponds to one of such genes
whose mRNA levels decrease during adipocyte differentiation. Pref-1 was
discovered after differential hybridisation screening of preadipocytes 3T3L1 and
corresponds to a cell surface protein that appears to have a role in maintaining
preadipocytes in the undifferentiated state (Smas and Sul 1993).
Constitutive expression was shown to inhibit adipogenesis, confirming a
regulatory role in adipocyte differentiation (Smas et al. 1994). As Pref-1 down
regulation is required for adipocyte differentiation, this should be reflected by
increased expression of mRNA in cells or culture conditions in which adipocyte
differentiation is inhibited. In order to assess a possible involvement of Pref-1 in this
blockage an RT-PCR assay was carried out with these clones. However, after
amplification, the 449 bp fragment was seen in all samples analysed even for those
that differentiated into adipocytes including the control (Figure 8.8 E). The reason
for this might be due to the fact that after differentiation into adipocytes there is
always a population (-5-10%) of cells that do not differentiate and remain as
preadipocytes. Thus, due to the high sensitivity of the PCR reaction just a small
number of template molecules may be enough to give a positive signal. This
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problem has been observed by other groups and a purification step of differentiated
adipocytes from the remaining preadipocytes by differential centrifugation with
bromobenzene has been suggested to overcome it (Smas and Sul, 1993).
Several studies have shown that the inhibition of cell division of cultured
preadipocytes lines clearly blocks their subsequent differentiation. In order to assess
whether cell division was impaired in these clones transfected with RAIDD, it was
decided to study the proliferation rate of these cells thorough the different steps of
the differentiation program. The same number of cells from control parental 3T3L1
and one of the clones transfected with RAIDD that had shown blockage of the
differentiation were plated on 6 well dishes and the number of cells determined with
an hematocytometer at different stages of the differentiation program, including at
confluence (-2), after induction with the hormones (+2) and after 6 days of
differentiation (+6).
Figure 8.9 shows similar number of cells for both groups when they reached
confluence thus indicating no inhibition in the proliferation rate for this clone
transfected with RAIDD in the preadipocyte state. Furthermore, after induction to
differentiate with the cocktail of hormones (+2 in Figure 8.9) both groups increased
the number of cells according to the clonal expansion induced by the combination of
mitogenic and adipogenic signals provided in the differentiation medium. Finally,
after 6 days of differentiation the number of cells remained similar for both groups,
although parental 3T3L1 cells underwent conversion into adipocytes, while this
clone transfected with RAIDD remained as preadipocyte. These results suggest that
cell proliferation is not impaired in these clones transfected with RAIDD and this
should not be the cause of the blockage of these cells to differentiate.
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Figure 8.8 Expression of various mRNAs from cells transfected with the
murine RAIDD cDNA.
5 pg of total RNA was DNAse treated, reverse transcribed with oligo (dT)12-18 mer
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Figure 8.9 Cell number quantitation at different points of the differentiation
program.
Cell number of the parental cells (3T3L1) and one of the clones transfected with
RAIDD (clone 6) were counted at different points of the differentiation program
including at confluence (-2) after hormonal induction (+2) and after 6 days of
differentiation (+6).
Each bar represents the mean ± SD of duplicates.
These studies allowed to conclude that adipogenesis as measured by i) lipid
accumulation, ii) cell morphology, and iii) induction of adipocytes-specific marker
proteins is severely inhibited in those clones transfected with RAIDD. These
findings indicate that an overexpression of RAIDD during adipocyte differentiation
is sufficient to fully inhibit 3T3L1 differentiation. Enforced expression of RAIDD
could block cell differentiation by perturbing one or several events that are important
steps leading to the terminally differentiated state.
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8.5 REGULATION OF TRANSCRIPTION FACTORS C/EBPa AND C/EBP(3
EXPRESSION DURING ADIPOCYTE DIFFERENTIATION OF CLONES
TRANSFECTED WITH THE MURINE RAIDD cDNA.
Adipocyte growth and differentiation follow patterns of sequential B-ZIP
protein expression, including AP-1 (Distel et al. 1987) and C/EBP family proteins
(McKnight et al. 1989). C/EBPa is the first member of the C/EBP family discovered
(Birkenmeier et al. 1989). It is expressed at high levels in both white and brown
adipose tissue of rodents and accumulates during adipocyte differentiation with a
temporal pattern similar to the acquisition of the differentiated phenotype. C/EBPa
is expressed just before the activation of several adipocytes specific genes, a number
of which contain C/EBP binding sites in their promoter (Herrera et al. 1989). Some
of these genes include glycerophosphate dehydrogenase, fatty acid synthase, acetyl
CoA carboxylase, Glut 4, insulin receptor and aP2, the adipocyte-selective fatty acid
binding protein (Spiegelman et al. 1993). Definitive proof that C/EBPa is required
for adipocyte differentiation came from the demonstration that antisense inhibition
of C/EBPa inhibited the terminal differentiation of 3T3L1 cells (Lin and Lane,
1992). Consistent with this finding, knockout mice lacking C/EBPa die shortly
after birth with no discernible development of white adipose tissue (Wang et al.
1995). Another possible function suggested for C/EBPa in the differentiation is
maintenance of the differentiated state through autoactivation of its own gene whose
promoter contains C/EBP binding sites (Lin et al. 1993).
Another C/EBP gene (C/EBPP) which, was discovered later than the
C/EBPa (Cao et al. 1991), functions prior to C/EBPa as transcriptional activator
and it is transiently induced by hormones such as cAMP or agents that increased its
levels as methylisobutylxanthine used in the differentiation program, though the
induction by these external hormones is just transient since expression is also
observed in actively dividing preadipocytes (Cao et al. 1991). The double knockout
of C/EBPP and C/EBP5, another member the C/EBP family also results in reduced
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fat mass (Tanaka et al. 1997), all this suggesting that C/EBP family proteins are
crucial factors in fat development.
Having established an initial characterization of the blockage in
differentiation of clones of 3T3L1 transfected with RAIDD, it was decided to study
in more detail the levels of expression by Northern blot of some of these crucial
transcription factors involved in the differentiation of 3T3L1 into adipocytes. It was
thought that RAIDD might be interfering in the normal expression of these
transcription factors thus precluding these cells from differentiating. 3T3L1
preadipocytes were induced to differentiate by using previously established methods
as described in chapter 2 and above (Student et al. 1980). Cells were grown to
confluence in growth medium containing calf serum and after two days
postconfluence shifted to differentiation medium containing 10% fetal calf serum,
insulin, dexamethasone and methylisobutylxanthine. Two days later, dexamethasone
and methylisobutylxanthine were removed. The progress of the differentiation was
monitored by measuring the accumulation of RNA encoding for the adipocyte-
specific protein aP2 (Bernlohr et al. 1984). Total RNA was harvested from cells
immediately before and at intervals after the addition of the differentiation medium.
The Northern blot in Figure 8.11 shows that expression of the mRNA
encoding fatty acid binding-protein aP2 was first detectable at low levels after the
induction to differentiate (day 3) and rose to maximal levels by day 8 in the control
cells but failed to appear in the other two clones. Only clone 6 showed a very low
signal after 8 days of differentiation thus confirming the failure of these cells to fully
express the differentiation markers and to accumulate triglycerides. Expression of
aP2 was accompanied by changes in cell morphology of the controls that included
the accumulation of triglycerides droplets in the cytoplasm of the cells (not shown).
This effect was not observed in any of the two clones analysed in this experiment.
The RNA samples collected before and during differentiation were also
hybridised with radioactively labeled cDNA fragments (purchased from the UK
HGMP Resource Centre) corresponding to C/EBPa and C/EBPP genes. Consistent
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with earlier studies (Birkenmeier et al. 1989), the mRNA encoding for C/EBPa was
not detected previous to the differentiation and was first detected at low levels on
day 2 and increased at day 8 in the control cells. However, no signal was observed
in any of the stages for the two clones analysed. The mRNA encoding for C/EBPp
on the other hand, was detectable in all undifferentiated cells and remained
detectable during the latter half of the differentiation program consistent with earlier
studies carried out by Cao et al. (1991). These findings strongly suggest that the
blockage in the differentiation of these clones correlates with the inappropriate
expression of the transcription factor C/EBPa.
Induction of C/EBPp and C/EBP5 expression is thought to be necessary for
the subsequent induction of C/EBPa and PPARy2, which in turn act to coordinate
the expression of a number of fat specific genes required for lipid metabolism,
including aP2, SCD1, and Glut 4. In marked contrast to C/EBPp, the expression of
C/EBPa was undetectable in the two clones analysed but was detectable in the
control cells. These results confirm the important role of C/EBPa in lipogenesis.
Furthermore, the expression of the adipocyte specific marker aP2 was severely
inhibited or undetectable in these clones thus demonstrating an impaired expression
of the transactivating protein C/EBPa.
These observations provide a molecular mechanism for the inability of the
cells transfected with RAIDD to accumulate cytoplasmic triglycerides and to
differentiate into adipocytes. Figure 8.10 below shows a summary of the stages
where RAIDD might be interfering in the appropriate differentiation of these clones.
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Figure 8.10 Model of RAIDD inhibitory effect in the adipocyte developmental
program.
RAIDD inhibitory effect is specifically in the terminal stages of the differentiation.
RAIDD may interfere with the activation of C/EBPa by inhibiting the
transactivation function of C/EBPp (or C/EBP5) or competing with the C/EBP









Figure 8.11 Northern analysis to assess the expression of crucial transcription
factors in the differentiation program of 3T3L1 cells.
10 pg of total RNA from two clones transfected with RAIDD and the parental cells
3T3L1 after different days of the differentiation program were run on a denaturing
agarose gel and Northern blot hybridised with probes: aP2, C/EBPa, C/EBPp and
7S as loading control.
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8.6 CONCLUSION.
Differentiation of 3T31 cells transfected with the murine RAIDD cDNA
resulted in a range of phenotypes from which the most surprising was a complete
blockage of these cells to differentiate into adipocytes, after exposure to the cocktail
of hormones/inducers. Other clones showed a partial accumulation of triglycerides
or differentiated adipocytes that escaped the blockage begun to die. These findings
suggest a possible dose response effect of the expression of RAIDD during
differentiation of these cells. A possible scenario for these effects would be that
higher levels of expression ofRAIDD early in the differentiation would result in the
blockage of these cells to differentiate. On the other hand, lower levels of expression
early in the differentiation would allow these cells to proceed normally through the
differentiation program but once aP2 promoter reaches its maximum activity (after
10 days of the differentiation, see Figure 3.10 in chapter 3) higher levels ofRAIDD
expressed from this promoter would render these cells susceptible to the RAIDD-
mediated ablation. Although the aP2 promoter does not support expression in
preadipocytes (Figure 3.10 in chapter 3), and its maximum activity is reached only
after ~10 days of the differentiation program, one might expect certain variation in
the developmental expression of a transgene driven by this promoter, if the
transgene is inserted in a site in the chromosome which is more permissible for its
expression. Furthermore, Lin and Lane (unpublished observations) have observed an
extremely low level of aP2 mRNA by RNase protection analysis in confluent, but
not proliferating, 3T3L1 preadipocytes before differentiation, thus confirming that
expression from this promoter can be observed earlier in the differentiation program
of these cells even before transactivation from C/EBPa.
Enforced expression of RAIDD could block cell differentiation by perturbing
one or several events that are important steps leading to the terminally differentiated
state. One can speculate on both positive (stimulation of anti-differentiation genes)
and negative (interference with expression of differentiation genes) mechanisms. By
analysing patterns of gene expression characteristic of each phase of the
differentiation program, it was determined that the RAIDD-mediated block in
differentiation of 3T3L1 is manifested during the terminal stages of the
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differentiation at least in those clones that failed to differentiate, since it was
excluded the alteration in the expression of the early stage gene C/EBPp. The more
likely scenario is that a decrease in the expression ofprodifferentiation proteins such
as C/EBPa and possibly PPARy (not analysed) prevent transactivation of the down
regulated adipocyte specific genes. Consistent with this view are the experiments
that demonstrated inhibition of the differentiation of 3T3L1 with anti sense
C/EBPa (Line and Lane, 1992). Since C/EBPa and PPARy2 are thought to act in
concert to induce expression of genes such as aP2, SCD1 which are required for
lipid metabolism, these results provide a molecular mechanism for the inability of
these cells transfected with RAIDD to accumulate triglycerides.
While these studies (may) define a specific point at which RAIDD represses
adipogenesis, they do not in themselves provide any mechanistic explanation of how
this happens. Since RAIDD function is primarily believed as an adapter in the
apoptotic-signalling pathway, it is possible that RAIDD differentiation block occurs
indirectly acting in a negative manner to block the transcription of one or more of
these masters genes as the results already shown suggest.
Whatever the mechanism underlying the blockage effect mediated by
RAIDD, the results presented here encourage further studies especially in a mouse
model overexpressing RAIDD in the adipose tissue. One might speculate that no
matter the result (adipocyte blockage or adipocyte death) the potential mouse model
that could be generated may provide an alternative system to ablate adipocytes and a
novel model where to study fat metabolism and the contribution of adipose tissue to
the pathogenesis of obesity and diabetes. Alternatively, this system could also
provide a new approach to the ablation of other cell types, thus allowing the creation




Adipocytes play a central role in maintaining energy balance in animals,
storing energy in the form of triglycerides in periods of nutritional abundance and
releasing it in a metabolically useful form at times of nutritional deprivation. The
inability of investigators to direct expression specifically to adipose tissue was a
major problem in the use of transgenic technology to study this tissue. The
discovery of a regulatory element (Ross et al. 1990) that can direct tissue specific
expression to adipocytes has opened up the possibility of experiments to regulating
the fatness of laboratory and domestic animals and the study of the metabolism and
physiology of this tissue. Some of these studies have included the delivery of toxic
genes to the adipose tissue (Ross et al. 1993, Burant et al. 1997), expression of
transgenes that can alter the amount or distribution of body fat by influencing energy
balance, or disrupting adipocyte differentiation or proliferation (Soloveva et al.
1997, Moitra et al. 1998, Shimomura et al. 1998) and finally the delivery of
transgenes that are non-toxic themselves but that can be activated by the
downstream administration of a substance (prodrug) that make them capable of
selective cell killing once they are activated as it is the NTR/CB1954 system (Clark
et al. 1997) that was used in this research project.
In the experiments more relevant to this thesis, the aP2 promoter/enhancer
was used to drive the expression of the Diphtheria toxin A chain to the adipose
tissue. High levels of expression caused neonatal death, while lower levels produced
loss of fat in aging mice and a resistance to diet induced obesity (Ross et al. 1993;
Burant et al. 1997). These results suggested that white adipose tissue was an
essential organ for life since no mouse model from either knockout or transgenic
technology had been created that was devoid of fat throughout development.
Nevertheless, two teams that used the same tissue-specific promoter recently
challenged this view creating WAT-free laboratory mice. While Shimomura et al.
(1998) directed adipocyte specific expression of a truncated form of SREBPlc, a
transcription factor involved in biosynthesis of both cholesterol and fatty acids,
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Moitra et al. (1998) on the other hand, utilised a truncated dominant negative
transcription factor that would bind and inhibits the function of transcription factors
that are critical for fat development. The resulting transgenic mice were remarkably
similar, WAT-free, profoundly insulin resistant, and markedly diabetic. This came
as a surprise since the general perception was that diabetes was a disease of the
obese. As important as these results are they fail in one simplistic but important
thing which is that they do not have the control over the ablation of the adipose
tissue, something that would be possible with an inducible system such as the
NTR/CB1954 used in this thesis. Experiments in transgenic animals using other
gene suicide systems have shown that targeted ablation of specific cell types in the
context of the whole animal can be a powerful tool for the study of organ
development and function and for the generation of transgenic models of human
diseases (Palmiter et al. 1987; Behringer et al. 1988; Bernstein and Breitman, 1989).
One potential problem associated with the use of some of these suicide
systems such as Diphtheria toxin A, or Ricin A derives from its extreme
cytotoxicity. Although this ensures that cells expressing low levels in a targeted cell
population will be killed, it also means that any leakiness from the transcriptional
regulatory elements that may result in ectopic expression of the toxin could lead to
embryo lethality or deleterious effects that could compromise the analysis of the
resulting transgenic animal. Ectopic expression of the targeting promoter sequences
could pose a major problem, especially if exacerbated by chromosomal position
effects, which are known to results in variable levels of expression among randomly
integrated transgenes (Palmiter and Brinster, 1986; Dobie et al. 1996). Therefore,
inducible ablation with NTR/CB1954 system affords the practical advantage of
allowing stable pedigrees to be established before the initiation of the ablation
studies. It also provides the means to control the timing and duration of toxic insult
and to assess the potential for recovery of an ablated cell population after a prodrug
free period in the transgenic animal.
When compared with other inducible systems such as tk/GCV, NTR/CB1954
still provides some important advantages that make this system a good alternative
for the ablation of specific cell populations in a transgenic model. While conditional
ablation with tk gene is likely to be effective only in proliferating cells, as cell
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killing is mediated through inhibition of DNA synthesis (Borrely et al. 1989) many
potential target cell populations, such as non-cycling stem cells and terminally
differentiated cell types such as adipocytes or neurons cells are likely to be
refractory to the toxic effects of the administered drug, despite significant
expression of the herpes tk gene. In addition to this, CB1954 readily crosses the
blood-brain barrier thus making feasible to target specific cell types within the
central nervous system (CNS). Furthermore, CB1954 is readily administered by
intraperitoneal injection whereas most ablation studies using tk/GCV have used
minipumps.
The work presented in this thesis was undertaken as a first step to assess the
susceptibility of non-dividing cells, such as adipocytes, to the ablation by this novel
approach NTR/CB1954 in the intact animal. To target the expression of the E.coli
nitroreductase gene into the adipose tissue, regulatory elements from the adipocyte-
specific lipid biding protein gene (aP2) were used (Ross et al. 1990). Preliminary
experiments in cells showed that this 5.4 kb fragment targets expression of linked
genes in a developmental manner similar to endogenous aP2. Activation of the
transgene by this promoter sequence indicated that E.coli NTR is not detrimental for
the survival of the cells and more importantly for an appropriate differentiation of
these cells into adipocytes. In the same way, no side effects associated with carrying
or expressing the NTR transgene were observed in those lines of transgenic mice
generated by microinjection and both sexes were fully fertile. This data confirmed
that the sequences of the aP2 promoter used contain all the necessary elements to
drive relatively strong levels of expression both in vitro and in vivo. The
demonstration of the appropriate translation of this prokaryotic protein confirmed
that eukaryotic cells (adipocytes) have no major problems in expressing this E.coli
NTR sequence.
When differentiated adipocytes were challenged to CB1954, specific killing
of nitroreductase expressing cells was observed. The degree of cytotoxicity
correlated with the level of nitroreductase activity in these cells, presumably due to a
more efficient conversion of the prodrug to the active metabolites, in agreement with
previous work in murine fibroblast and other human tumour cell lines (Bridgewater
et al. 1995; Green et al. 1997; McNeish et al. 1998). In the same way, low
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concentration of the prodrug rendered these cells more resistant to the killing,
requiring longer exposure times to achieve a similar toxic effect. Presumably at
lower concentrations the cells are still capable of repairing the DNA adducts formed
as a result of the bioactivation of the prodrug and over certain concentration they are
no longer capable of doing so. As a consequence of these lesions in the DNA, it has
been proposed that a self-destructive mechanism known as apoptosis is activated in
these cells. Experiments described in chapter 3 clearly confirmed that adipocytes
stably expressing the ntr gene die, after administration of CB1954, by this
mechanism of apoptosis. Both morphological and cellular data are consistent with
this observation. TdT-mediated dUTP nick end labeling (Tunel) showed specific
staining indicative of apoptosis-mediated DNA strand breaks in cells expressing
NTR treated with the prodrug. Furthermore, DNA fragmentation and morphological
analysis confirmed the apoptosis-mediated cell death.
Treatment of transgenic mice with the prodrug also showed specific killing
of adipocytes whereas other tissues were normal and comparable with non-
transgenic treated or untreated control mice, confirming the efficacy of this system
to kill terminally differentiated (non-dividing) cells in an animal model.
Furthermore, histological analysis of these mice showed that ablation of adipocytes
was not restricted to an specific fat pad since all major adipose deposits analysed
showed reduction or disappearance of adipose cells. As in the in vitro studies, the
magnitude of cell ablation was directly correlated to the dose of CB1954 used with a
much stronger effect at doses of 40 mg/kg of body weight. This higher dose resulted
in the complete disappearance of any visible adipose deposits in some transgenic
mice, thus suggesting that a bystander effect may have occurred in vivo, since
immunohistochemical analysis of sections of adipose tissue confirmed variegated
transgene expression in these cells.
Variegated transgene expression is a common problem in transgenesis. This
phenomenon results in patchy expression, frequently observed as cluster of
expressing cells next to clusters of non-expressing cells. The reason for this is not
clear but it has been suggested that the chromosomal site of transgene integration
and the transgene copy number may be responsible (Dobie et al. 1996). Thus,
transgenes inserted close to the centromere are more prone to random inactivation.
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This has been observed with many transgenes and it would appear that adipose
tissue is particularly prone to variegated expression since both lines analysed in this
thesis (lines 30 and 87) showed this problem. This mosaic expression was shown to
have important implications in the proposed ablation experiments, since it prevented
the ablation of 100% of adipocytes and resulted in a variable number of remaining
cells in this tissue. Nevertheless, complete disappearance of any visible fat pad
could also be observed in some experiments especially with higher doses of the
prodrug, which suggests that in vivo bystander effect of the prodrug may have
occurred.
A number of studies attempting gene delivery to tumours has shown that an
important proportion of cells remain unmodified (Ram et al. 1993). Gene delivery is
probably limited both by the efficiency of various current gene delivery technologies
and by restricted access to some tumour regions. Thus, a desirable feature of
enzyme/prodrug combinations for use in gene directed enzyme prodrug therapies
(GDEPT) is that the killing of modified cells result in the killing of adjacent
unmodified cells. This bystander effect, originally described with tk!GCV system
(Freeman et al. 1993), had been previously observed with the NTR/CB1954 by
some authors (Knox et al. 1988; Bridgewater et al. 1995), although the same effect
could not be observed by others (Clark et al. 1997). Here, in vitro studies clearly
confirmed this bystander effect of CB1954 in adipocytes and it was demonstrated
that this effect is due to a toxic metabolite of CB1954. A similar bystander effect
could be suggested to occur in vivo. The fact that this bystander effect has not been
always observed with this system can be attributed to the intrinsic resistance of some
cells to the prodrug or the lack of intimate cellular contact between nitroreductase
expressing and non-expressing cells. The short half-life of the active metabolites is
another possibility. This bystander effect is especially useful in gene addition
experiments involving the use of toxigenes, such as the experiments described in
this thesis, where the effects of variegated expression might silence the expression
of the transgenes. Therefore, this bystander effect will enable the killing of
surrounding silenced cells. On the other hand, the lack of a bystander effect, as
observed in other studies should also encourage the belief that the ablation of
specific cells in tissues such as pituitary, pancreas, CNS and immune system, which
189
comprise more than one cell type in close association, can be accomplished with this
approach. This would allow cell-lineage studies to unravel the developmental
relationships between different cells in a tissue. Clearly what may be a desirable
attribute in one set of circumstances need not be so desirable under other
circumstances. Thus in cell-lineage studies the aim might be to minimise the
bystander effect whereas in tumour destruction the aim would be to maximise the
response.
The lack of adipocytes led to dramatic consequences in some transgenic mice
especially in their ability to thermoregulate their body temperature. More extreme
cases included the death of some mice confirming the importance of the adipose
tissue for the normal development of life. Treatment of transgenic mice with a lower
dose of CB1954 results in a partial reduction of the adipose tissue leaving remaining
cells that do not express the transgene and thus escape the ablation with the prodrug.
These mice show no problems to thermoregulate body temperature and therefore can
be used for studies related to the consequences of fat ablation. One of these studies
assessed the ability of this tissue to regenerate after a prodrug free period. This
observation is based on the analyses of the total body lipid content in the carcasses
of these mice and the measurements of the wet weight of the gonadal fat pads, both
of which showed compensatory growth after a prodrug free period. Interestingly, it
was found that the compensatory growth of the adipose tissue did not include newly
formed transgenic cells. The reason for this is not clear but a possible scenario might
be that preadipocytes or stem cells die as result of a bystander effect. It is believed
that the mechanism of regeneration of the adipose tissue might involve hyperplasia
and/or hypertrophy of the remaining cells. This observation is based on
circumstantial evidence from immunohistochemistry analyses that showed a number
of small adipocytes growing alongside the much larger mature fat cells.
Confirmation of this should come from analysis of the number and size of these cells
in each of the fat pads.
Partial reduction of adipocytes caused no major physiological consequence,
with blood glucose, and plasma triglycerides, FFA and p-hydroxybutyrate levels
remaining normal or at levels comparable to the control groups. Nevertheless,
analysis of leptin showed that this hormone decreased significantly after ablation of
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adipose tissue thus, corroborating the proposed role of this hormone as an adiposity
indicator, the levels ofwhich return to normal after a recovery period of 30 days.
It is necessary to stress that a different situation might have been expected
with complete penetrance of the transgene i.e. if 100% of the cells had expressed the
transgene. In such situation one might expect that treatment with the prodrug should
enable the killing of nearly all adipocytes in the fat pad the consequences of which
could be as dramatic as those observed in clinical patients suffering of the genetic
condition known as lipoatrophic diabetes. Similar effects to those observed in these
patients were observed in two mouse models devoid of adipose tissue (Shimomura
et al. 1998, Moitra et al. 1998). Despite the lack of fat, these mice developed
diabetes, a condition normally associated with excess rather than a decrease in the
adipose tissue.
It would be interesting to test the effect of the prodrug in the other transgenic
lines that were generated. It is possible that these lines have a more uniform
expression in the adipose tissue. Immunohistochemical analysis should clarify this.
Alternatively, the creation of transgenic mice expressing the NTR by means of gene
targeting in ES cells might provide a better option to ensure the incorporation of
single copies of the transgene in a permissible site in the chromosome, which might
be less prone to effects of variegated transgene expression.
The inducible ablation of adipocytes in this transgenic model should provide
unique opportunities to study the effects of decreasing the number of adipocytes at
different stages of the mouse development including juvenile, adult and in
pathological conditions such as obesity, thus allowing the investigation of the
interrelationship between excessive adipose tissue mass and the associated disorders
(diabetes, hypertension, hyperlipidemia) through manipulation of the target cell
population. It is precisely obesity one of the diseases that could be best approached
with this model. The phenotype of the obese mice is consistent with the hypothesis
that metabolic abnormalities in diabetes are the result of an excess of adipose mass.
Although the preliminary experiments shown in chapter 7 are not very informative
with respect to the real potential of this approach, these must be taken as the starting
point for future experiments in this field. Conditional ablation in this model would
allow the removal of adipocytes before the symptoms of diabetes are manifested,
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therefore making it possible to assess the link between the excess of adipose tissue
and the associated disorders. To avoid long breeding generations with the obese
mice, and to avoid the effects of the different genetic background it would be
possible to induce obesity by overfeeding one of the wild-type mouse expressing the
NTR in the adipose tissue. Alternatively, obesity could be induced by chemical
damage in the hypothalamus (Bray and York, 1979, Ross et al. 1993) such as with
the administration of monosodium glutamate at birth in one of these transgenic
mice. More straightforward questions that could be answered with this model
include the link between infertility and excess of adipose tissue. A number of studies
have shown that reduction of adipose tissue mass restore fertility (Ross et al. 1993),
therefore it would appear that infertility in obese mice results from an excess of
adipose tissue. It has been suggested that this could be the result of exogenous
steroid production by adipose tissue, resulting in high estrogens or androgen levels
(Foster DW, 1985). Although it has been shown that leptin treatment, but not food
restriction, can rescue the infertility of ob/ob mice, it would be interesting to assess
whether reducing the adipose tissue would also restore the fertility of these mice.
To further expand the wide spectrum of applications of this inducible system
of NTR/CB1954, in utero ablation experiments were carried out to assess the
feasibility of the prodrug to cross the transplacental membrane. Experiments shown
in chapter 7 confirmed the ability of CB1954 to cross the transplacental barrier and
more importantly to induce ablation of nitroreductase expressing cells in the
developing pups. CB1954 produced a decreased in the number of transgenic pups
generated, which suggests a direct effect of the prodrug in those mice expressing the
NTR in the brown adipose tissue. Although is not clear whether transgenic offspring
died because of their inability to thermoregulate, two transgenic pups that survived
showed a large reduction in the size of the brown adipose tissue. It has been long
ago suggested that increased BAT thermogenic activity could prevent obesity when
a high caloric diet is given to mice and rats (Rotwell and Stock, 1979). Although this
hypothesis was based only in circumstantial evidence, it was not until Lowell et al.
(1993) created transgenic mice that became obese because of a large reduction in
brown adipose tissue, that this hypothesis was proved right. The possibility to ablate
brown adipose tissue with NTR/CB1954 could then provide an alternative model
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where to study the consequences of the ablation of this tissue. These experiments
encourage the belief that ablation of embryonic cells and other fetal cells can be
accomplished with this approach, which expand substantially the spectrum of
opportunities of this system.
Finally, the last chapter of this thesis described the preliminary experiments
carried out with a preadipocyte cell line (3T3L1) overexpressing the murine RAIDD
cDNA in an attempt to test the feasibility of the RAIDD-mediated ablation in these
cells. A range of phenotypes was observed in clones exposed to the cocktail of
hormones that induce the conversion of these cells into adipocytes. The most
notorious effect was a complete blockage of the differentiation of these cells into
adipocytes. Enforced expression of RAIDD could block cell differentiation by
perturbing one or several events that are important steps leading to the terminally
differentiated state. One can speculate on both positive (stimulation of anti-
differentiation genes) and negative (interference with expression of differentiation
genes) mechanisms. Since RAIDD function is primarily believed to be an adapter in
the apoptotic-signalling pathway, it is possible that the RAIDD differentiation block
occurs indirectly, acting in a negative manner to block the transcription of one or
more of these masters genes. Whatever the mechanism underlying the blockage
effect mediated by RAIDD, these results encourage the belief that it would be
possible to use this system as a novel approach to reduce adiposity in mice. One can
speculate that no matter the result (adipocyte blockage or adipocyte death) the
potential mouse model that could be generated would provide an alternative system
where to study fat metabolism and the contribution of adipose tissue to the
pathogenesis of obesity and diabetes.
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